首页 » 细胞株Cell Lines 52-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 52-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV52
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   M080904B

AC   CVCL_AT54

RX   PubMed=24581590;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AT53 ! M080904

CA   Cancer cell line

//

ID   M081008

AC   CVCL_AT64

RX   PubMed=22336146;

CC   From: URPP biobank; University of Zurich; Switzerland.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M081021

AC   CVCL_AT55

RX   PubMed=24581590;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M081028

AC   CVCL_AT56

RX   PubMed=24581590;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M1

AC   CVCL_2107

SY   M 1; M-1 myeloid leukemia

DR   BTO; BTO:0002037

DR   CLO; CLO_0007437

DR   CLO; CLO_0007448

DR   CLO; CLO_0050175

DR   CLDB; cl3308

DR   CLDB; cl3309

DR   CLDB; cl5166

DR   ATCC; TIB-192

DR   DSMZ; ACC-331

DR   ECACC; 91110711

DR   ECACC; 93120826

DR   IFO; IFO50006

DR   IZSLER; BS TCL 71

DR   KCLB; 40192

DR   RCB; RCB0169

DR   TOKU-E; 2269

RX   PubMed=4187945;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=M1

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

CC   Doubling time: ~25-50 hours (DSMZ).

CC   Breed/subspecies: SL.

DI   NCIt; C21889; Mouse myeloid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   M1-4HSC

AC   CVCL_M114

DR   BTO; BTO:0003531

RX   PubMed=15878400;

RX   PubMed=17760834;

CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   M1-T22

AC   CVCL_8368

SY   M1 clone T22

DR   JCRB; JCRB0110

CC   Breed/subspecies: SL.

DI   NCIt; C21889; Mouse myeloid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2107 ! M1

CA   Cancer cell line

//

ID   M1.4

AC   CVCL_9203

DR   CLO; CLO_0007450

DR   ATCC; CRL-2464

RX   PubMed=9609824;

CC   Monoclonal antibody target: UniProtKB; Q62005; Mouse Zp1.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   M1/22.25.8.HL

AC   CVCL_9204

SY   M1 clone 22.25

DR   CLO; CLO_0007451

DR   ATCC; TIB-121

RX   PubMed=81133;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1/42.3.9.8.HLK

AC   CVCL_9205

DR   CLO; CLO_0007452

DR   ATCC; TIB-126

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1/69.16.11.HL

AC   CVCL_9206

SY   M1 clone 69.16

DR   CLO; CLO_0007453

DR   ATCC; TIB-125

RX   PubMed=81133;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1/70.15.11.5.HL

AC   CVCL_9207

SY   M1 clone 70.15

DR   CLO; CLO_0007454

DR   ATCC; TIB-128

DR   BCRJ; 0152

RX   PubMed=81133;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1/75.16.4.HLK

AC   CVCL_9208

DR   CLO; CLO_0007455

DR   ATCC; TIB-127

CC   Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1/87.27.7.HLK

AC   CVCL_9209

SY   M1 clone 82.27

DR   CLO; CLO_0007456

DR   ATCC; TIB-123

RX   PubMed=81133;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1/89.18.7.HK

AC   CVCL_9210

SY   M1 clone 89.18

DR   CLO; CLO_0007457

DR   ATCC; TIB-124

RX   PubMed=81133;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1/9.3.4.HL.2

AC   CVCL_9211

SY   M1 clone 9.3

DR   CLO; CLO_0007458

DR   ATCC; TIB-122

RX   PubMed=81133;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M1(D+)

AC   CVCL_C021

DR   CLO; CLO_0050222

DR   RCB; RCB2621

DR   TKG; TKG 0319

CC   Breed/subspecies: SL.

DI   NCIt; C21889; Mouse myeloid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2107 ! M1

CA   Cancer cell line

//

ID   M10 [Human melanoma]

AC   CVCL_4715

SY   UCLA-SO-M10; UCLA SO M10; UCLA-SO-10; Melanoma 10

DR   BTO; BTO:0002965

DR   ATCC; CRL-12269

RX   Patent=US5840317;

RX   Patent=US5993828;

RX   PubMed=204583;

RX   PubMed=945229;

RX   PubMed=954005;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M10 [Mouse leukemia]

AC   CVCL_L284

DR   CLO; CLO_0050171

DR   RCB; RCB0136

RX   PubMed=221956;

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2097 ! L-5178-Y

SX   Female

CA   Cancer cell line

//

ID   M10^(-)

AC   CVCL_L285

DR   CLO; CLO_0050170

DR   RCB; RCB0137

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_L284 ! M10 [Mouse leukemia]

SX   Female

CA   Cancer cell line

//

ID   M101

AC   CVCL_L438

SY   UCLA-SO-M101

DR   ATCC; CRL-12271

RX   Patent=US5840317;

RX   Patent=US5993828;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M109

AC   CVCL_H602

SY   Madison 109; Madison lung; Madison; MADISON LUNG TA-109

DR   CLO; CLO_0007527

DR   CLDB; cl3333

DR   ChEMBL-Cells; CHEMBL3307527

DR   ChEMBL-Targets; CHEMBL614073

RX   PubMed=194826;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   M10K

AC   CVCL_8100

DR   Cosmic; 733821

DR   Cosmic; 933013

RX   CelloPub=CLPUB00243;

RX   PubMed=1568228;

RX   PubMed=2323006;

RX   PubMed=11283936;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M10T

AC   CVCL_M094

DR   BioSample; SAMN03151740

RX   PubMed=1246601;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   M12 [Human melanoma]

AC   CVCL_5T78

SY   UCLA-SO-M12; Melanoma 12

RX   PubMed=945229;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M12 [Human prostate]

AC   CVCL_4860

DR   BTO; BTO:0005128

RX   PubMed=9496902;

WW   http://capcelllines.ca/details.asp?id=149

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4865 ! M2182

SX   Male

CA   Transformed cell line

//

ID   M12 [Mouse lymphoma]

AC   CVCL_IU99

RX   PubMed=310843;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   M12.4

AC   CVCL_IV00

SY   m12.4

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-387.html

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_IU99 ! M12 [Mouse lymphoma]

CA   Cancer cell line

//

ID   M12.4.1

AC   CVCL_0402

SY   M1241

DR   MCCL; MCC:0000296

RX   PubMed=6809823;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_IV00 ! M12.4

CA   Cancer cell line

//

ID   M12.4.5

AC   CVCL_0403

SY   M1245

DR   MCCL; MCC:0000297

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_IV00 ! M12.4

CA   Cancer cell line

//

ID   M14

AC   CVCL_1395

SY   M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; Melanoma 14

DR   BTO; BTO:0002805

DR   EFO; EFO_0003056

DR   ChEMBL-Cells; CHEMBL3307591

DR   ChEMBL-Targets; CHEMBL614317

DR   Cosmic; 686479

DR   Cosmic; 687445

DR   Cosmic; 875889

DR   Cosmic; 897467

DR   Cosmic; 905975

DR   Cosmic; 974068

DR   Cosmic; 974261

DR   Cosmic; 1022278

DR   Cosmic; 1044265

DR   Cosmic; 1092611

DR   Cosmic; 1109808

DR   Cosmic; 1132591

DR   Cosmic; 1158815

DR   Cosmic; 1295340

DR   Cosmic; 1303040

DR   Cosmic; 1305365

DR   Cosmic; 1312348

DR   Cosmic; 1459642

DR   Cosmic; 1537485

DR   Cosmic; 1888913

DR   Cosmic; 1998453

DR   Cosmic-CLP; 905975

DR   GDSC; 905975

DR   GEO; GSM50201

DR   GEO; GSM50263

DR   GEO; GSM188222

DR   GEO; GSM188252

DR   GEO; GSM188311

DR   GEO; GSM750799

DR   GEO; GSM799352

DR   GEO; GSM799415

DR   GEO; GSM847034

DR   GEO; GSM844583

DR   GEO; GSM1153422

DR   GEO; GSM1181292

DR   GEO; GSM1181336

DR   GEO; GSM1670072

DR   SKY/M-FISH/CGH; 2813

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=204583;

RX   PubMed=954005;

RX   PubMed=945229;

RX   PubMed=1260767;

RX   PubMed=1918136;

RX   PubMed=2041050;

RX   PubMed=2060184;

RX   PubMed=3046746;

RX   PubMed=6470027;

RX   PubMed=6876798;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19549886;

RX   PubMed=19727395;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=48

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 26.3 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): Cosmic-CLP; DOI=10.4172/2157-7145.S2-005; PubMed=19372543

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 9,13

ST   D18S51: 13,17

ST   D19S433: 14,15

ST   D21S11: 30

ST   D2S1338: 19,24

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 21

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DI53 ! MF14

OI   CVCL_DI50 ! ML14

SX   Male

CA   Cancer cell line

//

ID   M14-A

AC   CVCL_A779

SY   M14-ascitic form

RX   PubMed=6470027;

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1395 ! M14

SX   Male

CA   Cancer cell line

//

ID   M146I-hiPSC

AC   CVCL_DQ95

RX   PubMed=27345998;

DI   NCIt; C123412; Familial Alzheimer's disease, type 3

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   M14K

AC   CVCL_8102

AS   CVCL_M199

SY   M-14-K; M14

DR   BTO; BTO:0003999

DR   Cosmic; 733822

RX   CelloPub=CLPUB00243;

RX   PubMed=1568228;

RX   PubMed=2323006;

RX   PubMed=11283936;

RX   PubMed=9533946;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U345 ! M14P

OI   CVCL_8103 ! M20 [Human mesothelioma]

SX   Male

CA   Cancer cell line

//

ID   M14M

AC   CVCL_U460

DR   Cosmic; 733824

DR   Cosmic; 934557

RX   PubMed=1568228;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U345 ! M14P

SX   Male

CA   Cancer cell line

//

ID   M14P

AC   CVCL_U345

DR   Cosmic; 733823

RX   PubMed=1568228;

RX   PubMed=2323006;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8102 ! M14K

OI   CVCL_8103 ! M20 [Human mesothelioma]

SX   Male

CA   Cancer cell line

//

ID   M15 [Human mesothelioma]

AC   CVCL_U344

DR   Cosmic; 733825

RX   PubMed=1568228;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M15 [Human prostate]

AC   CVCL_4861

RX   PubMed=9496902;

WW   http://capcelllines.ca/details.asp?id=150

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4865 ! M2182

SX   Male

CA   Transformed cell line

//

ID   M15 [Mouse]

AC   CVCL_3841

SY   Meso15

DR   CLO; CLO_0007461

DR   CLDB; cl3312

DR   ECACC; 95102517

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   m17.ASC

AC   CVCL_G357

DR   ECACC; 11112201

RX   Patent=US8835165;

RX   PubMed=23777308;

CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 10001.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Adult stem cell

//

ID   M17/4.4.11.9

AC   CVCL_9212

DR   CLO; CLO_0007463

DR   ATCC; TIB-217

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M17/5.2

AC   CVCL_9213

DR   CLO; CLO_0007464

DR   ATCC; TIB-237

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M18

AC   CVCL_D029

SY   EST133

DR   Cosmic; 1047644

DR   Cosmic; 2163832

DR   ESTDAB; ESTDAB-133

DR   GEO; GSM156004

RX   PubMed=17260012;

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D3S1358: 14,16

ST   D5S818: 11

ST   D7S820: 8

ST   FGA: 21,23

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M18/2.a.12.7

AC   CVCL_7681

DR   CLO; CLO_0007465

DR   ATCC; TIB-218

DR   CCRID; 3131C0001000600033

CC   Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_G215 ! M18/2.a.8

CA   Hybridoma

//

ID   M18/2.a.8

AC   CVCL_G215

RX   PubMed=6193226;

CC   Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M18/B7

AC   CVCL_D030

DR   ESTDAB; ESTDAB-041

CC   Transfected with: HGNC; 1700; CD80.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D3S1358: 14,16

ST   D5S818: 11

ST   D7S820: 8

ST   FGA: 21,23

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D029 ! M18

CA   Cancer cell line

//

ID   M19

AC   CVCL_M198

DR   Cosmic; 733827

DR   Cosmic; 934558

RX   PubMed=1568228;

RX   PubMed=2323006;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M197 ! M22K

SX   Male

CA   Cancer cell line

//

ID   M19-MEL

AC   CVCL_B415

SY   M19

DR   ChEMBL-Cells; CHEMBL3307506

DR   ChEMBL-Targets; CHEMBL614019

DR   Cosmic; 1181741

DR   Cosmic; 1303041

RX   PubMed=7999427;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M1929

AC   CVCL_4864

RX   PubMed=8077059;

WW   http://capcelllines.ca/details.asp?id=146

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4875 ! P69SV40T

SX   Male

CA   Transformed cell line

//

ID   M195

AC   CVCL_L542

DR   CLO; CLO_0007466

DR   ATCC; HB-10306

RX   Patent=US5730982;

RX   Patent=US6007814;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   M1Do

AC   CVCL_W290

SY   M1 (Do); M1

RX   DOI=10.1007/BF01753729;

RX   PubMed=3882112;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M1RW

AC   CVCL_4Z11

SY   MIRW

RX   PubMed=6770995;

RX   PubMed=6773878;

CC   Doubling time: 24 hours (PubMed=6770995); 23.6 hours (PubMed=6773878).

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M1RW5

AC   CVCL_4Z12

SY   MIRW5

RX   PubMed=3079741;

RX   PubMed=3667379;

RX   PubMed=3864528;

RX   PubMed=6581509;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4Z11 ! M1RW

SX   Male

CA   Cancer cell line

//

ID   M1WT2

AC   CVCL_3842

DR   CLO; CLO_0007467

DR   ATCC; CRL-1984

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   M1WT3

AC   CVCL_3843

DR   CLO; CLO_0007468

DR   CLDB; cl3314

DR   ATCC; CRL-1985

DR   ECACC; 940822109

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   M1WT5

AC   CVCL_3844

DR   CLO; CLO_0007469

DR   ATCC; CRL-1986

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   M2-1

AC   CVCL_2Z36

SY   WC00001

DR   CLO; CLO_0013435

DR   BioSamples; SAME17773

DR   Coriell; WC00001

CC   Discontinued: Coriell; WC00001; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M2-10B4

AC   CVCL_5794

DR   CLO; CLO_0007470

DR   BCRC; 60228

DR   ATCC; CRL-1972

DR   CLS; 400428/p589_M2-10B4

DR   IZSLER; BS CL 199

DR   KCLB; 21972

RX   PubMed=3261251;

CC   Breed/subspecies: C57BL/6J x C3H/HeJ.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   M2-1C6-4R3

AC   CVCL_4538

SY   M2-1C6; M2-1C6-5; WC00017

DR   CLO; CLO_0007471

DR   CLO; CLO_0012695

DR   CLDB; cl5224

DR   ATCC; HB-64

DR   BioSamples; SAME17713

DR   Coriell; WC00017

DR   IZSLER; BS Hy 29

RX   PubMed=7217668;

CC   Monoclonal antibody target: Influenza A virus matrix protein (M).

CC   Discontinued: Coriell; WC00017; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M2-21-4.6

AC   CVCL_5K10

SY   WC00028

DR   CLO; CLO_0012716

DR   BioSamples; SAME17797

DR   Coriell; WC00028

CC   Monoclonal antibody target: Influenza A virus matrix protein (M).

CC   Discontinued: Coriell; WC00028; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M2-40

AC   CVCL_5K04

SY   WC00016

DR   CLO; CLO_0012694

DR   BioSamples; SAME17709

DR   Coriell; WC00016

CC   Discontinued: Coriell; WC00016; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M2-58

AC   CVCL_5K05

SY   WC00043

DR   CLO; CLO_0012734

DR   BioSamples; SAME17829

DR   Coriell; WC00043

CC   Discontinued: Coriell; WC00043; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M20 [Human melanoma]

AC   CVCL_DI51

SY   M-20; UCLA-SO-M20

RX   PubMed=954005;

RX   PubMed=6876798;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DI54 ! MF20

CA   Cancer cell line

//

ID   M20 [Human mesothelioma]

AC   CVCL_8103

DR   Cosmic; 733828

RX   PubMed=1568228;

RX   PubMed=2323006;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8102 ! M14K

OI   CVCL_U345 ! M14P

SX   Male

CA   Cancer cell line

//

ID   M202

AC   CVCL_D746

DR   Cosmic; 1425343

DR   Cosmic; 1459667

DR   Cosmic; 1665002

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M207

AC   CVCL_D747

DR   Cosmic; 1425344

DR   Cosmic; 1459669

DR   Cosmic; 1665003

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M21

AC   CVCL_D031

SY   UCLA-SO-M21; UCLA SO M21

DR   ChEMBL-Cells; CHEMBL3307769

DR   ChEMBL-Targets; CHEMBL614117

DR   Cosmic; 928695

DR   ESTDAB; ESTDAB-042

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-388.html

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,9

ST   D3S1358: 14,18

ST   D5S818: 10,13

ST   D7S820: 10,12

ST   FGA: 20

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   M2182

AC   CVCL_4865

RX   PubMed=8077059;

RX   PubMed=9496902;

WW   http://capcelllines.ca/details.asp?id=147

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4864 ! M1929

SX   Male

CA   Transformed cell line

//

ID   M22

AC   CVCL_U978

DR   BTO; BTO:0002197

RX   PubMed=11751433;

RX   PubMed=12075625;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_U976 ! OC/CDE 22

SX   Male

CA   Cancer cell line

//

ID   M2205

AC   CVCL_4866

RX   PubMed=8077059;

RX   PubMed=9496902;

RX   PubMed=12581899;

WW   http://capcelllines.ca/details.asp?id=148

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4875 ! P69SV40T

SX   Male

CA   Transformed cell line

//

ID   M229

AC   CVCL_D748

DR   Cosmic; 1425351

DR   Cosmic; 1459649

DR   Cosmic; 1665011

DR   GEO; GSM612085

DR   GEO; GSM612086

DR   GEO; GSM1588914

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M229 R1

AC   CVCL_EI76

DR   Cosmic; 1545601

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R10

AC   CVCL_EI77

DR   Cosmic; 1545610

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R11

AC   CVCL_EI78

DR   Cosmic; 1545611

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R12

AC   CVCL_EI79

DR   Cosmic; 1545612

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R13

AC   CVCL_EI80

DR   Cosmic; 1545613

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R14

AC   CVCL_EI81

DR   Cosmic; 1545614

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R15

AC   CVCL_EI82

DR   Cosmic; 1545615

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R2

AC   CVCL_EI83

DR   Cosmic; 1545602

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R3

AC   CVCL_EI84

DR   Cosmic; 1545603

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R4

AC   CVCL_EI85

DR   Cosmic; 1545604

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R5

AC   CVCL_EI86

DR   Cosmic; 1545605

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R6

AC   CVCL_EI87

DR   Cosmic; 1545606

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R7

AC   CVCL_EI88

DR   Cosmic; 1545607

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R8

AC   CVCL_EI89

DR   Cosmic; 1545608

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229 R9

AC   CVCL_EI90

DR   Cosmic; 1545609

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229DDRpoly-PLXAZD

AC   CVCL_IM72

DR   GEO; GSM1588916

RX   PubMed=26359985;

CC   Selected for resistance to: ChEBI; CHEBI:90227; Selumetinib (AZD6244).

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M229R5-PLX

AC   CVCL_IM73

DR   GEO; GSM1588915

RX   PubMed=26359985;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D748 ! M229

CA   Cancer cell line

//

ID   M22K

AC   CVCL_M197

RX   PubMed=2323006;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M198 ! M19

SX   Male

CA   Cancer cell line

//

ID   M230

AC   CVCL_D749

DR   Cosmic; 1665177

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M233

AC   CVCL_D750

DR   Cosmic; 1425345

DR   Cosmic; 1459657

DR   Cosmic; 1665012

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M238

AC   CVCL_D751

DR   Cosmic; 1425352

DR   Cosmic; 1459647

DR   Cosmic; 1665013

DR   GEO; GSM612087

DR   GEO; GSM612088

DR   GEO; GSM1588917

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M238 R1

AC   CVCL_EI91

DR   Cosmic; 1545616

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D751 ! M238

CA   Cancer cell line

//

ID   M238 R2

AC   CVCL_EI92

DR   Cosmic; 1545617

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D751 ! M238

CA   Cancer cell line

//

ID   M238R1-PLX

AC   CVCL_IM74

DR   GEO; GSM1588918

RX   PubMed=26359985;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D751 ! M238

CA   Cancer cell line

//

ID   M24

AC   CVCL_D032

SY   UCLA-SO-M24; UCLA-SO-24

DR   ATCC; CRL-12270

DR   Cosmic; 2163789

DR   ESTDAB; ESTDAB-043

DR   ESTDAB; ESTDAB-134

RX   Patent=US5840317;

RX   Patent=US5993828;

RX   PubMed=2009538;

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D3S1358: 14,16

ST   D5S818: 13

ST   D7S820: 9

ST   FGA: 18,19

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M243

AC   CVCL_D752

DR   Cosmic; 1459663

DR   Cosmic; 1665004

RX   PubMed=20689758;

RX   PubMed=22515704;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M244

AC   CVCL_D753

DR   Cosmic; 1459664

DR   Cosmic; 1665006

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M245

AC   CVCL_D754

DR   Cosmic; 1459661

DR   Cosmic; 1665005

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M249

AC   CVCL_D755

DR   Cosmic; 1425353

DR   Cosmic; 1459652

DR   Cosmic; 1545618

DR   Cosmic; 1665014

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M249 R4

AC   CVCL_EI93

DR   Cosmic; 1545619

RX   PubMed=21107323;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D755 ! M249

CA   Cancer cell line

//

ID   M24K

AC   CVCL_8104

DR   Cosmic; 733829

DR   Cosmic; 933012

DR   Cosmic; 934556

RX   CelloPub=CLPUB00243;

RX   PubMed=1568228;

RX   PubMed=11283936;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M24met

AC   CVCL_3915

SY   M24 met

RX   PubMed=2009538;

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D032 ! M24

SX   Male

CA   Cancer cell line

//

ID   M24met H1.11

AC   CVCL_3916

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3915 ! M24met

SX   Male

CA   Cancer cell line

//

ID   M25.18A1

AC   CVCL_S554

DR   ATCC; HB-12152

RX   Patent=US5955311;

RX   Patent=US6365157;

RX   Patent=US6448077;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M255

AC   CVCL_D756

DR   Cosmic; 1425346

DR   Cosmic; 1665015

RX   PubMed=20406486;

RX   PubMed=22515704;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M257

AC   CVCL_D757

DR   Cosmic; 1425342

DR   Cosmic; 1459668

DR   Cosmic; 1665178

DR   Cosmic; 1949555

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M25K

AC   CVCL_8105

DR   Cosmic; 733830

RX   CelloPub=CLPUB00243;

RX   PubMed=1568228;

RX   PubMed=11283936;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M26

AC   CVCL_B416

DR   Cosmic; 1181765

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M262

AC   CVCL_D758

DR   Cosmic; 1425354

DR   Cosmic; 1459641

DR   Cosmic; 1665016

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M263

AC   CVCL_D759

DR   Cosmic; 1425348

DR   Cosmic; 1459658

DR   Cosmic; 1665017

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M275

AC   CVCL_D760

DR   Cosmic; 1459646

DR   Cosmic; 1665018

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M285

AC   CVCL_D761

DR   Cosmic; 1665179

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M288

AC   CVCL_D762

DR   Cosmic; 1459640

RX   PubMed=20689758;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M28K

AC   CVCL_8106

SY   M-28-K

DR   BTO; BTO:0004000

DR   Cosmic; 733831

RX   CelloPub=CLPUB00243;

RX   PubMed=1568228;

RX   PubMed=11283936;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M290

AC   CVCL_L705

DR   ECACC; 93012001

CC   Monoclonal antibody target: UniProtKB; Q60677; Mouse Itgae/Cd103.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M296

AC   CVCL_D763

DR   Cosmic; 1459670

DR   Cosmic; 1665007

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M297

AC   CVCL_D764

DR   Cosmic; 1665019

RX   PubMed=22515704;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M299

AC   CVCL_D765

DR   Cosmic; 1459654

DR   Cosmic; 1665020

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M2A7

AC   CVCL_3486

SY   A7

DR   CLO; CLO_0001608

DR   EFO; EFO_0002107

DR   CLDB; cl212

DR   ATCC; CRL-2500

DR   BioSample; SAMN03471597

DR   IGRhCellID; A7

RX   PubMed=1549777;

CC   Transfected with: HGNC; 3754; FLNA.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 9,12

ST   TH01: 7

ST   TPOX: 7

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M543 ! RPM-MC

CA   Cancer cell line

//

ID   M2B

AC   CVCL_DD25

RX   PubMed=25647616;

CC   Characteristics: Cell line persistantly infected with proteinase K resistant BSE (PrP(BSE)).

CC   Transfected with: UniProtKB; P10279; Bovine PRNP.

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_0421 ! MDBK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   M2Ge

AC   CVCL_W291

SY   M2 (Ge); M2

RX   DOI=10.1007/BF01753729;

RX   PubMed=3882112;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M3

AC   CVCL_4Y25

DR   BCRJ; 0154

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   M3/38.1.2.8 HL.2

AC   CVCL_7683

SY   M3/38.1.2.8.HL.2

DR   CLO; CLO_0007475

DR   ATCC; TIB-166

DR   BCRJ; 0155

DR   CCRID; 3131C0001000600031

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M3/84.6.34

AC   CVCL_9214

DR   CLO; CLO_0007476

DR   ATCC; TIB-168

DR   BCRJ; 0156

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M308

AC   CVCL_D766

DR   Cosmic; 1425347

DR   Cosmic; 1459666

DR   Cosmic; 1665021

RX   PubMed=20406486;

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M311

AC   CVCL_M771

DR   NIH-ARP; 1295-123

RX   PubMed=3422113;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0013 ! MOLT-4

SX   Male

CA   Cancer cell line

//

ID   M318

AC   CVCL_D767

DR   Cosmic; 1459660

DR   Cosmic; 1665008

RX   PubMed=20689758;

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M321

AC   CVCL_D768

DR   Cosmic; 1425349

DR   Cosmic; 1459653

RX   PubMed=20406486;

RX   PubMed=20689758;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M328

AC   CVCL_IW41

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M32K

AC   CVCL_U343

DR   Cosmic; 733832

RX   PubMed=1568228;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M33K

AC   CVCL_8107

DR   Cosmic; 733833

DR   Cosmic; 933011

DR   Cosmic; 934559

RX   CelloPub=CLPUB00243;

RX   PubMed=1568228;

RX   PubMed=2323006;

RX   PubMed=11283936;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M34

AC   CVCL_S680

DR   Cosmic; 1244761

DR   GEO; GSM202112

DR   IGRhCellID; M34%20GEO

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M35/01

AC   CVCL_M577

RX   PubMed=16368560;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M368

AC   CVCL_D769

DR   Cosmic; 1665180

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M375

AC   CVCL_D770

DR   Cosmic; 1665181

RX   PubMed=22515704;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M38K

AC   CVCL_8108

RX   CelloPub=CLPUB00243;

RX   PubMed=2323006;

RX   PubMed=9533946;

RX   PubMed=11283936;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M3Da

AC   CVCL_8336

SY   M3 (Da); M3

RX   DOI=10.1007/BF01753729;

RX   PubMed=3882112;

RX   PubMed=8125107;

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M3E3/C3

AC   CVCL_2108

DR   CLO; CLO_0007477

DR   DSMZ; ACC-340

RX   PubMed=6890064;

CC   Doubling time: ~40 hours (DSMZ).

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

CA   Spontaneously immortalized cell line

//

ID   M3F-1

AC   CVCL_0H19

DR   SKIP; SKIP000611

RX   PubMed=19269371;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0G94 ! GM01786

SX   Female

CA   Induced pluripotent stem cell

//

ID   M3F-2

AC   CVCL_0H20

DR   SKIP; SKIP000612

RX   PubMed=19269371;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0G94 ! GM01786

SX   Female

CA   Induced pluripotent stem cell

//

ID   M3WT4

AC   CVCL_4579

DR   CLO; CLO_0007478

DR   ATCC; CRL-1981

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   M3WT5

AC   CVCL_4580

DR   CLO; CLO_0007479

DR   ATCC; CRL-1982

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   M3WT8

AC   CVCL_4581

DR   CLO; CLO_0007480

DR   ATCC; CRL-1983

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   M4

AC   CVCL_U812

SY   M-4

DR   CLO; CLO_0050289

DR   RCB; RCB1611

RX   PubMed=6183338;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   M40

AC   CVCL_V744

SY   MEL40

DR   Cosmic; 1244758

DR   GEO; GSM202135

DR   IGRhCellID; MEL40%20GEO

RX   PubMed=19047099;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   M4A4

AC   CVCL_B057

SY   M-4A4

DR   ATCC; CRL-2914

DR   BioSample; SAMN03151831

DR   BioSample; SAMN03471696

RX   PubMed=14506175;

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   M4A4 GFP

AC   CVCL_B058

SY   M4A4-GFP; M-4A4-GFP

DR   ATCC; CRL-2915

RX   PubMed=14506175;

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B057 ! M4A4

SX   Male

CA   Cancer cell line

//

ID   M4A4 LM3-2 GFP

AC   CVCL_B059

DR   ATCC; CRL-2916

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

CC   Problematic cell line: Contaminated. Ancestral cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B058 ! M4A4 GFP

SX   Male

CA   Cancer cell line

//

ID   M4A4 LM3-4 CL16 GFP

AC   CVCL_B060

DR   ATCC; CRL-2917

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

CC   Problematic cell line: Contaminated. Ancestral cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B058 ! M4A4 GFP

SX   Male

CA   Cancer cell line

//

ID   M4b

AC   CVCL_9W66

RX   PubMed=11933048;

CC   Transformant: Unknown product of UCHT1 (CVCL_9W35) conditioned media.

CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   M4Beu

AC   CVCL_8337

SY   M4 (Beu); M4Be; M4

DR   ChEMBL-Cells; CHEMBL3307798

DR   ChEMBL-Targets; CHEMBL612270

RX   DOI=10.1007/BF01753729;

RX   PubMed=1937961;

RX   PubMed=3882112;

RX   PubMed=8125107;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M4T.4

AC   CVCL_DR62

SY   M4T4

RX   PubMed=12948546;

RX   PubMed=21961028;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: SJL/J.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_DR63 ! M4T.6

SX   Male

CA   Transformed cell line

//

ID   M4T.6

AC   CVCL_DR63

RX   PubMed=12948546;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: SJL/J.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_DR62 ! M4T.4

SX   Male

CA   Transformed cell line

//

ID   M5/114.15.2

AC   CVCL_9215

DR   CLO; CLO_0007482

DR   ATCC; TIB-120

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M5/49.4.1

AC   CVCL_9216

DR   CLO; CLO_0007483

DR   ATCC; TIB-238

DR   BCRC; 60190

CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M5/CDDP

AC   CVCL_5T74

RX   PubMed=8943689;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C30056; Mouse ovarian histiocytic sarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3997 ! M5076

CA   Cancer cell line

//

ID   M5/CDDPc

AC   CVCL_5T75

RX   PubMed=8943689;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C30056; Mouse ovarian histiocytic sarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3997 ! M5076

CA   Cancer cell line

//

ID   M5076

AC   CVCL_3997

SY   M5

DR   BTO; BTO:0001915

DR   CLO; CLO_0007484

DR   CLDB; cl3317

DR   CCRID; 3111C0001CCC000287

DR   ChEMBL-Cells; CHEMBL3307538

DR   ChEMBL-Targets; CHEMBL614120

DR   KCLB; 80019

RX   PubMed=7011532;

RX   PubMed=8943689;

CC   Discontinued: KCLB; 80019; probable.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C30056; Mouse ovarian histiocytic sarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   m5S

AC   CVCL_6417

DR   JCRB; JCRB1322

RX   PubMed=3571334;

CC   Breed/subspecies: ICR/Jcl.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   M6/B7

AC   CVCL_D034

SY   EST45

DR   Cosmic; 1047646

DR   Cosmic; 2163790

DR   ESTDAB; ESTDAB-045

DR   GEO; GSM156007

RX   PubMed=17260012;

CC   Transfected with: HGNC; 1700; CD80.

CC   Omics: Array-based CGH.

CC   Derived from metastatic site: Lung.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D3S1358: 17,18

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   FGA: 23,23.2

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T324 ! CaCL 73-36

SX   Female

CA   Cancer cell line

//

ID   M619

AC   CVCL_8472

DR   CCRID; 3111C0001CCC000224

RX   PubMed=18689700;

ST   Source(s): PubMed=18689700;

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 8,12

ST   D18S51: 15

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 12

ST   D8S1179: 13

ST   FGA: 20,21

ST   TH01: 8,9.3

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8471 ! C918

OI   CVCL_3447 ! MuM-2B

SX   Female

CA   Cancer cell line

//

ID   M7 [Human B-cell 12IHW]

AC   CVCL_E767

DR   dbMHC; 48963

DR   ECACC; 94022543

DR   IHW; IHW9215

DR   IMGT/HLA; 11030

WW   http://bioinformatics.hsanmartino.it/ecbr/cl215.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   M7 [Human melanoma]

AC   CVCL_DI52

SY   M-7; UCLA-SO-M7

RX   PubMed=6876798;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M73.24

AC   CVCL_S555

DR   ATCC; HB-12153

RX   Patent=US5955311;

RX   Patent=US6365157;

RX   Patent=US6448077;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   M7609

AC   CVCL_IW14

SY   M-7609

RX   PubMed=6998824;

RX   PubMed=8758929;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M7609/ADR

AC   CVCL_IW15

RX   PubMed=8758929;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_IW14 ! M7609

CA   Cancer cell line

//

ID   M7TS90

AC   CVCL_0404

DR   MCCL; MCC:0000298

RX   PubMed=11980662;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   M8166

AC   CVCL_1H07

DR   NIH-ARP; 11395-280

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1099 ! C8166

CA   Transformed cell line

//

ID   M88

AC   CVCL_D035

SY   EST135

DR   Cosmic; 1047645

DR   Cosmic; 2163833

DR   ESTDAB; ESTDAB-135

DR   GEO; GSM156018

RX   PubMed=17260012;

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,11

ST   D13S317: 11

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 12

ST   FGA: 25

ST   TH01: 6

ST   TPOX: 10

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M91-054

AC   CVCL_1G26

SY   M91 054

DR   Cosmic; 1211154

RX   PubMed=10952317;

RX   PubMed=23039341;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   M92-001

AC   CVCL_1G27

SY   M92 001

DR   Cosmic; 1211152

RX   PubMed=10952317;

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   M93-047

AC   CVCL_G298

DR   BTO; BTO:0005062

RX   PubMed=10952317;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   M950322

AC   CVCL_DI46

DR   GEO; GSM482469

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M950504

AC   CVCL_DI47

DR   GEO; GSM482470

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M961121

AC   CVCL_DI48

DR   GEO; GSM482477

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M970109

AC   CVCL_DI43

DR   GEO; GSM482478

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M970131

AC   CVCL_DI44

DR   GEO; GSM482480

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M970805

AC   CVCL_DI45

DR   GEO; GSM482481

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M971219

AC   CVCL_AT57

RX   PubMed=24581590;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M980513

AC   CVCL_S675

RX   PubMed=16827748;

RX   PubMed=18245463;

RX   PubMed=22336146;

CC   From: URPP biobank; University of Zurich; Switzerland.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M990115

AC   CVCL_S676

RX   PubMed=16827748;

RX   PubMed=24581590;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M990203

AC   CVCL_AT58

RX   PubMed=24581590;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M990514

AC   CVCL_S677

RX   PubMed=16827748;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M990802

AC   CVCL_S678

DR   GEO; GSM433917

DR   IGRhCellID; M990802

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M991121

AC   CVCL_S679

RX   PubMed=16827748;

RX   PubMed=18245463;

CC   From: URPP biobank; University of Zurich; Switzerland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   M9A

AC   CVCL_B417

DR   BTO; BTO:0005074

RX   PubMed=19116209;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0493 ! RAW 264.7

SX   Male

CA   Cancer cell line

//

ID   M9K

AC   CVCL_8109

SY   M-9-K

DR   BTO; BTO:0004001

DR   Cosmic; 733820

DR   Cosmic; 933010

DR   Cosmic; 934555

RX   PubMed=1568228;

RX   PubMed=2323006;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MA 2

AC   CVCL_7057

RX   PubMed=9131270;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MA 3

AC   CVCL_7058

RX   PubMed=9131270;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma Not

AC   CVCL_U784

DR   ATCC; CRL-1263

CC   Discontinued: ATCC; CRL-1263; true.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Ma San

AC   CVCL_3739

DR   CLO; CLO_0007493

DR   ATCC; CRL-1148

DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Ma Tru

AC   CVCL_U785

DR   ATCC; CRL-1309

CC   Discontinued: ATCC; CRL-1309; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MA-1

AC   CVCL_M665

SY   Ma-1

DR   BioSample; SAMN03151897

RX   PubMed=21837708;

RX   PubMed=23508748;

RX   PubMed=23508779;

RX   PubMed=23907998;

RX   PubMed=24285409;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Pfeiffer derivative (PubMed=23907998) and not a mucosa-associated lymphoid tissue (MALT) lymphoma cell line. This finding is disputed by the original authors (see PubMed=24285409).

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3326 ! Pfeiffer

SX   Male

CA   Cancer cell line

//

ID   Ma-1

AC   CVCL_7059

SY   Ma1

DR   BTO; BTO:0004160

DR   Cosmic; 801593

DR   Cosmic; 844836

DR   Cosmic; 876145

DR   Cosmic; 917983

DR   Cosmic; 1047095

DR   Cosmic; 1128252

DR   Cosmic; 1239874

DR   Cosmic; 1656895

DR   Cosmic; 2125271

RX   PubMed=1650680;

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=19472407;

RX   PubMed=22313637;

CC   Doubling time: 25.9 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-10

AC   CVCL_7061

SY   Ma10

DR   Cosmic; 801596

DR   Cosmic; 844838

DR   Cosmic; 876146

DR   Cosmic; 917994

DR   Cosmic; 1239875

DR   Cosmic; 1656897

DR   Cosmic; 2125272

RX   PubMed=1650680;

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=15802814;

RX   PubMed=19472407;

RX   PubMed=22313637;

CC   Doubling time: 75.0 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MA-10

AC   CVCL_D789

SY   MA10

DR   BTO; BTO:0003050

DR   ATCC; CRL-3050

RX   PubMed=6257492;

RX   PubMed=15541572;

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_U444 ! MA-12

OI   CVCL_3544 ! MLTC-1

SX   Male

CA   Cancer cell line

//

ID   MA-101

AC   CVCL_0A70

SY   MA 101; MA101; Microbiological Associates-101

RX   PubMed=4626908;

RX   PubMed=6500159;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

CA   Finite cell line

//

ID   MA-104

AC   CVCL_3845

SY   Ma-104; MA 104; MA104; Microbiological Associates-104

DR   BTO; BTO:0004983

DR   CLO; CLO_0007492

DR   CLO; CLO_0007494

DR   CLO; CLO_0051423

DR   CLDB; cl3324

DR   CLDB; cl3325

DR   CLDB; cl3326

DR   CLDB; cl3327

DR   ATCC; CRL-2378

DR   BCRJ; 0157

DR   BioSample; SAMN03152038

DR   CCLV; CCLV-RIE 0142

DR   CCRID; 3142C0001000000041

DR   ECACC; 85102918

DR   GEO; GSM758845

DR   GEO; GSM758846

DR   GEO; GSM758847

DR   GEO; GSM758848

DR   GEO; GSM758849

DR   GEO; GSM758850

DR   GEO; GSM758851

DR   GEO; GSM758852

DR   GEO; GSM758853

DR   GEO; GSM758854

DR   GEO; GSM758855

DR   GEO; GSM758856

DR   GEO; GSM758857

DR   GEO; GSM758858

DR   GEO; GSM758859

DR   IZSLER; BS CL 61

DR   KCB; KCB 201001YJ

DR   Lonza; 631

DR   NCBI_Iran; C486

DR   RCB; RCB0994

RX   PubMed=4043530;

RX   PubMed=4626908;

RX   PubMed=19941903;

RX   PubMed=20143388;

RX   PubMed=26235236;

WW   http://www.atcc.org/support/faqs/d0d17/MA104%20ATCC%20CRL2378-1067.aspx

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-391.html

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

WW   http://en.vircell.com/products/ma104-cell-line/

CC   Group: Non-human primate cell line.

CC   Problematic cell line: Misidentified. Originally thought to be of Rhesus macaque origin but found to be from African Green monkey (PubMed=4043530, PubMed=20143388).

CC   Discontinued: ATCC; CRL-2378; true.

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MA-104 Clone 1

AC   CVCL_3846

DR   CLO; CLO_0007495

DR   ATCC; CRL-2378.1

WW   http://www.atcc.org/support/faqs/d0d17/MA104%20ATCC%20CRL2378-1067.aspx

CC   Group: Non-human primate cell line.

CC   Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from African Green monkey instead of Rhesus macaque.

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

HI   CVCL_3845 ! MA-104

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Ma-11

AC   CVCL_D064

SY   Ma11

RX   PubMed=1650680;

CC   Doubling time: 41.3 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MA-111

AC   CVCL_U963

SY   MA 111; MA111; Microbiological Associates-111

DR   BioSample; SAMN03152039

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Group: Non-human primate cell line.

CC   Problematic cell line: Misidentified. Originally thought to be of rabbit origin but found to be from African Green monkey (PubMed=20143388). Originally thought to originate from kidney. Could be a VERO derivative.

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

SX   Sex undetermined

CA   Undefined cell line type

//

ID   Ma-12

AC   CVCL_7062

SY   MA12; Ma12

DR   Cosmic; 801597

DR   Cosmic; 876147

DR   Cosmic; 917997

DR   Cosmic; 1239876

DR   Cosmic; 2125273

RX   PubMed=1650680;

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=19472407;

CC   Doubling time: 23.0 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MA-12

AC   CVCL_U444

RX   PubMed=6257492;

RX   PubMed=15541572;

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_D789 ! MA-10

OI   CVCL_3544 ! MLTC-1

SX   Male

CA   Cancer cell line

//

ID   Ma-13

AC   CVCL_D065

SY   Ma13

RX   PubMed=1650680;

CC   Doubling time: 71.9 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-14

AC   CVCL_D066

SY   Ma14

RX   PubMed=1650680;

CC   Doubling time: 21.0 hours (PubMed=1650680).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-15

AC   CVCL_D067

SY   Ma15

RX   PubMed=1650680;

CC   Doubling time: 29.5 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-16

AC   CVCL_D068

SY   Ma16

RX   PubMed=1650680;

CC   Doubling time: 33.2 hours (PubMed=1650680).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MA-160

AC   CVCL_8261

SY   MA 160; MA160; Microbiological Associates-160

DR   BioSample; SAMN03151741

RX   CelloPub=CLPUB00262;

RX   DOI=10.1007/978-1-4757-1647-4_13;

RX   PubMed=66218;

RX   PubMed=87387;

RX   PubMed=93571;

RX   PubMed=535908;

RX   PubMed=1246601;

RX   PubMed=4319198;

RX   PubMed=4469665;

RX   PubMed=6451928;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=66218, PubMed=93571, PubMed=1246601, PubMed=4469665, PubMed=6451928, PubMed=20143388). Originally thought to originate from a benign prostatic hyperplasia biopsy from Monroe Vincent one of the authors of the original paper.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   Ma-17

AC   CVCL_7063

SY   Ma17

DR   Cosmic; 801598

DR   Cosmic; 844839

DR   Cosmic; 876148

DR   Cosmic; 917977

DR   Cosmic; 1239877

DR   Cosmic; 2125274

RX   PubMed=1650680;

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=19472407;

CC   Doubling time: 63.4 hours (PubMed=1650680).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-18

AC   CVCL_D069

SY   Ma18

RX   PubMed=1650680;

CC   Doubling time: 37.0 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-19

AC   CVCL_D070

SY   Ma19

RX   PubMed=1650680;

CC   Doubling time: 36.0 hours (PubMed=1650680).

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-2

AC   CVCL_7060

SY   Ma2

DR   Cosmic; 801594

DR   Cosmic; 844837

DR   Cosmic; 876177

DR   Cosmic; 917990

DR   Cosmic; 1239920

DR   Cosmic; 2125275

RX   PubMed=1650680;

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=19472407;

CC   Doubling time: 22.8 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-20

AC   CVCL_D071

SY   Ma20

RX   PubMed=1650680;

CC   Doubling time: 42.2 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-24

AC   CVCL_7064

SY   Ma24

DR   Cosmic; 801599

DR   Cosmic; 876149

DR   Cosmic; 917978

DR   Cosmic; 1239878

DR   Cosmic; 2125276

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=19472407;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-25

AC   CVCL_7065

SY   Ma25

DR   BTO; BTO:0004155

DR   Cosmic; 801600

DR   Cosmic; 844840

DR   Cosmic; 876178

DR   Cosmic; 917981

DR   Cosmic; 1047101

DR   Cosmic; 1239921

DR   Cosmic; 2125277

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=17332333;

RX   PubMed=19472407;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-26

AC   CVCL_7066

SY   Ma26

DR   Cosmic; 801601

DR   Cosmic; 844841

DR   Cosmic; 876150

DR   Cosmic; 917998

DR   Cosmic; 1239879

DR   Cosmic; 2125278

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=19472407;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-29

AC   CVCL_7067

SY   Ma29

DR   Cosmic; 801602

DR   Cosmic; 844842

DR   Cosmic; 876151

DR   Cosmic; 917982

DR   Cosmic; 1219059

DR   Cosmic; 1239880

DR   Cosmic; 1656898

DR   Cosmic; 2125189

RX   PubMed=9393586;

RX   PubMed=11005564;

RX   PubMed=19472407;

RX   PubMed=22313637;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-3

AC   CVCL_7068

SY   Ma3

DR   Cosmic; 801595

DR   Cosmic; 844814

DR   Cosmic; 917986

RX   PubMed=1650680;

RX   PubMed=9393586;

CC   Doubling time: 31.6 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-31

AC   CVCL_7069

DR   BTO; BTO:0004156

DR   Cosmic; 1047107

RX   PubMed=9393586;

RX   PubMed=15802814;

RX   PubMed=17332333;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MA-31750

AC   CVCL_F565

SY   31750; TER283; TER355

DR   IMGT/HLA; 11939

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Ma-34

AC   CVCL_7070

DR   BTO; BTO:0004157

DR   Cosmic; 1047105

RX   PubMed=17332333;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-4

AC   CVCL_D058

SY   Ma4

RX   PubMed=1650680;

CC   Doubling time: 49.1 hours (PubMed=1650680).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-43

AC   CVCL_IQ46

RX   PubMed=9393586;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-44

AC   CVCL_7071

SY   Ma44

RX   PubMed=10769649;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-45

AC   CVCL_7072

DR   BTO; BTO:0004158

DR   Cosmic; 1047103

RX   PubMed=9393586;

RX   PubMed=17332333;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-46

AC   CVCL_7073

RX   PubMed=9393586;

RX   PubMed=15802814;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-5

AC   CVCL_D059

SY   Ma5

RX   PubMed=1650680;

CC   Doubling time: 61.0 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-53

AC   CVCL_7074

DR   BTO; BTO:0004159

DR   Cosmic; 1047104

RX   PubMed=17332333;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-6

AC   CVCL_D060

SY   Ma6

RX   PubMed=1650680;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-7

AC   CVCL_D061

SY   Ma7

RX   PubMed=1650680;

CC   Doubling time: 28.7 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-8

AC   CVCL_D062

SY   Ma8

RX   PubMed=1650680;

CC   Doubling time: 50.0 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MA-89

AC   CVCL_J293

DR   IFO; IFO50293

CC   Doubling time: 24-36 hours (IFO).

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   Ma-9

AC   CVCL_D063

SY   Ma9

RX   PubMed=1650680;

CC   Doubling time: 65.5 hours (PubMed=1650680).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MA-Balb

AC   CVCL_5795

SY   Ma-Balb

DR   CLS; 400270/p560_MA-Balb

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   MA-CLS-2

AC   CVCL_4571

SY   MACLS-2

DR   CLS; 300271/p778_MA-CLS-2

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): CLS

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 15

ST   D21S11: 29

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 9,13

ST   Penta E: 13

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4017; Ductal breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-01

AC   CVCL_A115

SY   Ma-Mel-1

DR   BTO; BTO:0005336

DR   ESTDAB; ESTDAB-142

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D3S1358: 15,16

ST   D5S818: 12,13

ST   D7S820: 10,12

ST   FGA: 23,26

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-02

AC   CVCL_A116

SY   Ma-Mel-2; MaMel02

DR   Cosmic; 1181742

DR   Cosmic; 1467735

DR   ESTDAB; ESTDAB-148

DR   GEO; GSM436986

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   FGA: 22,23

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-04

AC   CVCL_A117

SY   Ma-Mel-4; MaMel4

DR   BTO; BTO:0005337

DR   Cosmic; 1846562

DR   ECACC; 13012519

DR   ESTDAB; ESTDAB-209

RX   PubMed=17311103;

CC   Derived from metastatic site: Urinary bladder.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 12

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   FGA: 20,24

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-05

AC   CVCL_A118

SY   Ma-Mel-5; MaMel05; MaMel5

DR   BTO; BTO:0005338

DR   Cosmic; 1181768

DR   Cosmic; 1467736

DR   Cosmic; 1846563

DR   Cosmic; 2163838

DR   ECACC; 13012461

DR   ESTDAB; ESTDAB-149

DR   GEO; GSM436987

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,13

ST   D16S539: 8,13

ST   D3S1358: 15,17

ST   D5S818: 9,11

ST   D7S820: 11

ST   FGA: 20,21

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-06

AC   CVCL_A119

SY   Ma-Mel-6; MaMel06; MaMel6

DR   Cosmic; 1467737

DR   Cosmic; 1846564

DR   Cosmic; 2163839

DR   ECACC; 13012465

DR   ESTDAB; ESTDAB-150

DR   GEO; GSM436988

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 12,13

ST   D3S1358: 14,15

ST   D5S818: 12,13

ST   D7S820: 10

ST   FGA: 22,26

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-07

AC   CVCL_A120

SY   Ma-Mel-7; MaMel7

DR   Cosmic; 1846565

DR   Cosmic; 2163835

DR   ECACC; 13012459

DR   ESTDAB; ESTDAB-137

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10

ST   D16S539: 9,12

ST   D3S1358: 17,18

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   FGA: 24,25

ST   TH01: 6,10

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-08a

AC   CVCL_A121

SY   Ma-Mel-8a; MaMel08a

DR   Cosmic; 1467738

DR   Cosmic; 1846566

DR   Cosmic; 2163818

DR   ECACC; 13012434

DR   ESTDAB; ESTDAB-105

DR   GEO; GSM436989

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 9,13

ST   D3S1358: 14,15

ST   D5S818: 12,13

ST   D7S820: 10

ST   FGA: 21

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A122 ! Ma-Mel-08b

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-08b

AC   CVCL_A122

SY   Ma-Mel-8b

DR   Cosmic; 1846567

DR   ESTDAB; ESTDAB-190

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 10

ST   FGA: 21

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A121 ! Ma-Mel-08a

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-10

AC   CVCL_A123

SY   MaMel10

DR   Cosmic; 1467739

DR   ESTDAB; ESTDAB-151

DR   GEO; GSM436990

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 8,12

ST   FGA: 23,26

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 13,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-100a

AC   CVCL_A124

SY   Ma-Mel-100

DR   Cosmic; 1846569

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-101

AC   CVCL_A125

SY   MaMel101

DR   Cosmic; 1467782

DR   Cosmic; 1846570

DR   GEO; GSM437032

DR   IGRhCellID; MaMel101

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-102a

AC   CVCL_A126

SY   Ma-Mel-102

DR   Cosmic; 1846571

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-103a

AC   CVCL_A127

SY   MaMel103a

DR   Cosmic; 1467783

DR   Cosmic; 1846572

DR   GEO; GSM437033

DR   IGRhCellID; MaMel103anew

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A128 ! Ma-Mel-103b

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-103b

AC   CVCL_A128

DR   Cosmic; 1846573

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A127 ! Ma-Mel-103a

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-104

AC   CVCL_A129

RX   PubMed=17311103;

CC   Derived from metastatic site: Lung.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-105

AC   CVCL_A130

DR   Cosmic; 1846575

RX   PubMed=17311103;

CC   Derived from metastatic site: Liver.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-107

AC   CVCL_A131

SY   MaMel107

DR   Cosmic; 1467784

DR   GEO; GSM437034

DR   IGRhCellID; MaMel107

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-108

AC   CVCL_A132

SY   Ma-mel-108

DR   Cosmic; 1846577

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-11

AC   CVCL_A133

SY   MaMel11

DR   BTO; BTO:0005339

DR   Cosmic; 1467740

DR   Cosmic; 1846578

DR   Cosmic; 2163820

DR   ESTDAB; ESTDAB-108

DR   GEO; GSM436991

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D3S1358: 17

ST   D5S818: 10,11

ST   D7S820: 10

ST   FGA: 25,26

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-110

AC   CVCL_A134

SY   MaMel110

DR   Cosmic; 1467785

DR   Cosmic; 1846579

DR   GEO; GSM437035

DR   IGRhCellID; MaMel110

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-112

AC   CVCL_A135

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-113

AC   CVCL_A136

SY   MaMel113

DR   Cosmic; 1467786

DR   GEO; GSM437036

DR   IGRhCellID; MaMel113

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-114

AC   CVCL_A137

SY   MaMel114

DR   Cosmic; 1467787

DR   Cosmic; 1846582

DR   GEO; GSM437037

DR   IGRhCellID; MaMel114new

RX   PubMed=17311103;

CC   Derived from metastatic site: Brain.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-119

AC   CVCL_A138

SY   MaMel119

DR   Cosmic; 1467788

DR   Cosmic; 1846583

DR   GEO; GSM437038

DR   IGRhCellID; MaMel119

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-12

AC   CVCL_A139

SY   MaMel12

DR   BTO; BTO:0005340

DR   Cosmic; 1467741

DR   Cosmic; 1846584

DR   ESTDAB; ESTDAB-103

DR   GEO; GSM436992

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-120

AC   CVCL_A140

DR   Cosmic; 1846585

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-121a

AC   CVCL_A141

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-122

AC   CVCL_A142

SY   Ma-mel-122

DR   Cosmic; 1846587

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-123

AC   CVCL_A143

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-126

AC   CVCL_A144

SY   MaMel126

DR   Cosmic; 1467789

DR   Cosmic; 1846589

DR   GEO; GSM437039

DR   IGRhCellID; MaMel126

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-128a

AC   CVCL_A145

SY   MaMel128a

DR   Cosmic; 1467790

DR   Cosmic; 1846590

DR   GEO; GSM437040

DR   IGRhCellID; MaMel128a

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-13

AC   CVCL_A146

SY   MaMel13

DR   Cosmic; 1181754

DR   Cosmic; 1467742

DR   Cosmic; 1846591

DR   GEO; GSM436993

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-130

AC   CVCL_A147

SY   MaMel130

DR   Cosmic; 1467791

DR   Cosmic; 1846592

DR   GEO; GSM437042

DR   IGRhCellID; MaMel130

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-134

AC   CVCL_A148

SY   MaMel134

DR   Cosmic; 1467792

DR   Cosmic; 1846593

DR   GEO; GSM437043

DR   IGRhCellID; MaMel134

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-136

AC   CVCL_A149

SY   MaMel136

DR   Cosmic; 1467793

DR   GEO; GSM437044

DR   IGRhCellID; MaMel136

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-14

AC   CVCL_A150

DR   Cosmic; 1181758

DR   Cosmic; 1846595

DR   ESTDAB; ESTDAB-210

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 8,10

ST   FGA: 20,23

ST   TH01: 7

ST   TPOX: 9,12

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-15

AC   CVCL_A151

SY   Ma-mel-15

DR   Cosmic; 1181744

DR   ECACC; 13012520

DR   ESTDAB; ESTDAB-138

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 9,11

ST   D3S1358: 14,16

ST   D5S818: 11,13

ST   D7S820: 9,12

ST   FGA: 21

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-150a

AC   CVCL_A152

SY   MaMel150a

DR   Cosmic; 1467794

DR   Cosmic; 1846597

DR   GEO; GSM437045

DR   IGRhCellID; MaMel150a

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-16

AC   CVCL_A153

DR   Cosmic; 1181756

DR   Cosmic; 1846598

DR   ESTDAB; ESTDAB-165

RX   PubMed=17311103;

CC   Derived from metastatic site: Small bowel.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-16a

AC   CVCL_A154

DR   Cosmic; 906460

RX   PubMed=15760917;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-17

AC   CVCL_A155

SY   MaMel17

DR   BTO; BTO:0005341

DR   Cosmic; 1181757

DR   Cosmic; 1467743

DR   Cosmic; 1846599

DR   GEO; GSM436994

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-19

AC   CVCL_A156

SY   MaMel19

DR   BTO; BTO:0005342

DR   Cosmic; 1181750

DR   Cosmic; 1467744

DR   Cosmic; 1846600

DR   Cosmic; 2163840

DR   ECACC; 13012460

DR   ESTDAB; ESTDAB-152

DR   GEO; GSM436995

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 11,13

ST   D3S1358: 17

ST   D5S818: 9,12

ST   D7S820: 8,9

ST   FGA: 18,22

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-20

AC   CVCL_A157

DR   Cosmic; 1846601

DR   Cosmic; 2163841

DR   ESTDAB; ESTDAB-153

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D3S1358: 15,18

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   FGA: 23

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-21

AC   CVCL_A158

SY   MaMel21

DR   Cosmic; 1467745

DR   Cosmic; 1846602

DR   Cosmic; 2163842

DR   ESTDAB; ESTDAB-154

DR   GEO; GSM436996

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   FGA: 23,24

ST   TH01: 7

ST   TPOX: 11,12

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-22

AC   CVCL_A159

DR   Cosmic; 1846603

DR   ECACC; 13012452

DR   ESTDAB; ESTDAB-143

RX   PubMed=17311103;

CC   Derived from metastatic site: Kidney.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8,11

ST   D16S539: 11,14

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-23

AC   CVCL_A160

SY   MaMel23

DR   Cosmic; 1467746

DR   Cosmic; 2163843

DR   ESTDAB; ESTDAB-155

DR   GEO; GSM436997

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 9

ST   FGA: 21

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-24

AC   CVCL_N784

DR   Cosmic; 1846605

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-25

AC   CVCL_A161

DR   Cosmic; 2163851

DR   ESTDAB; ESTDAB-167

RX   PubMed=17311103;

CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   FGA: 21,25

ST   TH01: 8,9

ST   TPOX: 8,9

ST   vWA: 14,15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-26a

AC   CVCL_A162

SY   Ma-Mel-26A; MaMel26a

DR   Cosmic; 1181764

DR   Cosmic; 1467747

DR   Cosmic; 1846607

DR   ESTDAB; ESTDAB-156

DR   GEO; GSM436998

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_N785 ! Ma-Mel-26b

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-26b

AC   CVCL_N785

DR   Cosmic; 1846608

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A162 ! Ma-Mel-26a

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-27

AC   CVCL_A163

SY   MaMel27

DR   Cosmic; 1181769

DR   Cosmic; 1467748

DR   Cosmic; 2163852

DR   ECACC; 13012485

DR   ESTDAB; ESTDAB-168

DR   GEO; GSM436999

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,13 (ECACC)

ST   CSF1PO: 10 (ESTDAB)

ST   D13S317: 8,11

ST   D16S539: 11,14

ST   D3S1358: 16,18

ST   D5S818: 12

ST   D7S820: 10,12

ST   FGA: 20,21

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-28

AC   CVCL_A164

SY   Ma-mel-28; MaMel28

DR   Cosmic; 906465

DR   Cosmic; 1181763

DR   Cosmic; 2163816

DR   ECACC; 13012515

DR   ESTDAB; ESTDAB-102

RX   PubMed=15760917;

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 8,12

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 8

ST   FGA: 19,21

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-30

AC   CVCL_A165

SY   MaMel30

DR   Cosmic; 1467749

DR   Cosmic; 2163817

DR   ESTDAB; ESTDAB-104

DR   GEO; GSM437000

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 10,11

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 11

ST   FGA: 21,23.2

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-31

AC   CVCL_A166

DR   Cosmic; 1846612

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-32

AC   CVCL_A167

SY   MaMel32

DR   Cosmic; 1467750

DR   Cosmic; 1846613

DR   Cosmic; 2163853

DR   ESTDAB; ESTDAB-170

DR   GEO; GSM437001

DR   IGRhCellID; MaMel32new

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D3S1358: 15,16

ST   D5S818: 9,12

ST   D7S820: 9,10

ST   FGA: 20

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-33

AC   CVCL_A168

DR   Cosmic; 1846614

DR   ESTDAB; ESTDAB-139

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-34

AC   CVCL_A169

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-35

AC   CVCL_A170

SY   MaMel35

DR   Cosmic; 1467751

DR   GEO; GSM437002

DR   IGRhCellID; MaMel35

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-36

AC   CVCL_A171

SY   MaMel36

DR   Cosmic; 1467752

DR   Cosmic; 1846616

DR   ESTDAB; ESTDAB-144

DR   GEO; GSM437003

DR   IGRhCellID; MaMel36new

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-37a

AC   CVCL_A172

SY   MaMel37a

DR   Cosmic; 1467753

DR   Cosmic; 1846617

DR   GEO; GSM437004

DR   IGRhCellID; MaMel37a

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A173 ! Ma-Mel-37b

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-37b

AC   CVCL_A173

DR   BTO; BTO:0005343

DR   Cosmic; 1846618

DR   ESTDAB; ESTDAB-211

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 8,10

ST   D13S317: 9,11

ST   D3S1358: 14,16

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   FGA: 21,25

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A172 ! Ma-Mel-37a

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-38

AC   CVCL_A174

SY   MaMel38

DR   Cosmic; 1467754

DR   Cosmic; 1846619

DR   Cosmic; 2163854

DR   ESTDAB; ESTDAB-171

DR   GEO; GSM437005

DR   IGRhCellID; MaMel38

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8,10

ST   D3S1358: 17,18

ST   D5S818: 11,12

ST   D7S820: 10

ST   FGA: 25

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-39a

AC   CVCL_A175

SY   Ma-Mel-39A; MaMel39a

DR   Cosmic; 1467755

DR   Cosmic; 1846620

DR   Cosmic; 2163855

DR   ECACC; 13012489

DR   ESTDAB; ESTDAB-172

DR   GEO; GSM437006

DR   IGRhCellID; MaMel39a

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 13

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 10

ST   FGA: 21,22

ST   TH01: 6,8

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-40

AC   CVCL_A176

SY   MaMel40

DR   Cosmic; 1467756

DR   Cosmic; 1846621

DR   ESTDAB; ESTDAB-212

DR   GEO; GSM437007

DR   IGRhCellID; MaMel40

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D3S1358: 16,17

ST   D5S818: 10,13

ST   D7S820: 8,10

ST   FGA: 24

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-41

AC   CVCL_A177

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-42

AC   CVCL_A178

RX   PubMed=17311103;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-42a

AC   CVCL_C572

SY   Ma-Mel-42A

DR   ESTDAB; ESTDAB-140

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 10,14

ST   FGA: 19,22

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C287 ! Ma-Mel-42b

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-42b

AC   CVCL_C287

DR   BTO; BTO:0005344

DR   ESTDAB; ESTDAB-213

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 10,14

ST   FGA: 19,22

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C572 ! Ma-Mel-42a

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-43

AC   CVCL_A179

DR   Cosmic; 906466

RX   PubMed=15760917;

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-45a

AC   CVCL_A180

SY   Ma-Mel-45A; MaMel45a

DR   Cosmic; 1467757

DR   Cosmic; 1846625

DR   Cosmic; 2163856

DR   ECACC; 13012486

DR   ESTDAB; ESTDAB-173

DR   GEO; GSM437008

DR   IGRhCellID; MaMel45a

RX   PubMed=17311103;

CC   Derived from metastatic site: Brain.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 12

ST   D3S1358: 14,18

ST   D5S818: 12

ST   D7S820: 9,13

ST   FGA: 21

ST   TH01: 7,8

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C262 ! Ma-Mel-45b

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-45b

AC   CVCL_C262

DR   Cosmic; 1846626

DR   ESTDAB; ESTDAB-193

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D3S1358: 14,18

ST   D5S818: 12

ST   D7S820: 9,13

ST   FGA: 21

ST   TH01: 7,8

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A180 ! Ma-Mel-45a

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-46

AC   CVCL_A181

DR   Cosmic; 1846627

DR   ESTDAB; ESTDAB-214

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8,10

ST   FGA: 19,25

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-47

AC   CVCL_A182

DR   BTO; BTO:0005345

DR   Cosmic; 1846628

DR   Cosmic; 2163862

DR   ESTDAB; ESTDAB-194

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   FGA: 24

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-48a

AC   CVCL_A183

SY   Ma-Mel-48A

DR   Cosmic; 1846629

DR   Cosmic; 2163863

DR   ESTDAB; ESTDAB-195

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 14

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 9

ST   FGA: 21,23

ST   TH01: 6,8

ST   TPOX: 8,10

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_N786 ! Ma-Mel-48b

OI   CVCL_N787 ! Ma-Mel-48c

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-48b

AC   CVCL_N786

DR   Cosmic; 1846630

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A183 ! Ma-Mel-48a

OI   CVCL_N787 ! Ma-Mel-48c

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-48c

AC   CVCL_N787

DR   Cosmic; 1846631

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A183 ! Ma-Mel-48a

OI   CVCL_N786 ! Ma-Mel-48b

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-49

AC   CVCL_A184

RX   PubMed=17311103;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-50

AC   CVCL_A185

RX   PubMed=17311103;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-51

AC   CVCL_A186

SY   MaMel51

DR   Cosmic; 906461

DR   Cosmic; 1467758

DR   Cosmic; 1846635

DR   Cosmic; 2163864

DR   ESTDAB; ESTDAB-196

DR   GEO; GSM437009

DR   IGRhCellID; MaMel51

RX   PubMed=15760917;

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9,11

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 8,9

ST   FGA: 24,25

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-52

AC   CVCL_A187

DR   BTO; BTO:0005346

DR   Cosmic; 1846636

DR   ESTDAB; ESTDAB-197

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D3S1358: 14,16

ST   D5S818: Not_detected

ST   D7S820: 8,14

ST   FGA: 20,21

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-53

AC   CVCL_A188

SY   MaMel53

DR   Cosmic; 1467759

DR   Cosmic; 1846637

DR   ESTDAB; ESTDAB-198

DR   GEO; GSM437010

DR   IGRhCellID; MaMel53

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 11,13

ST   D3S1358: 17,18

ST   D5S818: 12

ST   D7S820: 10

ST   FGA: 20,23

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-54a

AC   CVCL_A189

DR   Cosmic; 1846639

DR   Cosmic; 2163857

DR   ECACC; 13012484

DR   ESTDAB; ESTDAB-174

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,13

ST   D16S539: 9,11

ST   D3S1358: 14,16

ST   D5S818: 12,13

ST   D7S820: 12,13 (ECACC)

ST   D7S820: 12 (ESTDAB)

ST   FGA: 22,22.2

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C288 ! Ma-Mel-54b

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-54b

AC   CVCL_C288

DR   ESTDAB; ESTDAB-215

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,13

ST   D3S1358: 14,16

ST   D5S818: 12,13

ST   D7S820: 12,13

ST   FGA: 22

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A189 ! Ma-Mel-54a

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-55

AC   CVCL_A190

DR   Cosmic; 1846640

DR   Cosmic; 2163865

DR   ESTDAB; ESTDAB-199

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D3S1358: 15,17

ST   D5S818: 10,11

ST   D7S820: 8,10

ST   FGA: 23,24

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-56

AC   CVCL_A191

DR   Cosmic; 1846641

DR   Cosmic; 2163866

DR   ESTDAB; ESTDAB-200

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D3S1358: 17

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   FGA: 25

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-57

AC   CVCL_A192

SY   MaMel57

DR   Cosmic; 906462

DR   Cosmic; 1467760

DR   Cosmic; 1846642

DR   GEO; GSM437011

DR   IGRhCellID; MaMel57

RX   PubMed=15760917;

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-58

AC   CVCL_A193

SY   MaMel58

DR   Cosmic; 1467761

DR   GEO; GSM437012

DR   IGRhCellID; MaMel58

RX   PubMed=17311103;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-59a

AC   CVCL_A194

SY   MaMel59a

DR   Cosmic; 1467762

DR   Cosmic; 1846644

DR   ESTDAB; ESTDAB-202

DR   GEO; GSM437013

DR   IGRhCellID; MaMel59a

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 8,12

ST   FGA: 20,22

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C289 ! Ma-Mel-59b

OI   CVCL_C290 ! Ma-Mel-59c

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-59b

AC   CVCL_C289

DR   Cosmic; 1846645

DR   ESTDAB; ESTDAB-216

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 8,12

ST   FGA: 20,22

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A194 ! Ma-Mel-59a

OI   CVCL_C290 ! Ma-Mel-59c

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-59c

AC   CVCL_C290

DR   Cosmic; 1846646

DR   ESTDAB; ESTDAB-217

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 8,12

ST   FGA: 20,22

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A194 ! Ma-Mel-59a

OI   CVCL_C289 ! Ma-Mel-59b

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-60

AC   CVCL_A195

SY   MaMel60

DR   Cosmic; 1467763

DR   Cosmic; 1846647

DR   ESTDAB; ESTDAB-203

DR   GEO; GSM437014

DR   IGRhCellID; MaMel60

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D3S1358: 15,16

ST   D5S818: 9

ST   D7S820: 10

ST   FGA: 25

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-61a

AC   CVCL_C291

AS   CVCL_A196

SY   Ma-Mel-61A; MaMel61a; Ma-Mel-61

DR   Cosmic; 1467764

DR   Cosmic; 1846648

DR   ESTDAB; ESTDAB-218

DR   GEO; GSM437015

DR   IGRhCellID; MaMel61a

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C292 ! Ma-Mel-61b

OI   CVCL_S666 ! Ma-Mel-61c

OI   CVCL_S667 ! Ma-Mel-61e

OI   CVCL_S668 ! Ma-Mel-61f

OI   CVCL_S669 ! Ma-Mel-61g

OI   CVCL_S670 ! Ma-Mel-61h

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-61b

AC   CVCL_C292

DR   Cosmic; 1846649

DR   ESTDAB; ESTDAB-219

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 9,12

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 12

ST   FGA: 20

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C291 ! Ma-Mel-61a

OI   CVCL_S666 ! Ma-Mel-61c

OI   CVCL_S667 ! Ma-Mel-61e

OI   CVCL_S668 ! Ma-Mel-61f

OI   CVCL_S669 ! Ma-Mel-61g

OI   CVCL_S670 ! Ma-Mel-61h

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-61c

AC   CVCL_S666

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C291 ! Ma-Mel-61a

OI   CVCL_C292 ! Ma-Mel-61b

OI   CVCL_S667 ! Ma-Mel-61e

OI   CVCL_S668 ! Ma-Mel-61f

OI   CVCL_S669 ! Ma-Mel-61g

OI   CVCL_S670 ! Ma-Mel-61h

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-61e

AC   CVCL_S667

DR   Cosmic; 1846651

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C291 ! Ma-Mel-61a

OI   CVCL_C292 ! Ma-Mel-61b

OI   CVCL_S666 ! Ma-Mel-61c

OI   CVCL_S668 ! Ma-Mel-61f

OI   CVCL_S669 ! Ma-Mel-61g

OI   CVCL_S670 ! Ma-Mel-61h

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-61f

AC   CVCL_S668

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C291 ! Ma-Mel-61a

OI   CVCL_C292 ! Ma-Mel-61b

OI   CVCL_S666 ! Ma-Mel-61c

OI   CVCL_S667 ! Ma-Mel-61e

OI   CVCL_S669 ! Ma-Mel-61g

OI   CVCL_S670 ! Ma-Mel-61h

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-61g

AC   CVCL_S669

DR   Cosmic; 1846653

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C291 ! Ma-Mel-61a

OI   CVCL_C292 ! Ma-Mel-61b

OI   CVCL_S666 ! Ma-Mel-61c

OI   CVCL_S667 ! Ma-Mel-61e

OI   CVCL_S668 ! Ma-Mel-61f

OI   CVCL_S670 ! Ma-Mel-61h

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-61h

AC   CVCL_S670

DR   Cosmic; 1846654

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C291 ! Ma-Mel-61a

OI   CVCL_C292 ! Ma-Mel-61b

OI   CVCL_S666 ! Ma-Mel-61c

OI   CVCL_S667 ! Ma-Mel-61e

OI   CVCL_S668 ! Ma-Mel-61f

OI   CVCL_S669 ! Ma-Mel-61g

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-62

AC   CVCL_A197

SY   MaMel62

DR   Cosmic; 1467765

DR   Cosmic; 1846655

DR   GEO; GSM437016

DR   IGRhCellID; MaMel62

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-63a

AC   CVCL_A198

SY   Ma-Mel-63A; MaMel63a

DR   Cosmic; 1181755

DR   Cosmic; 1467766

DR   Cosmic; 1846656

DR   GEO; GSM437017

DR   IGRhCellID; MaMel63a

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C293 ! Ma-Mel-63b

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-63b

AC   CVCL_C293

DR   Cosmic; 1846657

DR   ESTDAB; ESTDAB-220

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,13

ST   D3S1358: 15,17

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   FGA: 22,23

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A198 ! Ma-Mel-63a

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-64

AC   CVCL_A199

RX   PubMed=17311103;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-65

AC   CVCL_A200

DR   Cosmic; 1846659

DR   ESTDAB; ESTDAB-221

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D3S1358: 15,17

ST   D5S818: 12,14

ST   D7S820: 10,12

ST   FGA: 19,23

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-66a

AC   CVCL_A201

SY   MaMel66a

DR   Cosmic; 1467767

DR   Cosmic; 1846660

DR   GEO; GSM437018

DR   IGRhCellID; MaMel66a

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A202 ! Ma-Mel-66b

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-66b

AC   CVCL_A202

DR   Cosmic; 1846661

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A201 ! Ma-Mel-66a

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-67

AC   CVCL_A203

SY   MaMel67

DR   Cosmic; 1467768

DR   Cosmic; 1846662

DR   GEO; GSM437019

DR   IGRhCellID; MaMel67

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-68

AC   CVCL_A204

DR   Cosmic; 1846663

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-69

AC   CVCL_A205

SY   MaMel69

DR   Cosmic; 1467769

DR   Cosmic; 1846664

DR   GEO; GSM437020

DR   IGRhCellID; MaMel69

RX   PubMed=17311103;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-70

AC   CVCL_A206

DR   Cosmic; 1846558

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-71

AC   CVCL_A207

SY   MaMel71

DR   Cosmic; 1181743

DR   Cosmic; 1467770

DR   ESTDAB; ESTDAB-205

DR   GEO; GSM437021

DR   IGRhCellID; MaMel71new

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D3S1358: 17

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   FGA: 23

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-73a

AC   CVCL_A208

SY   MaMel73a

DR   Cosmic; 1467771

DR   ESTDAB; ESTDAB-206

DR   GEO; GSM437022

DR   IGRhCellID; MaMel73a

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D3S1358: 14,15

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   FGA: 19

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A209 ! Ma-Mel-73b

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-73b

AC   CVCL_A209

DR   ESTDAB; ESTDAB-207

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10

ST   D3S1358: 14,15

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   FGA: 19,26

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A208 ! Ma-Mel-73a

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-74

AC   CVCL_A210

DR   Cosmic; 1846667

DR   ESTDAB; ESTDAB-208

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 9,11

ST   D3S1358: 15

ST   D5S818: 11,13

ST   FGA: 23,24

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-75

AC   CVCL_A211

SY   MaMel75

DR   Cosmic; 1467772

DR   GEO; GSM437023

DR   IGRhCellID; MaMel75

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-76

AC   CVCL_A212

SY   MaMel76

DR   Cosmic; 1467773

DR   GEO; GSM437024

DR   IGRhCellID; MaMel76

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-79

AC   CVCL_A213

SY   MaMel79

DR   Cosmic; 1181761

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-79b

AC   CVCL_A214

SY   Ma-Mel-79B; MaMel79b

DR   Cosmic; 1467774

DR   GEO; GSM437025

DR   IGRhCellID; MaMel79b

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-80a

AC   CVCL_A215

SY   MaMel80a

DR   Cosmic; 1181760

DR   Cosmic; 1467775

DR   Cosmic; 1846671

DR   GEO; GSM437026

DR   IGRhCellID; MaMel80anew

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-81

AC   CVCL_A216

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-82

AC   CVCL_A217

SY   MaMel82

DR   Cosmic; 1846673

RX   PubMed=17311103;

RX   PubMed=24581590;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-83

AC   CVCL_A218

SY   MaMel83

DR   Cosmic; 1181751

DR   Cosmic; 1846674

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-84

AC   CVCL_A219

DR   Cosmic; 1846675

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-85

AC   CVCL_A220

SY   Ma-mel-85; MaMel85

DR   Cosmic; 1181753

DR   Cosmic; 1467776

DR   Cosmic; 1846676

DR   GEO; GSM437027

DR   IGRhCellID; MaMel85

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-86a

AC   CVCL_A221

SY   MaMel86a

DR   Cosmic; 1181752

DR   Cosmic; 1467777

DR   Cosmic; 1846677

DR   GEO; GSM437028

DR   IGRhCellID; MaMel86a

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A222 ! Ma-Mel-86b

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-86b

AC   CVCL_A222

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A221 ! Ma-Mel-86a

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-90

AC   CVCL_A223

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-91

AC   CVCL_A224

SY   MaMel91

DR   Cosmic; 1181762

DR   Cosmic; 1846679

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-92

AC   CVCL_A225

SY   MaMel92

DR   Cosmic; 1181759

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-92d

AC   CVCL_A226

DR   Cosmic; 1846680

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-93

AC   CVCL_A227

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-94

AC   CVCL_A228

SY   MaMel94

DR   Cosmic; 1467778

DR   Cosmic; 1846682

DR   GEO; GSM437029

DR   IGRhCellID; MaMel94

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-95

AC   CVCL_A229

SY   MaMel95

DR   Cosmic; 1467779

DR   Cosmic; 1846683

DR   GEO; GSM437030

DR   IGRhCellID; MaMel95

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ma-Mel-96

AC   CVCL_A230

DR   Cosmic; 1846684

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-97

AC   CVCL_A231

DR   Cosmic; 1846685

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ma-Mel-99

AC   CVCL_A232

SY   MaMel99

DR   Cosmic; 1467780

DR   Cosmic; 1846686

DR   GEO; GSM437031

DR   IGRhCellID; MaMel99new

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ma-Mel-KNUD

AC   CVCL_C505

SY   KNUD; MaMel_KNUD

DR   Cosmic; 1467781

DR   Cosmic; 2163834

DR   ESTDAB; ESTDAB-136

DR   GEO; GSM437046

DR   IGRhCellID; MaMel_KNUD

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8

ST   D3S1358: 14,17

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   FGA: 20,24

ST   TH01: 9.3

ST   TPOX: 8,12

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MA01

AC   CVCL_C341

SY   MA 01; Ma01; ACTe001-A

DR   hPSCreg; ACTe001-A

DR   ISCR; 135

RX   PubMed=16929302;

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-38(1).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MA03

AC   CVCL_C342

SY   MA 03

DR   ISCR; 136

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MA04

AC   CVCL_C343

SY   MA 04

DR   ISCR; 138

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MA09

AC   CVCL_C344

SY   MA 09; Ma09; ACTe002-A

DR   hPSCreg; ACTe002-A

DR   ISCR; 137

RX   PubMed=16929302;

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-38(2).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MA1-3

AC   CVCL_J837

RX   PubMed=6809625;

CC   Monoclonal antibody target: UniProtKB; Q9I4Z4; Pseudomonas aeruginosa oprL (H2) (also reacts with other species).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MA1-6

AC   CVCL_J838

DR   CLO; CLO_0007496

DR   ATCC; CRL-1783

RX   PubMed=6809625;

CC   Monoclonal antibody target: UniProtKB; Q9I4Z4; Pseudomonas aeruginosa oprL (H2) (also reacts with other species).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MA1-8

AC   CVCL_J839

RX   PubMed=6809625;

CC   Monoclonal antibody target: UniProtKB; Q9I4Z4; Pseudomonas aeruginosa oprL (H2) (also reacts with other species).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MA126

AC   CVCL_B895

SY   MA 126; NED1; NED 1

DR   ISCR; 144

RX   PubMed=18371431;

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MA127

AC   CVCL_B896

SY   MA 127; NED2; NED 2

DR   ISCR; 145

RX   PubMed=18371431;

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MA128

AC   CVCL_B897

SY   MA 128; NED3; NED 3

DR   ISCR; 146

RX   PubMed=18371431;

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MA129

AC   CVCL_B898

SY   MA 129; NED4; NED 4

DR   ISCR; 147

RX   PubMed=18371431;

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MA133

AC   CVCL_B899

SY   MA 133

DR   ISCR; 148

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA135

AC   CVCL_B900

SY   MA 135

DR   ISCR; 149

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=402

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0072.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA136

AC   CVCL_B901

SY   MA 136

DR   ISCR; 150

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA137

AC   CVCL_B902

SY   MA 137

DR   ISCR; 151

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA138

AC   CVCL_B903

SY   MA 138

DR   ISCR; 152

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA139

AC   CVCL_B904

SY   MA 139

DR   ISCR; 153

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA140

AC   CVCL_B905

SY   MA 140

DR   ISCR; 154

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA141

AC   CVCL_C116

SY   MA 141

DR   ISCR; 155

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MA148

AC   CVCL_AK47

SY   MA 148; MA-148

RX   PubMed=8640821;

RX   PubMed=10786683;

RX   PubMed=12361951;

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MA1K

AC   CVCL_S499

DR   ATCC; CRL-6284

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6284; true.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

SX   Sex undetermined

CA   Finite cell line

//

ID   MA2.1

AC   CVCL_L672

DR   CLO; CLO_0007497

DR   ATCC; HB-54

RX   PubMed=6167544;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MA214L

AC   CVCL_5I01

SY   RAFT0069

DR   ECACC; 07042302

RX   PubMed=9138163;

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3267; Wilms tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MA2T

AC   CVCL_S500

DR   ATCC; CRL-6285

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6285; true.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

SX   Sex undetermined

CA   Cancer cell line

//

ID   MA40

AC   CVCL_C337

SY   MA 40

DR   ISCR; 140

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MA42

AC   CVCL_C338

SY   MA 42

DR   ISCR; 141

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Ma44-3

AC   CVCL_W133

RX   PubMed=15161017;

RX   PubMed=16170033;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7071 ! Ma-44

CA   Cancer cell line

//

ID   Ma44-3-GFP

AC   CVCL_W134

RX   PubMed=15161017;

CC   Transfected with: UniProtKB; P42212; GFP.

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W133 ! Ma44-3

CA   Cancer cell line

//

ID   MA50

AC   CVCL_C339

SY   MA 50

DR   ISCR; 142

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: Advanced Cell Technology, Inc.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MA99

AC   CVCL_C340

SY   MA 99

DR   ISCR; 143

WW   http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf

CC   From: Advanced Cell Technology, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Mab 108

AC   CVCL_L581

DR   CLO; CLO_0007502

DR   ATCC; HB-9764

RX   Patent=US6217866;

CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Mab 126

AC   CVCL_L582

DR   CLO; CLO_0007503

DR   ATCC; HB-8568

RX   Patent=US4675287;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   mAb 13-1

AC   CVCL_L583

DR   CLO; CLO_0007504

DR   ATCC; HB-10565

RX   Patent=US5981714;

CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   mAb 13-2

AC   CVCL_L584

DR   ATCC; HB-10566

RX   Patent=US5981714;

CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.

CC   Discontinued: ATCC; HB-10566; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   MAb 151-45-4

AC   CVCL_L585

DR   CLO; CLO_0007505

DR   ATCC; HB-12682

RX   Patent=US6323325;

RX   PubMed=10376770;

CC   Monoclonal antibody target: UniProtKB; P11509; Human CYP2A6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MAb 175-62

AC   CVCL_W643

DR   ATCC; PTA-1553

RX   Patent=US6998468;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MAb 1812-4-8

AC   CVCL_L586

DR   CLO; CLO_0007506

DR   ATCC; HB-12683

RX   Patent=US6335428;

CC   Monoclonal antibody target: UniProtKB; P05177; Human CYP1A2.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   Mab 1E8

AC   CVCL_L587

DR   CLO; CLO_0007507

DR   ATCC; HB-11490

RX   Patent=US6232080;

CC   Monoclonal antibody target: UniProtKB; P18428; Human LBP.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   mAb 239

AC   CVCL_L687

SY   239

DR   ATCC; HB-8288

RX   Patent=US5009995;

CC   Monoclonal antibody target: UniProtKB; P40189; Human IL6ST/CD130/gp130.

CC   Discontinued: ATCC; HB-8288; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   mAb 24-1

AC   CVCL_L588

SY   mAB 24-1

DR   CLO; CLO_0007508

DR   ATCC; HB-11947

RX   Patent=US5981714;

CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   mAb 24-2

AC   CVCL_L589

SY   mAB 24-2

DR   CLO; CLO_0007509

DR   ATCC; HB-11946

RX   Patent=US5981714;

CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   MAb 26-7-5

AC   CVCL_L590

DR   CLO; CLO_0007510

DR   ATCC; HB-12681

RX   Patent=US6335428;

CC   Monoclonal antibody target: UniProtKB; P05177; Human CYP1A2.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   mAb 270

AC   CVCL_9217

DR   CLO; CLO_0007511

DR   ATCC; HB-189

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4696 ! S194/5.XXO.BU.1

CA   Hybridoma

//

ID   Mab 2B5

AC   CVCL_L591

DR   CLO; CLO_0007512

DR   ATCC; HB-11491

RX   Patent=US6232080;

CC   Monoclonal antibody target: UniProtKB; P18428; Human LBP.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   mAb 35

AC   CVCL_4539

SY   mAB 35; MAB 35; mAb35

DR   CLO; CLO_0007513

DR   CLO; CLO_0007514

DR   CLO; CLO_0007524

DR   CLDB; cl5225

DR   ATCC; HB-8857

DR   ATCC; TIB-175

DR   IZSLER; BS Hy 10

RX   PubMed=6948300;

CC   Monoclonal antibody target: UniProtKB; P09688; Electrophorus electricus chrna1.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4696 ! S194/5.XXO.BU.1

CA   Hybridoma

//

ID   MAb 5.2

AC   CVCL_L592

SY   #5.2

DR   CLO; CLO_0007515

DR   ATCC; HB-9148

RX   Patent=US5376370;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   Mab 543

AC   CVCL_L593

DR   CLO; CLO_0007516

DR   ATCC; HB-8592

RX   Patent=US4672044;

CC   Monoclonal antibody target: UniProtKB; P17927; Human CR1/CD35.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   Mab 62B1-PC

AC   CVCL_3393

SY   62B1

DR   CLO; CLO_0007517

DR   CLDB; cl4917

DR   ICLC; HYL98001

RX   PubMed=3319299;

CC   Monoclonal antibody target: Human unidentified plasma cell-associated antigen.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   mAb 64

AC   CVCL_8963

SY   mAb64

DR   CLO; CLO_0007525

DR   ATCC; HB-8987

RX   PubMed=6948300;

CC   Monoclonal antibody target: UniProtKB; P02709; Bovine CHRNA1.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   mAb 829

AC   CVCL_L688

SY   829

DR   ATCC; HB-8289

RX   Patent=US5009995;

CC   Monoclonal antibody target: UniProtKB; P40189; Human IL6ST/CD130/gp130.

CC   Discontinued: ATCC; HB-8289; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Mab 8A-PC

AC   CVCL_3394

SY   8A

DR   CLO; CLO_0007518

DR   CLDB; cl4915

DR   ICLC; HYL98002

RX   PubMed=3319299;

CC   Monoclonal antibody target: Human unidentified plasma cell-associated antigen.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   Mab 8F6-PC

AC   CVCL_3395

SY   8F6

DR   CLO; CLO_0007519

DR   CLDB; cl4916

DR   ICLC; HYL98003

RX   PubMed=3319299;

CC   Monoclonal antibody target: Human unidentified plasma cell-associated antigen.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MAb 951-5-1

AC   CVCL_L594

DR   CLO; CLO_0007520

DR   ATCC; HB-12684

RX   Patent=US6335428;

CC   Monoclonal antibody target: UniProtKB; P05177; Human CYP1A2.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   Mab 96

AC   CVCL_L595

DR   CLO; CLO_0007521

DR   ATCC; HB-9763

RX   Patent=US6217866;

CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.

CC   Discontinued: ATCC; HB-9763; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   mAb 986.35

AC   CVCL_L689

SY   986.35; 986; mAB 986

DR   ATCC; HB-9284

RX   Patent=US5009995;

CC   Monoclonal antibody target: UniProtKB; P40189; Human IL6ST/CD130/gp130.

CC   Discontinued: ATCC; HB-9284; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   mAb BB7

AC   CVCL_L596

DR   CLO; CLO_0007522

DR   ATCC; CRL-2501

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MAb D10

AC   CVCL_Z990

RX   Patent=US8975030;

CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center (CGMCC); CGMCC No.2904.

CC   Monoclonal antibody target: UniProtKB; P07900; Human HSP90AA1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MAb E9

AC   CVCL_Z989

RX   Patent=US8975030;

CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center (CGMCC); CGMCC No.2903.

CC   Monoclonal antibody target: UniProtKB; P07900; Human HSP90AA1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MAb104

AC   CVCL_G668

DR   CLO; CLO_0007523

DR   ATCC; CRL-2067

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Maben

AC   CVCL_X194

RX   DOI=10.1007/978-1-4757-1647-4_13;

RX   PubMed=13258519;

RX   PubMed=13472685;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MAC 13

AC   CVCL_S000

SY   MAC13; Murine Adenocarcinoma of the Colon 13

DR   ChEMBL-Cells; CHEMBL3307283

DR   ChEMBL-Targets; CHEMBL614042

RX   PubMed=9683789;

RX   PubMed=11440905;

CC   Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).

CC   Breed/subspecies: NMRI.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MAC 15A

AC   CVCL_H587

SY   MAC15A; Murine Adenocarcinoma of the Colon 15A

DR   ChEMBL-Cells; CHEMBL3307539

DR   ChEMBL-Targets; CHEMBL614121

WW   http://www.ukessays.com/essays/sciences/mac-15a-cell-line.php

CC   Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).

CC   Breed/subspecies: NMRI.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MAC 16

AC   CVCL_S001

SY   MAC16; Murine Adenocarcinoma of the Colon 16

DR   ChEMBL-Cells; CHEMBL3307490

DR   ChEMBL-Targets; CHEMBL614318

RX   PubMed=9683789;

RX   PubMed=11440905;

CC   Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).

CC   Breed/subspecies: NMRI.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MAC 2-48

AC   CVCL_L547

DR   CLO; CLO_0007526

DR   ATCC; HB-10714

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MAC 26

AC   CVCL_S002

SY   MAC26; Murine Adenocarcinoma of the Colon 26

DR   ChEMBL-Cells; CHEMBL3307878

DR   ChEMBL-Targets; CHEMBL614122

RX   PubMed=9683789;

CC   Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).

CC   Breed/subspecies: NMRI.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Mac-1

AC   CVCL_H631

SY   MAC-1; MAC1; McG-1

DR   BTO; BTO:0004869

DR   Cosmic; 2013355

DR   GEO; GSM1217151

RX   CelloPub=CLPUB00077;

RX   PubMed=1532439;

RX   PubMed=2456698;

RX   PubMed=2898211;

DI   NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_H632 ! Mac-2

SX   Male

CA   Cancer cell line

//

ID   Mac-2

AC   CVCL_H632

SY   MAC-2; McG-2

RX   CelloPub=CLPUB00077;

RX   PubMed=2456698;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_H631 ! Mac-1

SX   Male

CA   Cancer cell line

//

ID   MAC-2

AC   CVCL_S921

RX   PubMed=8039117;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mac-2A

AC   CVCL_H637

SY   MAC-2A; McG-2A; PB-2A

RX   PubMed=1532439;

RX   PubMed=2789474;

RX   PubMed=15356658;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H632 ! Mac-2

SX   Male

CA   Cancer cell line

//

ID   Mac-2B

AC   CVCL_H638

SY   MAC-2B; McG-2B

RX   PubMed=1532439;

RX   PubMed=2789474;

RX   PubMed=15356658;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H632 ! Mac-2

SX   Male

CA   Cancer cell line

//

ID   MAC-21

AC   CVCL_M627

SY   MAC 21

RX   CelloPub=CLPUB00262;

RX   PubMed=13806813;

RX   PubMed=14098906;

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative. Originally thought to originate from a male patient lung adenocarcinoma. The original MAC-21 cell line was never tested for contamination. See the colorful description of the MAC-21 contamination story in the book from Michael Gold (CLPUB00262).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   MAC-T

AC   CVCL_U226

SY   Mac-T; MacT; Mammary Alveolar Cells-large T antigen

DR   ATCC; CRL-10274

DR   BCRJ; 0315

DR   GEO; GSE46476

RX   Patent=US5227301;

RX   Patent=US5455164;

RX   DOI=10.4172/2329-888X.1000103;

RX   PubMed=1423654;

RX   PubMed=1659986;

RX   PubMed=7540186;

RX   PubMed=14550508;

RX   PubMed=26659725;

CC   Doubling time: ~17 hours (PubMed=1659986); 48 hours, in serum-free medium (PubMed=7540186).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Omics: Transcriptome analysis.

CC   Anecdotal: Nexia, a former Canadian biotech company was orignally developed to make lactose-free free milk using MAC-T.

CC   Discontinued: ATCC; CRL-10274; probable.

OX   NCBI_TaxID=9913; ! Bos taurus

SX   Female

CA   Transformed cell line

//

ID   MAC-T CU-1

AC   CVCL_U230

SY   CU-1; MAC-T Cornell University-1

RX   PubMed=7540186;

CC   Doubling time: 16 hours, 78 hours, in serum-free medium (PubMed=7540186).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Miscellaneous: Cell line not available (personal communication of Politis I.).

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_U226 ! MAC-T

SX   Female

CA   Transformed cell line

//

ID   MAC-T CU-2

AC   CVCL_U231

SY   CU-2; MAC-T Cornell University-2

RX   PubMed=7540186;

CC   Doubling time: 15 hours, 46 hours, in serum-free medium (PubMed=7540186).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Miscellaneous: Cell line not available (personal communication of Politis I.).

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_U226 ! MAC-T

SX   Female

CA   Transformed cell line

//

ID   MAC-T CU-3

AC   CVCL_U232

SY   CU-3; MAC-T Cornell University-3

RX   PubMed=7540186;

CC   Doubling time: 14 hours, 80 hours, in serum-free medium (PubMed=7540186).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Miscellaneous: Cell line not available (personal communication of Politis I.).

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_U226 ! MAC-T

SX   Female

CA   Transformed cell line

//

ID   MaCa 1

AC   CVCL_M375

SY   MaCa1

RX   PubMed=7923078;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MaCa 2

AC   CVCL_M376

SY   MaCa2

RX   PubMed=7923078;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Machi

AC   CVCL_R796

DR   Wikidata; Q28521737

RX   PubMed=92573;

RX   PubMed=1690682;

RX   PubMed=8891732;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Transformed cell line

//

ID   MACKI

AC   CVCL_0A71

SY   Macki

DR   ATCC; CRL-6582

RX   PubMed=6500159;

CC   Group: Non-human primate cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ATCC; CRL-6582; true.

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Transformed cell line

//

ID   MacKinley

AC   CVCL_L362

SY   McKinley

DR   GEO; GSM1974793

RX   PubMed=21908323;

RX   PubMed=22916246;

RX   PubMed=26842912;

RX   PubMed=27197945;

RX   PubMed=27257868;

CC   Part of: FACC canine tumor cell line panel.

CC   Doubling time: 27.6 hours (PubMed=22916246).

CC   Omics: Transcriptome analysis.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   MACL-1

AC   CVCL_6846

DR   BTO; BTO:0005048

RX   PubMed=19725227;

RX   PubMed=23404580;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mad/C1

AC   CVCL_S501

DR   ATCC; CRL-6366

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6366; true.

DI   NCIt; C21762; Adenoma of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Mad/C3

AC   CVCL_S502

SY   Mad-C3

DR   ATCC; CRL-6367

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6367; true.

DI   NCIt; C21762; Adenoma of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MAD,MF

AC   CVCL_E768

SY   MAD, MF

DR   dbMHC; 48964

DR   ECACC; 94082232

DR   IHW; IHW9133

DR   IMGT/HLA; 11676

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl133.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MADB106

AC   CVCL_BT04

DR   CCRID; 3142C0001000000125

DR   KCB; KCB 2013045YJ

RX   PubMed=10220071;

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   Madsen

AC   CVCL_M139

DR   BTO; BTO:0004329

RX   PubMed=19831134;

CC   From: Youle R.; National Institutes of Health; Bethesda; USA.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MADURA

AC   CVCL_E769

SY   MADURA-T; GM08598

DR   CLO; CLO_0010592

DR   Coriell; GM08598

DR   dbMHC; 48965

DR   ECACC; 88052069

DR   IHW; IHW9069

DR   IMGT/HLA; 11044

WW   http://bioinformatics.hsanmartino.it/ecbr/cl69.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   MAEC

AC   CVCL_U411

DR   CLO; CLO_0051046

DR   RCB; RCB2712

RX   PubMed=17215585;

CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MAF

AC   CVCL_R844

SY   Megalobrama Amblycephala Fin

RX   PubMed=23532304;

CC   Group: Fish cell line.

OX   NCBI_TaxID=75352; ! Megalobrama amblycephala

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Mahlavu

AC   CVCL_0405

SY   MAHLAVU

DR   BTO; BTO:0004471

DR   MCCL; MCC:0000299

DR   Cosmic; 873398

DR   Cosmic; 948064

DR   Cosmic; 979727

DR   Cosmic; 1019317

DR   Cosmic; 2162534

DR   Cosmic; 2321039

RX   CelloPub=CLPUB00076;

RX   PubMed=179808;

RX   PubMed=2439335;

RX   PubMed=6268737;

RX   PubMed=8050184;

RX   PubMed=23887712;

RX   PubMed=25574106;

CC   Misspelling: Occasionally 'Malhavu'.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MAIL8

AC   CVCL_0406

DR   MCCL; MCC:0000300

RX   PubMed=15701651;

CC   Transfected with: HGNC; 16608; PYCARD.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   Mais-BL

AC   CVCL_7200

SY   Mais

RX   PubMed=9882297;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Maja

AC   CVCL_F516

SY   MAJA; GM03099

DR   CLO; CLO_0013481

DR   Coriell; GM03099

RX   PubMed=6806098;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   Maku

AC   CVCL_1Q44

AS   CVCL_W929

SY   MAKU; Mak-BL; MAK-BL; MAK; NK-51; NK51

RX   PubMed=170370;

RX   PubMed=2824665;

RX   PubMed=2943927;

RX   PubMed=3027441;

RX   PubMed=4122458;

RX   PubMed=4320167;

RX   PubMed=4364259;

RX   PubMed=4907973;

RX   PubMed=7316467;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Malme-3

AC   CVCL_1437

SY   MALME-3

DR   BTO; BTO:0004161

DR   CLO; CLO_0007528

DR   ATCC; HTB-102

DR   BCRJ; 0286

DR   BioSample; SAMN03471086

DR   Cosmic; 2233661

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Discontinued: BCRJ; 0286; probable.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,13

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 9,12

ST   TH01: 7,8

ST   TPOX: 8,9

ST   vWA: 15,16

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1438 ! Malme-3M

OI   CVCL_1E90 ! Malme-3S

SX   Male

CA   Finite cell line

//

ID   Malme-3M

AC   CVCL_1438

SY   MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M

DR   BTO; BTO:0004162

DR   CLO; CLO_0007529

DR   CLO; CLO_0007530

DR   EFO; EFO_0002243

DR   CLDB; cl3334

DR   ATCC; HTB-64

DR   BCRJ; 0287

DR   BioSample; SAMN03470851

DR   BioSample; SAMN03472750

DR   CCLE; MALME3M_SKIN

DR   ChEMBL-Cells; CHEMBL3307507

DR   ChEMBL-Targets; CHEMBL614021

DR   Cosmic; 686474

DR   Cosmic; 687438

DR   Cosmic; 706116

DR   Cosmic; 875884

DR   Cosmic; 888864

DR   Cosmic; 905953

DR   Cosmic; 933002

DR   Cosmic; 974071

DR   Cosmic; 974256

DR   Cosmic; 1006558

DR   Cosmic; 1022281

DR   Cosmic; 1045408

DR   Cosmic; 1067226

DR   Cosmic; 1092616

DR   Cosmic; 1132592

DR   Cosmic; 1155270

DR   Cosmic; 1175870

DR   Cosmic; 1303042

DR   Cosmic; 1305364

DR   Cosmic; 1312347

DR   Cosmic; 1458963

DR   Cosmic; 1459637

DR   Cosmic; 1477403

DR   Cosmic; 1507615

DR   Cosmic; 1669122

DR   Cosmic; 1998458

DR   Cosmic; 2230113

DR   GEO; GSM50202

DR   GEO; GSM50264

DR   GEO; GSM188223

DR   GEO; GSM188253

DR   GEO; GSM188312

DR   GEO; GSM206522

DR   GEO; GSM750822

DR   GEO; GSM799353

DR   GEO; GSM799416

DR   GEO; GSM847035

DR   GEO; GSM887288

DR   GEO; GSM888363

DR   GEO; GSM1138789

DR   GEO; GSM1153423

DR   GEO; GSM1181293

DR   GEO; GSM1181295

DR   GEO; GSM1670073

DR   IGRhCellID; Malme3M

DR   KCLB; 30064

DR   SKY/M-FISH/CGH; 2740

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=2041050;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=7999427;

RX   PubMed=19372543;

RX   PubMed=15009714;

RX   PubMed=17088437;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=44

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/malme-3m-human-melanoma-cell-line

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2009-092.

CC   Doubling time: 46.2 hours (DTP).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MELM-3M' in Cosmic 1458963.

CC   Derived from metastatic site: Lung.

ST   Source(s): ATCC; KCLB; PubMed=19372543

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,13

ST   D16S539: 9,12

ST   D18S51: 14

ST   D19S433: 13,14

ST   D21S11: 30.2,32.2

ST   D2S1338: 24

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 9,12

ST   D8S1179: 13

ST   FGA: 21,22

ST   TH01: 8

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1437 ! Malme-3

OI   CVCL_1E90 ! Malme-3S

SX   Male

CA   Cancer cell line

//

ID   Malme-3S

AC   CVCL_1E90

RX   DOI=10.1007/978-1-4757-1647-4_5;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Lung.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1437 ! Malme-3

OI   CVCL_1438 ! Malme-3M

SX   Male

CA   Cancer cell line

//

ID   MAME

AC   CVCL_G035

DR   IMGT/HLA; 11048

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MaMi

AC   CVCL_5796

RX   PubMed=9740146;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MaMi

DI   NCIt; C8973; Endometrioid stromal sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Man-1

AC   CVCL_B893

SY   MAN-1; UMANe001-A

DR   hPSCreg; UMANe001-A

DR   ISCR; 1647

RX   PubMed=20177994;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/man-1.aspx

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-08-017, Steering comm. appl. SCSC08-02.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Man-10

AC   CVCL_L198

SY   MAN-10

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-17.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-11

AC   CVCL_L199

SY   MAN-11; MAN11; Man11

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-26.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Man-12

AC   CVCL_L200

SY   MAN-12; MAN12; Man12

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-27.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Man-13

AC   CVCL_L201

SY   MAN-13; MAN13; Man13; UMANe002-A

DR   BioSamples; SAMEA7792168

DR   hPSCreg; UMANe002-A

CC   Group: Clinical grade hESC cell line.

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-28.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-14

AC   CVCL_BW68

SY   MAN-14; MAN14; Man14

CC   Group: Clinical grade hESC cell line.

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-23.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-15

AC   CVCL_BW69

SY   MAN-15; MAN15; Man15

CC   Group: Clinical grade hESC cell line.

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-24.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-16

AC   CVCL_BW70

SY   MAN-16; MAN16; Man16

CC   Group: Clinical grade hESC cell line.

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-25.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-2

AC   CVCL_B894

SY   MAN-2; CMFTe001-A

DR   hPSCreg; CMFTe001-A

DR   ISCR; 1648

RX   PubMed=20177994;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/man-2.aspx

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-09-011, Steering comm. appl. SCSC09-01.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Man-3

AC   CVCL_L191

SY   MAN-3

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-20.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-4

AC   CVCL_L192

SY   MAN-4

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-21.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-5

AC   CVCL_L193

SY   MAN-5

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-22.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-6

AC   CVCL_L194

SY   MAN-6

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-23.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-7

AC   CVCL_L195

SY   MAN-7

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-24.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-8

AC   CVCL_L196

SY   MAN-8

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-25.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Man-9

AC   CVCL_L197

SY   MAN-9

CC   From: University of Manchester; Manchester; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-16.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MANIKA

AC   CVCL_E770

SY   MANIKAM

DR   dbMHC; 48966

DR   ECACC; 94122027

DR   IHW; IHW9106

DR   IMGT/HLA; 11640

RX   PubMed=11782282;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl106.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   Mano

AC   CVCL_W901

SY   MANO

RX   PubMed=892930;

RX   PubMed=6826254;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mao

AC   CVCL_BT01

SY   MAO

DR   CCRID; 3153C0001000000101

DR   KCB; KCB 200711M

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   mAQC2

AC   CVCL_5A33

SY   AQ.C2-9

DR   ATCC; PTA-3273

RX   Patent=US7358054;

CC   Monoclonal antibody target: UniProtKB; P56199; Human ITGA1/CD49a.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5A32 ! FL653

CA   Hybridoma

//

ID   MAR

AC   CVCL_0B87

SY   Mar; MA-R

DR   Cosmic; 2239098

RX   PubMed=3034934;

RX   PubMed=7736387;

RX   PubMed=9559344;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MAR 18.5

AC   CVCL_D294

DR   CLO; CLO_0007532

DR   ATCC; TIB-216

DR   BCRJ; 0158

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   Mar Bel

AC   CVCL_G291

SY   Mar-Bel; MAR BEL

DR   ATCC; CRL-1186

DR   ChEMBL-Cells; CHEMBL3308602

DR   ChEMBL-Targets; CHEMBL614653

CC   Discontinued: ATCC; CRL-1186; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Mar Nol

AC   CVCL_3016

DR   CLO; CLO_0007533

DR   ATCC; CRL-1257

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Mar Ton

AC   CVCL_3017

DR   CLO; CLO_0007534

DR   ATCC; CRL-1252

DI   NCIt; C34568; Ehlers-Danlos syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Mar Vin

AC   CVCL_3018

DR   CLO; CLO_0007535

DR   ATCC; CRL-1138

DI   NCIt; C125696; Ehlers-Danlos syndrome, type I

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MAR00333IN

AC   CVCL_E164

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9540; ! Macaca arctoides

SX   Sex undetermined

CA   Transformed cell line

//

ID   MAR00334IN

AC   CVCL_E165

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9540; ! Macaca arctoides

SX   Sex undetermined

CA   Transformed cell line

//

ID   MARC 29F8

AC   CVCL_L546

SY   29F8

DR   CLO; CLO_0007537

DR   ATCC; CRL-2508

RX   PubMed=9041412;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MARC 2B7

AC   CVCL_L544

SY   2B7

DR   CLO; CLO_0007538

DR   ATCC; CRL-2509

RX   PubMed=8795222;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MARC 46E9-9

AC   CVCL_L545

SY   46E9-9

RX   PubMed=8795222;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MARC S5

AC   CVCL_L536

SY   S5

DR   CLO; CLO_0007539

DR   ATCC; CRL-2507

RX   PubMed=9041412;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MARC-145

AC   CVCL_4540

SY   Marc-145; MARC 145; Marc 145; MARC145; Marc145; Meat Animal Research Center-145

DR   CLO; CLO_0007536

DR   CLDB; cl5226

DR   ATCC; CRL-12219

DR   ATCC; CRL-12230

DR   GEO; GSM1263300

DR   GEO; GSM1263301

DR   GEO; GSM1263302

DR   GEO; GSM1263303

DR   IZSLER; BS CL 127

DR   KCB; KCB 200801YJ

RX   Patent=US5690940;

RX   PubMed=8257302;

RX   PubMed=17081295;

RX   PubMed=23148668;

CC   Group: Non-human primate cell line.

CC   Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from African Green monkey instead of Rhesus macaque.

CC   Characteristics: Highly permissive to porcine reproductive and respiratory syndrome virus (PRRSV) infection.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-12219; probable.

CC   Discontinued: ATCC; CRL-12230; probable.

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

HI   CVCL_3845 ! MA-104

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MARC-Nsp11

AC   CVCL_HA70

DR   GEO; GSM1263298

DR   GEO; GSM1263299

RX   PubMed=24719865;

CC   Group: Non-human primate cell line.

CC   Problematic cell line: Misidentified. Great-parent cell line (MA-104) has been shown to be from African Green monkey instead of Rhesus macaque.

CC   Transfected with: UniProtKB; Q6QDR0; Porcine reproductive and respiratory syndrome virus strain NVSL 97-7895 nsp11 (AA 1088-1310).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

HI   CVCL_4540 ! MARC-145

CA   Spontaneously immortalized cell line

//

ID   MARC.BGCF.1-3

AC   CVCL_0F31

SY   MARC Bovine Genome Cow Fibroblasts 1-3

DR   ATCC; CRL-2875

RX   PubMed=20015332;

CC   Omics: Genome sequenced.

CC   Discontinued: ATCC; CRL-2875; true.

CC   Breed/subspecies: Hereford.

OX   NCBI_TaxID=9913; ! Bos taurus

OI   CVCL_0F30 ! MARC.BGCF.2

SX   Female

CA   Finite cell line

//

ID   MARC.BGCF.2

AC   CVCL_0F30

SY   MARC Bovine Genome Cow Fibroblasts 2

DR   ATCC; CRL-2874

RX   PubMed=20015332;

CC   Omics: Genome sequenced.

CC   Discontinued: ATCC; CRL-2874; true.

CC   Breed/subspecies: Hereford.

OX   NCBI_TaxID=9913; ! Bos taurus

OI   CVCL_0F31 ! MARC.BGCF.1-3

SX   Female

CA   Finite cell line

//

ID   MARC.OKF

AC   CVCL_W365

SY   USMARC Ovine Kidney Fibroblast; AG19825

DR   Coriell; AG19825

RX   PubMed=18432399;

CC   Discontinued: Coriell; AG19825; probable.

CC   Breed/subspecies: Texel.

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_W366 ! MARC.OVSM

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MARC.OVSM

AC   CVCL_W366

SY   USMARC Ovine Vascular Smooth Muscle; AG19826

DR   Coriell; AG19826

RX   PubMed=18432399;

CC   Discontinued: Coriell; AG19826; probable.

CC   Breed/subspecies: Texel.

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_W365 ! MARC.OKF

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Marcus

AC   CVCL_3019

SY   AJ

DR   BioSample; SAMN03472776

DR   CGH-DB; 149-1

DR   IFO; IFO50290

RX   PubMed=283420;

RX   PubMed=16232199;

CC   Discontinued: IFO; IFO50290; probable.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12,15

ST   D13S317: 11

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Margret

AC   CVCL_X929

SY   NK11a; NK 11

RX   PubMed=4174339;

RX   PubMed=4178827;

RX   PubMed=5021706;

RX   PubMed=5786183;

CC   Characteristics: EBV-negative.

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Marimo

AC   CVCL_6992

SY   MARIMO

DR   Cosmic; 787448

DR   Cosmic; 975266

DR   Cosmic; 1012083

DR   Cosmic; 1281324

DR   Cosmic; 1465956

DR   Cosmic; 1465959

DR   Cosmic; 2306195

RX   PubMed=9406575;

RX   PubMed=16408098;

DI   NCIt; C8252; Therapy-related acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Marisco

AC   CVCL_L363

SY   Moresco

DR   BTO; BTO:0005359

DR   GEO; GSM1974794

RX   PubMed=21552385;

RX   PubMed=21908323;

RX   PubMed=22916246;

RX   PubMed=27197945;

RX   PubMed=27257868;

CC   Part of: FACC canine tumor cell line panel.

CC   Doubling time: 22.1 hours (PubMed=22916246).

CC   Omics: Transcriptome analysis.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   MARMarg

AC   CVCL_E771

SY   TER236

DR   dbMHC; 48967

DR   ECACC; 94050340

DR   IHW; IHW9307

DR   IMGT/HLA; 11052

WW   http://bioinformatics.hsanmartino.it/ecbr/cl307.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   MARMari

AC   CVCL_E772

DR   dbMHC; 48968

DR   IHW; IHW9308

DR   IMGT/HLA; 11053

WW   http://bioinformatics.hsanmartino.it/ecbr/cl308.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   MASE

AC   CVCL_HF45

SY   Misgurnus Anguillicaudatus Skin Epidermis

RX   PubMed=27288257;

CC   Group: Fish cell line.

CC   Doubling time: 53.3 hours (PubMed=27288257).

OX   NCBI_TaxID=75329; ! Misgurnus anguillicaudatus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Mash-1

AC   CVCL_8158

DR   BioSample; SAMN03151848

DR   RCB; RCB1386

RX   PubMed=12366446;

RX   PubMed=16643607;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a MMAc derivative (PubMed=16643607, PubMed=20143388).

CC   Discontinued: RCB; RCB1386; true.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5951 ! MMAc

SX   Female

CA   Cancer cell line

//

ID   Maska-98

AC   CVCL_IW67

RX   PubMed=11279638;

CC   Characteristics: Produces high level of lactate dehydrogenase (LDH).

CC   Doubling time: 36-48 hours (PubMed=11279638).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MAST

AC   CVCL_M374

RX   PubMed=8601577;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MasterShef1

AC   CVCL_BW74

SY   MstrShef1; MShef1; UOSe001-A

DR   hPSCreg; UOSe001-A

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-02.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MasterShef10

AC   CVCL_BW82

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC13-05.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MasterShef11

AC   CVCL_BW83

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC13-06.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MasterShef12

AC   CVCL_BW84

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC13-07.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MasterShef13

AC   CVCL_BW85

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC13-08.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MasterShef14

AC   CVCL_BW86

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-65.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MasterShef2

AC   CVCL_BW75

SY   MstrShef2; MShef2; UOSe007-A

DR   hPSCreg; UOSe007-A

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-03.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MasterShef3

AC   CVCL_BW76

SY   MstrShef3; MShef3; UOSe008-A

DR   hPSCreg; UOSe008-A

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-04.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MasterShef4

AC   CVCL_BW77

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-05.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MasterShef5

AC   CVCL_BW78

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-06.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MasterShef6

AC   CVCL_BW79

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-07.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   MasterShef7

AC   CVCL_BW80

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-08.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MasterShef8

AC   CVCL_BW81

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC12-09.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MAT-28-24

AC   CVCL_J233

DR   TKG; TKG 0224

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3419 ! SHM-D33

CA   Hybridoma

//

ID   MAT-28b-12-11-30

AC   CVCL_J234

DR   TKG; TKG 0225

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3419 ! SHM-D33

CA   Hybridoma

//

ID   MAT-Lu

AC   CVCL_3847

DR   CLO; CLO_0007540

DR   CLDB; cl3337

DR   ATCC; JHU-4

DR   ECACC; 94102735

RX   PubMed=3174494;

RX   PubMed=3774632;

CC   Discontinued: ATCC; JHU-4; true.

CC   Breed/subspecies: Copenhagen.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3568 ! R-3327-AT-1

SX   Male

CA   Cancer cell line

//

ID   MAT-LyLu

AC   CVCL_3848

AS   CVCL_2168

SY   Mat-Ly-Lu; MATLyLu; R3327-MATLyLu; R3327-MatLyLu; Dunning R 3327 MAT LyLu; Metastatic AT tumor able to disseminate to lymph nodes and lung

DR   BTO; BTO:0003306

DR   CLO; CLO_0007541

DR   CLDB; cl3338

DR   ATCC; JHU-5

DR   ATCC; JHU-92

DR   ChEMBL-Cells; CHEMBL3307987

DR   ChEMBL-Targets; CHEMBL612579

DR   DSMZ; ACC-609

DR   ECACC; 94101454

RX   PubMed=3174494;

RX   PubMed=3774632;

RX   PubMed=7251319;

RX   PubMed=7910810;

RX   PubMed=8687134;

RX   PubMed=23467722;

CC   Doubling time: ~15 hours (DSMZ).

CC   Discontinued: ATCC; JHU-5; true.

CC   Discontinued: ATCC; JHU-92; true.

CC   Breed/subspecies: Copenhagen.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3568 ! R-3327-AT-1

SX   Male

CA   Cancer cell line

//

ID   MAT-LyLu-B-1

AC   CVCL_Y659

SY   MAT-Ly-Lu-B-1; MLLB-1

RX   PubMed=9494564;

CC   Breed/subspecies: Copenhagen.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3848 ! MAT-LyLu

SX   Male

CA   Cancer cell line

//

ID   MAT-LyLu-B-2

AC   CVCL_3849

SY   MAT-Ly-Lu-B-2; MLLB-2; MLLB2

DR   CLO; CLO_0007542

DR   ATCC; CRL-2376

RX   PubMed=9494564;

CC   Breed/subspecies: Copenhagen.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3848 ! MAT-LyLu

SX   Male

CA   Cancer cell line

//

ID   MATAG 12

AC   CVCL_K144

DR   ATCC; CRL-9456

DR   ATCC; HB-9456

RX   Patent=US5512443;

CC   Discontinued: ATCC; CRL-9456; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MaTi

AC   CVCL_E999

RX   PubMed=20444890;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Matsu

AC   CVCL_X925

RX   PubMed=7535998;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).

OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata

CA   Transformed cell line

//

ID   MaTu

AC   CVCL_5328

SY   MATU

DR   BioSample; SAMN03151742

DR   Cosmic; 1523956

RX   PubMed=212193;

RX   PubMed=9150904;

RX   PubMed=10508494;

RX   PubMed=15677628;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a breast carcinoma.

CC   Microsatellite instability: Stable (MSS) (PubMed=15677628).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   MaTu/Ham

AC   CVCL_5329

RX   PubMed=11044355;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/MaTuHam.html

CC   Problematic cell line: Contaminated. Parent cell line (Matu) has been shown to be a HeLa derivative.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5328 ! MaTu

SX   Female

CA   Cancer cell line

//

ID   MAVER-1

AC   CVCL_1831

SY   Maver-1; MAntle cell VERona-1

DR   ATCC; CRL-3008

DR   BioSample; SAMN03471709

DR   Cosmic; 2078182

DR   Cosmic; 2088018

DR   DSMZ; ACC-717

RX   PubMed=16434369;

RX   PubMed=25315077;

CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).

CC   Doubling time: 24 hours (PubMed=25315077); ~48 hours (DSMZ).

ST   Source(s): ATCC; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,13

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 8

ST   TH01: 8,9

ST   TPOX: 8,12

ST   vWA: 14,18

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MaWi

AC   CVCL_S810

SY   Mawi; MAWI; MAwi

DR   Cosmic; 687534

RX   PubMed=12068308;

DI   NCIt; C5105; Colorectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Max-ST

AC   CVCL_0D06

WW   http://www.cvm.umn.edu/accr/research/modianolab/scientificresources/reagentsandscientificresources/home.html

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   MAXF 401NL

AC   CVCL_D131

SY   MAXF401; MAXF 401; MAXF-401; 401NL

DR   ChEMBL-Cells; CHEMBL3307805

DR   ChEMBL-Targets; CHEMBL612703

RX   DOI=10.1016/0165-4608(96)85254-X;

RX   PubMed=21556597;

CC   Derived from metastatic site: Lung.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MAXF 449

AC   CVCL_D246

SY   MAXF449; MaxF449

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MAXF 583

AC   CVCL_D245

SY   MAXF-583; MAXF583

RX   DOI=10.1016/0165-4608(96)85254-X;

RX   PubMed=21556597;

CC   Derived from metastatic site: Lung.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MAXF 713

AC   CVCL_D247

SY   MAXF-713

RX   DOI=10.1016/0165-4608(96)85254-X;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MAY

AC   CVCL_E773

DR   IHW; IHW1003

WW   http://bioinformatics.hsanmartino.it/ecbr/cl377.html

CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   May Roy

AC   CVCL_1864

DR   CLO; CLO_0007543

DR   ATCC; CRL-1250

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Mayes

AC   CVCL_4Y74

RX   PubMed=13502746;

CC   Miscellaneous: Cell line has been lost.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MB

AC   CVCL_5M21

RX   PubMed=4735239;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_5M20 ! KF

OI   CVCL_5M22 ! TD

OI   CVCL_5M23 ! WE

CA   Cancer cell line

//

ID   MB III

AC   CVCL_3741

SY   MB-III; de Bruyn-Gey cells

DR   CLO; CLO_0007546

DR   CLO; CLO_0007567

DR   CLDB; cl3345

DR   ATCC; CCL-32

DR   ECACC; 90111914

CC   Discontinued: ECACC; 90111914; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MB-02

AC   CVCL_7075

SY   MB02; MBO2

DR   BTO; BTO:0004767

DR   Cosmic; 787449

DR   Cosmic; 924045

DR   Cosmic; 975267

DR   Cosmic; 1012052

DR   Cosmic; 1012084

DR   Cosmic; 1281325

DR   Cosmic; 1465957

DR   Cosmic; 2306216

RX   PubMed=1954374;

RX   PubMed=16408098;

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MB-020

AC   CVCL_Z317

DR   CLO; CLO_0007547

DR   CLDB; cl3339

DR   DSMZ; ACC-79

RX   DOI=10.1080/03235408909438893;

CC   Group: Insect cell line.

CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI 10.1080/03235408909438893) as the reference for the establishment of this cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

HI   CVCL_Z314 ! MB-H 260

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-021

AC   CVCL_Z318

DR   CLO; CLO_0007548

DR   CLDB; cl3340

DR   DSMZ; ACC-85

RX   DOI=10.1080/03235408909438893;

CC   Group: Insect cell line.

CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI 10.1080/03235408909438893) as the reference for the establishment of this cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

HI   CVCL_Z314 ! MB-H 260

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-03

AC   CVCL_Z319

DR   CLO; CLO_0007549

DR   CLDB; cl3341

DR   DSMZ; ACC-97

RX   DOI=10.1080/03235408909438893;

CC   Group: Insect cell line.

CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI 10.1080/03235408909438893) as the reference for the establishment of this cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

HI   CVCL_Z314 ! MB-H 260

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-03C4

AC   CVCL_Z501

SY   MB-O3C4

DR   CLO; CLO_0007550

DR   CLDB; cl3342

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/smb.htm

CC   Group: Insect cell line.

OX   NCBI_TaxID=47767; ! Agrotis segetum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-03C5-688

AC   CVCL_Z502

SY   MB-O3C5-688

DR   CLO; CLO_0007551

DR   CLDB; cl3343

CC   Group: Insect cell line.

OX   NCBI_TaxID=47767; ! Agrotis segetum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-04

AC   CVCL_Z320

DR   CLO; CLO_0007552

DR   CLDB; cl3344

DR   DSMZ; ACC-122

RX   DOI=10.1080/03235408909438893;

CC   Group: Insect cell line.

CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI 10.1080/03235408909438893) as the reference for the establishment of this cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

HI   CVCL_Z314 ! MB-H 260

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-1

AC   CVCL_2109

SY   MB1

DR   BioSample; SAMN03473455

DR   DSMZ; ACC-638

RX   PubMed=18616678;

CC   Doubling time: ~60-100 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 10

ST   D7S820: 9

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MB-9812

AC   CVCL_0A72

SY   MB 9812; MB9812; MBA 9812; MBA-9812; Line 9812; 9812

DR   Cosmic; 2301572

DR   GEO; GSM784229

RX   PubMed=5431618;

RX   PubMed=6500159;

RX   PubMed=6935474;

RX   PubMed=7459858;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MB-H 260

AC   CVCL_Z314

RX   DOI=10.1080/03235408909438893;

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-L11

AC   CVCL_Z315

DR   CLO; CLO_0007568

DR   CLDB; cl3346

DR   DSMZ; ACC-113

RX   DOI=10.1080/03235408909438893;

CC   Group: Insect cell line.

CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI 10.1080/03235408909438893) as the reference for the establishment of this cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

HI   CVCL_Z314 ! MB-H 260

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB-L2

AC   CVCL_Z316

DR   CLO; CLO_0007569

DR   CLDB; cl3347

DR   DSMZ; ACC-76

RX   DOI=10.1080/03235408909438893;

CC   Group: Insect cell line.

CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI 10.1080/03235408909438893) as the reference for the establishment of this cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

HI   CVCL_Z314 ! MB-H 260

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MB0002

AC   CVCL_8Y12

DR   ECACC; 00051801

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   MB0008

AC   CVCL_8Y13

DR   ECACC; 00110316

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C26900; Turner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8Y14 ! MB0009

SX   Female

CA   Transformed cell line

//

ID   MB0009

AC   CVCL_8Y14

DR   ECACC; 00110317

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C26900; Turner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8Y13 ! MB0008

SX   Female

CA   Transformed cell line

//

ID   MB0012

AC   CVCL_8Y15

DR   ECACC; 00121101

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C84801; Klippel-Trenaunay-Weber syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MB0014

AC   CVCL_8Y16

DR   ECACC; 01010504

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C125485; Microcornea

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   MB0015

AC   CVCL_8Y17

DR   ECACC; 01012005

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C26782; Glaucoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MB01

AC   CVCL_C382

SY   Maria Biotech 01; MIHe001-A

DR   hPSCreg; MIHe001-A

DR   ISCR; 1110

RX   PubMed=14998970;

WW   http://stemcells.nih.gov/research/registry/unavailable/pages/maria.aspx

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MB02

AC   CVCL_C383

SY   Maria Biotech 02; MIHe002-A

DR   hPSCreg; MIHe002-A

DR   ISCR; 1111

RX   PubMed=14998970;

WW   http://stemcells.nih.gov/research/registry/unavailable/pages/maria.aspx

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MB03

AC   CVCL_C384

SY   Maria Biotech 03; MIHe003-A

DR   hPSCreg; MIHe003-A

DR   ISCR; 1112

RX   PubMed=14998970;

WW   http://stemcells.nih.gov/research/registry/unavailable/pages/maria.aspx

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MB04

AC   CVCL_C385

SY   Maria Biotech 04; MIHe004-A

DR   hPSCreg; MIHe004-A

DR   ISCR; 1113

RX   PubMed=14998970;

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MB05

AC   CVCL_C386

SY   Maria Biotech 05; MIHe005-A

DR   hPSCreg; MIHe005-A

DR   ISCR; 1114

RX   PubMed=14998970;

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MB06

AC   CVCL_C387

SY   Maria Biotech 06; MIHe006-A

DR   hPSCreg; MIHe006-A

DR   ISCR; 1115

RX   PubMed=14998970;

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MB07

AC   CVCL_C388

SY   Maria Biotech 07; MIHe007-A

DR   hPSCreg; MIHe007-A

DR   ISCR; 1116

RX   PubMed=14998970;

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MB08

AC   CVCL_C389

SY   Maria Biotech 08; MIHe008-A

DR   hPSCreg; MIHe008-A

DR   ISCR; 1117

RX   PubMed=14998970;

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MB09

AC   CVCL_C390

SY   Maria Biotech 09; MIHe009-A

DR   hPSCreg; MIHe009-A

DR   ISCR; 1118

RX   PubMed=14998970;

CC   From: Maria Infertility Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MB15C11

AC   CVCL_CY50

RX   PubMed=2475124;

CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MB16tsA clone 1B5

AC   CVCL_6499

SY   Mbeta16tsA clone 1B5

DR   CLO; CLO_0007553

DR   ATCC; CRL-2307

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   MB19tsA clone 2B2

AC   CVCL_6500

SY   Mbeta19tsA clone 2B2

DR   CLO; CLO_0007554

DR   ATCC; CRL-2308

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MB23G2

AC   CVCL_9218

DR   CLO; CLO_0007555

DR   ATCC; HB-220

RX   PubMed=2475124;

CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MB352

AC   CVCL_6778

DR   CLO; CLO_0007556

DR   ATCC; CRL-2821

CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MB355

AC   CVCL_6779

DR   CLO; CLO_0007557

DR   ATCC; CRL-2818

CC   Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.

CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MB40.2

AC   CVCL_G232

SY   MB 40.2

DR   CLO; CLO_0007558

DR   ATCC; HB-59

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MB40.3

AC   CVCL_G233

SY   MB 40.3

DR   CLO; CLO_0007545

DR   ATCC; HB-105

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MB40.5

AC   CVCL_G234

SY   MB 40.5

DR   CLO; CLO_0007559

DR   ATCC; HB-116

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MB49

AC   CVCL_7076

SY   MB-49

DR   BTO; BTO:0003562

RX   PubMed=107359;

CC   Breed/subspecies: C57BL/Icrfa(t).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   MB4B4

AC   CVCL_9219

DR   CLO; CLO_0007560

DR   ATCC; HB-223

RX   PubMed=2475124;

CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MB63

AC   CVCL_0F71

RX   PubMed=107359;

RX   PubMed=6724740;

CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).

CC   Breed/subspecies: C57BL/Icrfa(t).

DI   NCIt; C25806; Mouse urinary tract neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   MB86

AC   CVCL_J274

DR   JCRB; JCRB0090

RX   PubMed=2420716;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MBA C57.Li

AC   CVCL_P675

DR   ATCC; CRL-6369

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6369; true.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_S462 ! MBA C57.Ut

OI   CVCL_6501 ! MBA C57.We

SX   Female

CA   Finite cell line

//

ID   MBA C57.Ut

AC   CVCL_S462

DR   ATCC; CRL-6368

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6368; true.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_P675 ! MBA C57.Li

OI   CVCL_6501 ! MBA C57.We

SX   Female

CA   Finite cell line

//

ID   MBA C57.We

AC   CVCL_6501

DR   CLO; CLO_0007565

DR   ATCC; CRL-6370

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6370; true.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_P675 ! MBA C57.Li

OI   CVCL_S462 ! MBA C57.Ut

SX   Female

CA   Finite cell line

//

ID   MBA-1

AC   CVCL_B418

RX   PubMed=2981238;

CC   Breed/subspecies: SJL/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   MBA-13

AC   CVCL_B419

RX   PubMed=2981238;

CC   Breed/subspecies: Nude ICR.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   MBA-14

AC   CVCL_B420

RX   PubMed=2981238;

RX   PubMed=6693503;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   MBA-15

AC   CVCL_B421

DR   BTO; BTO:0003051

RX   PubMed=2981238;

RX   PubMed=6693503;

RX   PubMed=7942158;

CC   Breed/subspecies: SJL/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   MBA-2

AC   CVCL_B422

RX   PubMed=2981238;

CC   Breed/subspecies: RF/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   MBA-2.1

AC   CVCL_B423

RX   PubMed=2981238;

CC   Breed/subspecies: RF/J.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B422 ! MBA-2

CA   Stromal cell line

//

ID   MBA-2.4

AC   CVCL_B424

RX   PubMed=2981238;

CC   Breed/subspecies: RF/J.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B422 ! MBA-2

CA   Stromal cell line

//

ID   MBA-HE

AC   CVCL_Y447

DR   ATCC; CRL-6286

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6286; true.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

CA   Finite cell line

//

ID   MBC(5)

AC   CVCL_5330

DR   CLO; CLO_0007566

DR   ATCC; CRL-6069

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6069; true.

OX   NCBI_TaxID=9913; ! Bos taurus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   MBC1

AC   CVCL_T035

RX   PubMed=23106969;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MBC2

AC   CVCL_T036

RX   PubMed=23106969;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mbd3KO

AC   CVCL_AR59

DR   ECACC; 11041301

RX   PubMed=16462733;

CC   Knockout cell: Method=KO mouse; MGI; MGI:1333812; Mbd3.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   MBEC4

AC   CVCL_0407

SY   MBEC-4

DR   MCCL; MCC:0000301

RX   PubMed=1356979;

RX   PubMed=9862771;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MBHL-2

AC   CVCL_2I37

DR   CLO; CLO_0050501

DR   RCB; RCB1444

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MBHL-3

AC   CVCL_2I38

DR   CLO; CLO_0050502

DR   RCB; RCB1445

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MBL-1

AC   CVCL_Z537

RX   PubMed=2120094;

CC   Breed/subspecies: 129/Sv He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MBL-2 [Mouse ESC]

AC   CVCL_Z538

RX   PubMed=2120094;

CC   Breed/subspecies: 129/Sv He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MBL-2 [Mouse myeloma]

AC   CVCL_J302

SY   MBL2

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MBL-3

AC   CVCL_Z539

RX   PubMed=2120094;

CC   Breed/subspecies: 129/Sv He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   MbL-3

AC   CVCL_Z542

RX   PubMed=8578995;

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MBL-4

AC   CVCL_Z540

RX   PubMed=2120094;

CC   Breed/subspecies: 129/Sv He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   MBL-5

AC   CVCL_Z541

RX   PubMed=2120094;

CC   Breed/subspecies: 129/Sv He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MBL-Sm-1A6

AC   CVCL_G235

DR   CLO; CLO_0007570

DR   ATCC; HB-194

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MBL-Sm-4B1

AC   CVCL_G236

DR   CLO; CLO_0007571

DR   ATCC; HB-193

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MBM

AC   CVCL_F271

RX   PubMed=7618261;

OX   NCBI_TaxID=9685; ! Felis catus

CA   Spontaneously immortalized cell line

//

ID   mBMS-B1

AC   CVCL_6D84

RX   PubMed=9041049;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   mBMS-B14

AC   CVCL_6D86

RX   PubMed=9041049;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   mBMS-B18

AC   CVCL_6D87

RX   PubMed=9041049;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   mBMS-B2

AC   CVCL_6D85

RX   PubMed=9041049;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   mBMS-B21

AC   CVCL_6D88

RX   PubMed=9041049;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   mbn-2

AC   CVCL_Z706

SY   Mbn-2; mbn2; l(2)mbn; L(2)mbn; Blood II; BII

DR   BTO; BTO:0001898

DR   EFO; EFO_0005820

DR   DGRC; 147

DR   ENCODE; ENCBS358WCU

RX   CelloPub=CLPUB00202;

RX   DOI=10.1002/arch.940020307;

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   PubMed=1445351;

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=24985917;

RX   PubMed=25262759;

CC   Group: Insect cell line.

CC   Part of: modENCODE project cell lines.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   mbn-3

AC   CVCL_0A30

SY   l(3)mbn; Blood III

RX   CelloPub=CLPUB00202;

RX   DOI=10.1016/B978-012229460-0/50004-X;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MBSa1

AC   CVCL_L364

RX   PubMed=20974873;

CC   Breed/subspecies: German Shepherd.

DI   NCIt; C128195; Canine sarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   MBT-2

AC   CVCL_4660

SY   MBT2; Mouse Bladder Tumor line-2

DR   BTO; BTO:0003555

DR   CLO; CLO_0050945

DR   IFO; IFO50041

DR   RCB; RCB0544

RX   DOI=10.4051/ibc.2010.2.4.0014;

RX   PubMed=406041;

CC   Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).

CC   Breed/subspecies: C3H/He.

DI   NCIt; C25823; Mouse bladder transitional cell carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MBU-IM

AC   CVCL_EG12

DR   DSMZ; ACC-796

RX   PubMed=27074337;

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 13,15

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MBU-T

AC   CVCL_EG13

DR   DSMZ; ACC-799

RX   PubMed=27074337;

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 13,15

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EG12 ! MBU-IM

SX   Male

CA   Transformed cell line

//

ID   MBU-Ts1

AC   CVCL_EG14

SY   MBU-TS1

DR   DSMZ; ACC-800

RX   PubMed=27074337;

CC   Doubling time: ~100-140 hours (DSMZ).

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 13,15

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EG13 ! MBU-T

SX   Male

CA   Transformed cell line

//

ID   MBU-Ts4

AC   CVCL_EG15

SY   MBU-TS4

DR   DSMZ; ACC-801

RX   PubMed=27074337;

CC   Doubling time: ~80-100 hours (DSMZ).

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 13,15

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EG13 ! MBU-T

SX   Male

CA   Transformed cell line

//

ID   MC

AC   CVCL_W203

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=6986835;

CC   Doubling time: ~12 hours (PubMed=6986835).

DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mc 39-16

AC   CVCL_L537

DR   ECACC; 89072609

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MC-1010

AC   CVCL_1396

DR   ATCC; CRL-12253

DR   Cosmic; 683546

DR   Cosmic; 907798

DR   Cosmic-CLP; 907798

DR   GDSC; 907798

RX   Patent=US5804443;

RX   PubMed=167748;

RX   PubMed=8594420;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D5S818: 11,14

ST   D7S820: 8,12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MC-26

AC   CVCL_0240

SY   MC26; Colon 26; Colon-26; Colon26; C-26; C26

DR   BTO; BTO:0004013

DR   CLO; CLO_0051596

DR   MCCL; MCC:0000130

DR   ChEMBL-Cells; CHEMBL3307623

DR   ChEMBL-Targets; CHEMBL614466

DR   CLS; 400156/p742_Colon-26

DR   RCB; RCB2657

DR   TKG; TKG 0518

RX   PubMed=1149045;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   MC-38

AC   CVCL_B288

SY   MCA-38; MCA 38; MCA38; MC38; Mouse Colon 38; Murine Carcinoma-38; Colon 38; Colon-38; Colon38; C38

DR   BTO; BTO:0004163

DR   ChEMBL-Cells; CHEMBL3307696

DR   ChEMBL-Cells; CHEMBL3307810

DR   ChEMBL-Cells; CHEMBL3307933

DR   ChEMBL-Targets; CHEMBL612821

DR   ChEMBL-Targets; CHEMBL614463

DR   ChEMBL-Targets; CHEMBL614739

DR   Lonza; 893

RX   PubMed=1149045;

RX   PubMed=1255804;

RX   PubMed=25434994;

WW   https://www.kerafast.com/product/2720/mc-38-cell-line

CC   Omics: Mitochondrial genome sequenced.

CC   Caution: The authors of PubMed=25434994 indicate that they have sequenced the mitochondrial genome of the 'rat' cell line MCA38. Their submitted DNA sequence (KM820832.1) is indeed a rat sequence but is labelled as originating from 'rat isolate 406'.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   MC-38-CEA-1

AC   CVCL_5I36

SY   MC-38-cea1

RX   PubMed=1712245;

WW   https://www.kerafast.com/product/2405/mc-38-cea-cell-lines

CC   Transfected with: HGNC; 1817; CEACAM5.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B288 ! MC-38

SX   Female

CA   Cancer cell line

//

ID   MC-38-CEA-2

AC   CVCL_5I37

SY   MC-38-cea2

RX   PubMed=1712245;

WW   https://www.kerafast.com/product/2405/mc-38-cea-cell-lines

CC   Transfected with: HGNC; 1817; CEACAM5.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B288 ! MC-38

SX   Female

CA   Cancer cell line

//

ID   MC-38-MUC-1

AC   CVCL_5I38

SY   MC38/MUC1

RX   PubMed=9101412;

WW   https://www.kerafast.com/product/2406/mc-38-muc-1-cell-line

CC   Transfected with: HGNC; 7508; MUC1.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B288 ! MC-38

SX   Female

CA   Cancer cell line

//

ID   MC-MA1

AC   CVCL_D025

RX   PubMed=8120418;

CC   Derived from metastatic site: Inguinal lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MC-NB-1

AC   CVCL_E058

DR   CLO; CLO_0051541

DR   BioSample; SAMN03472326

DR   RCB; RCB0482

RX   PubMed=6616438;

RX   PubMed=6888561;

CC   Doubling time: ~35 hours (PubMed=6616438).

CC   Misspelling: 'MCN-1' in PubMed=6888561.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,13,14

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MC-SV-HUC T-1

AC   CVCL_IP86

SY   MC-SV-HUC T1

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   MC-SV-HUC T-10

AC   CVCL_IP89

SY   MC-SV-HUC T10

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   MC-SV-HUC T-11

AC   CVCL_IP90

SY   MC-SV-HUC T11

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   MC-SV-HUC T-16

AC   CVCL_IP91

SY   MC-SV-HUC T16

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   MC-SV-HUC T-2

AC   CVCL_6418

SY   MC-SV-HUC T2; MC-T2

DR   CLO; CLO_0007620

DR   ATCC; CRL-9519

DR   BCRC; 60409

DR   BioSample; SAMN03471217

RX   Patent=US4980290;

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 11

ST   D5S818: 12,14

ST   D7S820: 10

ST   TH01: 9,9.3

ST   TPOX: 8,10

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   MC-SV-HUC T-7

AC   CVCL_IP87

SY   MC-SV-HUC T7

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   MC-SV-HUC T-9

AC   CVCL_IP88

SY   MC-SV-HUC T9

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   MC-TGS17-51

AC   CVCL_4982

SY   MC-TGS17-51 [Mutatect]; MC17-51; Mutatect

DR   CLO; CLO_0007579

DR   ATCC; CRL-2799

RX   PubMed=7577474;

CC   Breed/subspecies: C57BL/10.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4983 ! MC1A-C1

SX   Male

CA   Cancer cell line

//

ID   MC/9

AC   CVCL_0408

SY   MC9; CL MC/9

DR   CLO; CLO_0007574

DR   MCCL; MCC:0000302

DR   ATCC; CRL-8306

DR   Lonza; 1232

DR   NCBI_Iran; C588

RX   Patent=US4559310;

RX   PubMed=6972009;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MC%2f9

CC   Characteristics: IL3 dependent.

CC   Breed/subspecies: C57BL/6 x A/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Factor-dependent cell line

//

ID   MC/9.IL4

AC   CVCL_5428

RX   PubMed=8018917;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MC%2f9%2eIL4

CC   Characteristics: IL4 dependent.

CC   Breed/subspecies: C57BL/6 x A/J.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0408 ! MC/9

CA   Factor-dependent cell line

//

ID   MC/CAR

AC   CVCL_1397

SY   MC-CAR; MCCAR

DR   CLO; CLO_0007575

DR   EFO; EFO_0002229

DR   CLDB; cl5227

DR   ATCC; CRL-8083

DR   BioSample; SAMN03471132

DR   ChEMBL-Cells; CHEMBL3308240

DR   ChEMBL-Targets; CHEMBL2366274

DR   Cosmic; 683665

DR   Cosmic; 2131565

DR   Cosmic-CLP; 683665

DR   GDSC; 683665

DR   GEO; GSM1670075

DR   IGRhCellID; MCCAR

DR   IZSLER; BS TCL 134

RX   Patent=US4434230;

RX   PubMed=2537114;

RX   PubMed=10516762;

RX   PubMed=10936422;

RX   PubMed=27397505;

CC   Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D5S818: 11,14

ST   D7S820: 9,13

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MC/CAR-Z2

AC   CVCL_6671

DR   CLO; CLO_0007576

DR   ATCC; CRL-8147

DR   BioSample; SAMN03471194

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D5S818: 11,14,15

ST   D7S820: 9,13

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1397 ! MC/CAR

SX   Male

CA   Transformed cell line

//

ID   MC1

AC   CVCL_H810

CC   From: Johns Hopkins University Transgenic Core Facility; Baltimore; USA.

CC   Breed/subspecies: 129S6/SvEvTac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MC116

AC   CVCL_1399

SY   MC-116; MC 116

DR   CLO; CLO_0007577

DR   CLO; CLO_0007578

DR   EFO; EFO_0002228

DR   CLDB; cl3354

DR   CLDB; cl3355

DR   ATCC; CRL-1649

DR   BCRC; 60292

DR   BioSample; SAMN03473002

DR   CCLE; MC116_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308210

DR   ChEMBL-Targets; CHEMBL2366256

DR   Cosmic; 687847

DR   Cosmic; 907799

DR   Cosmic; 931128

DR   Cosmic; 1086339

DR   Cosmic-CLP; 907799

DR   DSMZ; ACC-82

DR   ECACC; 90110501

DR   GDSC; 907799

DR   GEO; GSM887289

DR   GEO; GSM888364

DR   GEO; GSM1374642

DR   GEO; GSM1670074

DR   IGRhCellID; MC116

RX   PubMed=2052620;

RX   PubMed=3080238;

RX   PubMed=6243721;

RX   PubMed=6243722;

RX   PubMed=6265077;

RX   PubMed=6286763;

RX   PubMed=7757991;

RX   PubMed=8316623;

RX   PubMed=8344493;

RX   PubMed=8515068;

RX   PubMed=9473234;

RX   PubMed=22460905;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~24-48 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 12,13

ST   D21S11: 29

ST   D3S1358: 14,17

ST   D5S818: 12

ST   D7S820: 10,13

ST   D8S1179: 14,15

ST   FGA: 20,26

ST   Penta D: 9,13

ST   Penta E: 7,12

ST   TH01: 9.3,10

ST   TPOX: 8,10

ST   vWA: 15,17

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MC1A-C1

AC   CVCL_4983

RX   PubMed=7577474;

CC   Breed/subspecies: C57BL/10.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   MC2/3

AC   CVCL_4588

DR   CLO; CLO_0007580

DR   ATCC; CRL-2143

RX   PubMed=8000142;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HE53 ! CAK-TK-

CA   Hybrid cell line

//

ID   MC3

AC   CVCL_0087

SY   MC-3

DR   CLO; CLO_0007581

DR   Cosmic; 787502

DR   Cosmic; 1012085

RX   PubMed=7787756;

RX   PubMed=8632663;

RX   PubMed=16408098;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MC38/0

AC   CVCL_0A68

RX   PubMed=15055737;

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B288 ! MC-38

SX   Female

CA   Cancer cell line

//

ID   MC38/IL-12

AC   CVCL_0A69

RX   PubMed=15055737;

CC   Transfected with: MGI; MGI:96539; Il12a.

CC   Transfected with: MGI; MGI:96540; Il12b.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0A68 ! MC38/0

SX   Female

CA   Cancer cell line

//

ID   MC38Luc1

AC   CVCL_0A67

RX   PubMed=19128467;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B288 ! MC-38

SX   Female

CA   Cancer cell line

//

ID   MC3T3

AC   CVCL_0D74

SY   MC-3T3; MC3T3-E

DR   BTO; BTO:0005485

DR   Wikidata; Q6714803

RX   DOI=10.2330/joralbiosci1965.23.899;

WW   https://en.wikipedia.org/wiki/MC3T3

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MC3T3-E1

AC   CVCL_0409

SY   MC3T3E1; MC-3T3-E1; MC 3T3-E1

DR   BTO; BTO:0001957

DR   CLO; CLO_0007582

DR   CLO; CLO_0050208

DR   MCCL; MCC:0000303

DR   CLDB; cl40

DR   ATCC; CRL-2953

DR   CCRID; 3111C0001CCC000012

DR   DSMZ; ACC-210

DR   ECACC; 99072810

DR   KCB; KCB 200786YJ

DR   Lonza; 521

DR   RCB; RCB1126

RX   DOI=10.2330/joralbiosci1965.23.899;

RX   DOI=10.4051/ibc.2010.2.4.0014;

RX   PubMed=6826647;

WW   https://en.wikipedia.org/wiki/MC3T3

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-393.html

CC   Doubling time: ~1-2 days (DSMZ).

CC   Discontinued: ATCC; CRL-2953; probable.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0D74 ! MC3T3

CA   Spontaneously immortalized cell line

//

ID   MC3T3-E1 Subclone 14

AC   CVCL_5437

SY   MC3T3-E1 SUBCLONE 14

DR   CLO; CLO_0007583

DR   ATCC; CRL-2594

DR   BCRJ; 0285

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0409 ! MC3T3-E1

CA   Spontaneously immortalized cell line

//

ID   MC3T3-E1 Subclone 24

AC   CVCL_5438

DR   CLO; CLO_0007584

DR   ATCC; CRL-2595

DR   CCRID; 3131C0001000300015

DR   IZSLER; BS CL 201

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0409 ! MC3T3-E1

CA   Spontaneously immortalized cell line

//

ID   MC3T3-E1 Subclone 30

AC   CVCL_5439

DR   CLO; CLO_0007585

DR   ATCC; CRL-2596

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0409 ! MC3T3-E1

CA   Spontaneously immortalized cell line

//

ID   MC3T3-E1 Subclone 4

AC   CVCL_5440

SY   MC3T3, E1 subgroup-4 clone; MC3T3-E1(C4)

DR   BTO; BTO:0004473

DR   CLO; CLO_0007586

DR   ATCC; CRL-2593

DR   IZSLER; BS CL 181

DR   TOKU-E; 2372

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0409 ! MC3T3-E1

CA   Spontaneously immortalized cell line

//

ID   MC3T3-G2/PA6

AC   CVCL_5441

SY   MC3T3-G2-PA6; PA6

DR   RCB; RCB1127

RX   PubMed=2787384;

RX   PubMed=3264531;

RX   PubMed=7107717;

RX   PubMed=7107718;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=PA6

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   MC4-L1

AC   CVCL_0R48

RX   PubMed=11196177;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0R49 ! MC4-L2

OI   CVCL_0R50 ! MC4-L3

OI   CVCL_0R51 ! MC4-L5

SX   Female

CA   Cancer cell line

//

ID   MC4-L2

AC   CVCL_0R49

RX   PubMed=11196177;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0R48 ! MC4-L1

OI   CVCL_0R50 ! MC4-L3

OI   CVCL_0R51 ! MC4-L5

SX   Female

CA   Cancer cell line

//

ID   MC4-L3

AC   CVCL_0R50

RX   PubMed=11196177;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0R48 ! MC4-L1

OI   CVCL_0R49 ! MC4-L2

OI   CVCL_0R51 ! MC4-L5

SX   Female

CA   Cancer cell line

//

ID   MC4-L5

AC   CVCL_0R51

RX   PubMed=11196177;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0R48 ! MC4-L1

OI   CVCL_0R49 ! MC4-L2

OI   CVCL_0R50 ! MC4-L3

SX   Female

CA   Cancer cell line

//

ID   MC4000

AC   CVCL_5331

SY   MC-4000

DR   BioSample; SAMN03151743

RX   PubMed=9150904;

RX   PubMed=10508494;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a breast carcinoma.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   MC5

AC   CVCL_1N49

SY   MC-5

RX   PubMed=2687628;

RX   PubMed=7404270;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MC57G

AC   CVCL_4985

SY   MC57

DR   BTO; BTO:0005218

DR   CLO; CLO_0007587

DR   ATCC; CRL-2295

DR   Lonza; 130

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: C57BL/6J.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MC615

AC   CVCL_0410

DR   MCCL; MCC:0000304

RX   PubMed=7682698;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MC615 4B5

AC   CVCL_H341

SY   4B5

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4C1

AC   CVCL_H342

SY   4C1

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4C3

AC   CVCL_H343

SY   4C3

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4C6

AC   CVCL_H344

SY   4C6

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4C9

AC   CVCL_H345

SY   4C9

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4D5

AC   CVCL_H346

SY   4D5

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4D7

AC   CVCL_H347

SY   4D7

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4E3

AC   CVCL_H348

SY   4E3

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4F6

AC   CVCL_H349

SY   4F6

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4G11

AC   CVCL_H350

SY   4G11

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 4H4

AC   CVCL_H351

SY   4H4

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 5A2

AC   CVCL_H352

SY   5A2

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 5F12

AC   CVCL_H353

SY   5F12

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC615 5F9

AC   CVCL_H354

SY   5F9

RX   PubMed=19670270;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0410 ! MC615

CA   Transformed cell line

//

ID   MC7-2A

AC   CVCL_0R52

RX   PubMed=14758093;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0R53 ! MC7-2B

OI   CVCL_0R54 ! MC7-L1

SX   Female

CA   Cancer cell line

//

ID   MC7-2B

AC   CVCL_0R53

RX   PubMed=14758093;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0R52 ! MC7-2A

OI   CVCL_0R54 ! MC7-L1

SX   Female

CA   Cancer cell line

//

ID   MC7-L1

AC   CVCL_0R54

RX   PubMed=11196177;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0R52 ! MC7-2A

OI   CVCL_0R53 ! MC7-2B

SX   Female

CA   Cancer cell line

//

ID   MCA-B1

AC   CVCL_W820

RX   PubMed=7709052;

CC   Breed/subspecies: Aika.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   McA-RH7777

AC   CVCL_0444

SY   McA-RH 7777; MCA-RH 7777; McArdle RH-7777; McARH7777; RH7777; Mc Ardle 7777

DR   BTO; BTO:0000358

DR   CLO; CLO_0007594

DR   CLO; CLO_0007595

DR   MCCL; MCC:0000340

DR   CLDB; cl3362

DR   CLDB; cl3363

DR   CLDB; cl3364

DR   CLDB; cl4991

DR   ATCC; CRL-1601

DR   BCRJ; 0159

DR   ChEMBL-Cells; CHEMBL3307729

DR   ChEMBL-Targets; CHEMBL614876

DR   ECACC; 90021504

DR   ICLC; ATL00002

DR   IZSLER; BS TCL 217

DR   Lonza; 1280

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-142.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-595.html

CC   Breed/subspecies: Buffalo.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_2113 ! MH-7777A

OI   CVCL_0F78 ! 7777-14b-aza

SX   Female

CA   Cancer cell line

//

ID   McA-RH8994

AC   CVCL_3396

SY   McA-RH 8994; RH8994

DR   CLO; CLO_0007596

DR   ATCC; CRL-1602

DR   BCRC; 60232

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   MCA-TCL15

AC   CVCL_U204

SY   MCA-TCL15/P3; MCA-TCL-15; TCL-15

RX   PubMed=4796800;

CC   Breed/subspecies: C3H.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0190 ! C3H/10T1/2 clone 8

CA   Transformed cell line

//

ID   MCA-TCL16

AC   CVCL_U205

SY   MCA-TCL16/P3

DR   JCRB; JCRB0712

RX   PubMed=4796800;

CC   Breed/subspecies: C3H.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0190 ! C3H/10T1/2 clone 8

CA   Transformed cell line

//

ID   MCa3D

AC   CVCL_5797

SY   MCA3D; MCA-3D; MCA/3D; MCA 3D

DR   CLS; 400437/p519_MCA-3D

DR   NCBI_Iran; C619

RX   PubMed=1934268;

RX   PubMed=6196137;

CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MCa3F

AC   CVCL_5U31

SY   MCA-3F; MCA 3F

RX   PubMed=1934268;

RX   PubMed=6196137;

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MCAS

AC   CVCL_3020

DR   EFO; EFO_0006453

DR   BioSample; SAMN03472857

DR   CCLE; MCAS_OVARY

DR   CGH-DB; 343-2

DR   CGH-DB; 9356-4

DR   Cosmic; 849612

DR   Cosmic; 931362

DR   Cosmic; 948290

DR   Cosmic; 1707559

DR   Cosmic; 2429301

DR   Cosmic; 2582802

DR   Cosmic-CLP; 1240171

DR   GDSC; 1240171

DR   GEO; GSM659382

DR   GEO; GSM827228

DR   GEO; GSM851924

DR   GEO; GSM887290

DR   GEO; GSM888365

DR   JCRB; JCRB0240

DR   TKG; TKG 0662

RX   PubMed=4056530;

RX   PubMed=9290701;

RX   PubMed=11330945;

RX   PubMed=12417041;

RX   PubMed=17671176;

RX   PubMed=22246397;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=23839242;

RX   PubMed=24023729;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 27 hours (PubMed=4056530).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): JCRB; PubMed=25877200; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D16S539: 12

ST   D18S51: 15

ST   D21S11: 29,31

ST   D3S1358: 16,17

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   D8S1179: 11,12

ST   FGA: 18,21

ST   Penta D: 10,12

ST   Penta E: 16

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCAS-3

AC   CVCL_U210

RX   PubMed=7882618;

DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3020 ! MCAS

SX   Female

CA   Cancer cell line

//

ID   MCB3901

AC   CVCL_6419

SY   AV12-664; AV12

DR   CLO; CLO_0007597

DR   ATCC; CRL-9595

DR   CCRID; 3142C0001000000434

RX   Patent=US4975369;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

CA   Transformed cell line

//

ID   MCC-1

AC   CVCL_D730

DR   Cosmic; 1623851

RX   PubMed=11319762;

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCC-2

AC   CVCL_6B10

RX   PubMed=11329612;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MCC-35

AC   CVCL_6B12

RX   PubMed=11329612;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MCC-5

AC   CVCL_6B11

RX   PubMed=11329612;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MCC1 [Human Merkel cell carcinoma]

AC   CVCL_4558

SY   MCC1TC; MCC1 TC

DR   Cosmic; 912927

RX   PubMed=8244578;

CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1335 but was never distributed.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCC1 [Human mucinous cystic carcinoma]

AC   CVCL_D729

RX   PubMed=15688169;

DI   NCIt; C41247; Pancreatic mucinous-cystic neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCC12

AC   CVCL_4446

SY   MCC12TC; MCC12 TC

RX   PubMed=8244578;

CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1337 but was never distributed.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MCC13

AC   CVCL_2583

SY   MCC13TC; MCC13 TC

DR   CBA; CBA-1338

DR   Cosmic; 912929

DR   Cosmic; 1693075

DR   Cosmic; 1699815

DR   Cosmic; 2273913

DR   Cosmic-CLP; 1333003

DR   ECACC; 10092302

DR   GDSC; 1333003

RX   PubMed=7814141;

RX   PubMed=12209990;

RX   PubMed=20444890;

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCC14/1

AC   CVCL_4447

SY   MCC14/1TC; MCC14/1 TC

DR   Cosmic; 912930

RX   PubMed=7814141;

CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1339 but is not yet ready for distribution.

CC   Derived from metastatic site: Iliac lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2584 ! MCC14/2

SX   Male

CA   Cancer cell line

//

ID   MCC14/2

AC   CVCL_2584

SY   MCC14/2TC; MCC14/2 TC

DR   CBA; CBA-1340

DR   Cosmic; 912931

DR   Cosmic; 2273914

DR   ECACC; 10092303

RX   PubMed=7814141;

CC   Derived from metastatic site: Iliac lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4447 ! MCC14/1

SX   Male

CA   Cancer cell line

//

ID   MCC15

AC   CVCL_D021

SY   MCC15TC; MCC15 TC

RX   PubMed=7814141;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCC19

AC   CVCL_4448

SY   MCC19TC; MCC19 TC

DR   Cosmic; 912932

RX   PubMed=12209986;

CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1343 but was never distributed.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MCC26

AC   CVCL_2585

SY   MCC26TC; MCC26 TC

DR   CBA; CBA-1341

DR   Cosmic; 912933

DR   Cosmic; 1693076

DR   Cosmic; 1699816

DR   Cosmic; 2273915

DR   Cosmic-CLP; 1298234

DR   ECACC; 10092304

DR   GDSC; 1298234

RX   PubMed=12209986;

RX   PubMed=12209990;

CC   Omics: Deep exome analysis.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCC5

AC   CVCL_4444

SY   MCC5TC; MCC5 TC

RX   PubMed=8244578;

CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1336 but was never distributed.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCC6

AC   CVCL_4445

SY   MCC6TC; MCC6 TC

DR   Cosmic; 912928

RX   PubMed=8244578;

CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1334 but was never distributed.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MCCL-1

AC   CVCL_D026

SY   MC-MA2

DR   Cosmic; 740970

RX   PubMed=8120418;

RX   PubMed=11992403;

CC   Derived from metastatic site: Cutaneous.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCCL-2

AC   CVCL_IR17

DR   Cosmic; 740972

RX   PubMed=11992403;

CC   Derived from metastatic site: Cutaneous.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCCL-3

AC   CVCL_IR18

DR   Cosmic; 740975

RX   PubMed=11992403;

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCCL-4

AC   CVCL_IR19

DR   Cosmic; 740977

RX   PubMed=11992403;

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCCL-5

AC   CVCL_IR20

DR   Cosmic; 740979

RX   PubMed=11992403;

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCCL-6

AC   CVCL_IR21

DR   Cosmic; 740981

RX   PubMed=11992403;

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   McCoy

AC   CVCL_3742

SY   MCCOY; Mc Coy; McCoy B

DR   CLO; CLO_0007573

DR   CLO; CLO_0007598

DR   CLDB; cl3349

DR   CLDB; cl3350

DR   CLDB; cl3352

DR   ATCC; CRL-1696

DR   BCRC; 60064

DR   BCRJ; 0160

DR   BioSample; SAMN03151926

DR   ECACC; 90010305

DR   IZSLER; BS CL 62

DR   NCBI_Iran; C123

RX   PubMed=4110420;

RX   PubMed=6451928;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

WW   http://en.vircell.com/products/mccoy-cell-line/

CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be a mouse NCTC clone 929 derivative (PubMed=6451928, PubMed=20143388). Were thought to originate from the synovial fluid in the knee joint of a patient suffering from degenerative arthritis.

CC   Breed/subspecies: C3H/An.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0462 ! NCTC clone 929

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MCD-1

AC   CVCL_M701

RX   PubMed=8971690;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCE301

AC   CVCL_6B09

SY   MCE 301

RX   PubMed=11235898;

RX   PubMed=11520047;

RX   PubMed=16678170;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MCEC

AC   CVCL_D355

SY   Mouse Cardiac Endothelial Cells

RX   PubMed=17317723;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU510?lob=Cellutions

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: FVB.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MCF 10A-H2B-mCherry

AC   CVCL_IV14

DR   LINCS; 51124

RX   PubMed=27135972;

CC   Characteristics: Retroviral transformation with an H2B-mCherry expression cassette.

CC   Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10-2A

AC   CVCL_3743

DR   CLO; CLO_0007602

DR   ATCC; CRL-10781

DR   BioSample; SAMN03471306

RX   Patent=US5238840;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 9,11

ST   vWA: 15,17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0598 ! MCF-10A

OI   CVCL_3633 ! MCF-10F

OI   CVCL_5553 ! MCF-10-2F

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10-2F

AC   CVCL_5553

DR   ATCC; CRL-10780

DR   BioSample; SAMN03471305

RX   Patent=US5238840;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 9,11

ST   vWA: 15,17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0598 ! MCF-10A

OI   CVCL_3633 ! MCF-10F

OI   CVCL_3743 ! MCF-10-2A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10A

AC   CVCL_0598

SY   MCF 10A; MCF.10A; MCF10A; MCF10a; Michigan Cancer Foundation-10A

DR   BTO; BTO:0001939

DR   CLO; CLO_0007599

DR   EFO; EFO_0001200

DR   MCCL; MCC:0000305

DR   ATCC; CRL-10317

DR   BCRJ; 0161

DR   BioSample; SAMN03471375

DR   CCRID; 3131C0001000200025

DR   ChEMBL-Cells; CHEMBL3307364

DR   ChEMBL-Targets; CHEMBL614321

DR   Cosmic; 1136376

DR   Cosmic; 1176649

DR   Cosmic; 2318371

DR   ENCODE; ENCBS066ENC

DR   ENCODE; ENCBS067ENC

DR   ENCODE; ENCBS617ENC

DR   ENCODE; ENCBS618ENC

DR   ENCODE; ENCBS619ENC

DR   ENCODE; ENCBS620ENC

DR   ENCODE; ENCBS621ENC

DR   ENCODE; ENCBS622ENC

DR   ENCODE; ENCBS623ENC

DR   GEO; GSM155217

DR   GEO; GSM320171

DR   GEO; GSM350543

DR   GEO; GSM498022

DR   GEO; GSM498026

DR   GEO; GSM756371

DR   GEO; GSM845395

DR   GEO; GSM844584

DR   GEO; GSM1328939

DR   GEO; GSM1328940

DR   GEO; GSM1328941

DR   IGRhCellID; MCF10A

DR   IZSLER; BS CL 174

DR   KCB; KCB 2014066YJ

DR   LINCS; 50583

DR   Lonza; 131

DR   NCBI_Iran; C609

DR   PRIDE; PXD000309

DR   PRIDE; PXD000593

DR   PRIDE; PXD000691

DR   TOKU-E; 2378

RX   Patent=US5436152;

RX   PubMed=12661003;

RX   PubMed=15375546;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=20169162;

RX   PubMed=22414580;

RX   PubMed=24162158;

RX   PubMed=24262153;

RX   PubMed=25485619;

RX   PubMed=26055192;

RX   PubMed=26218769;

RX   PubMed=28196595;

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=81

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).

CC   Omics: CNV analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Glycoproteome analysis by proteomics.

CC   Omics: Metabolome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,9

ST   D16S539: 11,12

ST   D18S51: 18,19

ST   D21S11: 28,30

ST   D3S1358: 14,18

ST   D5S818: 10,13

ST   D7S820: 10,11

ST   D8S1179: 14,16

ST   FGA: 22,24

ST   Penta D: 10,12

ST   Penta E: 13,14

ST   TH01: 8,9.3

ST   TPOX: 9,11

ST   vWA: 15,17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3633 ! MCF-10F

OI   CVCL_3743 ! MCF-10-2A

OI   CVCL_5553 ! MCF-10-2F

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10A-erbB-2

AC   CVCL_IP85

SY   MCF-10AerbB-2

RX   PubMed=10433219;

CC   Transfected with: HGNC; 3430; ERBB2.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10A-neo

AC   CVCL_6C54

SY   MCF-10A neo; MCF-10ANeo; MCF10A-neo; MCF10Aneo

RX   PubMed=1885681;

RX   PubMed=2009132;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10A-neoN

AC   CVCL_6C55

SY   MCF-10A neoN; MCF-10AneoN; MCF10AneoN

RX   PubMed=1885681;

RX   PubMed=2009132;

CC   Transfected with: HGNC; 5173; HRAS.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10A-neoT

AC   CVCL_5554

SY   MCF-10A neoT; MCF-10AneoT; MCF10AneoT; MCF10-AneoT

DR   BTO; BTO:0005127

RX   PubMed=1885681;

RX   PubMed=2009132;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Transformed cell line

//

ID   MCF-10A/Twist

AC   CVCL_DS00

RX   PubMed=20019840;

CC   Transfected with: HGNC; 12428; TWIST1.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-10AT

AC   CVCL_5555

SY   MCF10AT

DR   GEO; GSM498023

DR   GEO; GSM498027

DR   IGRhCellID; MCF10AT

RX   PubMed=8546221;

RX   PubMed=15375546;

RX   PubMed=20169162;

RX   PubMed=24262153;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Omics: CNV analysis.

CC   Omics: Glycoproteome analysis by proteomics.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5554 ! MCF-10A-neoT

SX   Female

CA   Transformed cell line

//

ID   MCF-10F

AC   CVCL_3633

SY   MCF 10F; MCF10F; Michigan Cancer Foundation-10F

DR   BTO; BTO:0003900

DR   CLO; CLO_0007600

DR   ATCC; CRL-10318

DR   Cosmic; 1136377

DR   LINCS; 50584

RX   Patent=US5436152;

RX   PubMed=12353263;

RX   PubMed=12800145;

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

CC   Part of: ICBP43 breast cancer cell line panel.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,9

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 9,11

ST   vWA: 15,17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0598 ! MCF-10A

OI   CVCL_3743 ! MCF-10-2A

OI   CVCL_5553 ! MCF-10-2F

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-12A

AC   CVCL_3744

SY   MCF12A; Michigan Cancer Foundation-12A

DR   BTO; BTO:0002544

DR   CLO; CLO_0007603

DR   EFO; EFO_0001202

DR   ATCC; CRL-10782

DR   BioSample; SAMN03472816

DR   ChEMBL-Cells; CHEMBL3307365

DR   ChEMBL-Targets; CHEMBL614322

DR   Cosmic; 1017163

DR   Cosmic; 1136378

DR   Cosmic; 1176637

DR   GEO; GSM756372

DR   GEO; GSM845396

DR   GEO; GSM844585

DR   LINCS; 51089

DR   TOKU-E; 2381

RX   Patent=US5206165;

RX   PubMed=17157791;

RX   PubMed=24162158;

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,11

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3745 ! MCF-12F

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-12F

AC   CVCL_3745

SY   MCF12F; Michigan Cancer Foundation-12F

DR   BTO; BTO:0002545

DR   CLO; CLO_0007604

DR   ATCC; CRL-10783

DR   GEO; GSM756373

RX   Patent=US5206165;

RX   PubMed=24162158;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,11

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3744 ! MCF-12A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF-7

AC   CVCL_0031

SY   MCF 7; MCF.7; MCF7; Michigan Cancer Foundation-7; ssMCF-7; ssMCF7; MCF7/WT; IBMF-7; MCF7-CTRL

DR   BTO; BTO:0000093

DR   CLO; CLO_0007601

DR   CLO; CLO_0007605

DR   CLO; CLO_0007606

DR   CLO; CLO_0050868

DR   EFO; EFO_0001203

DR   MCCL; MCC:0000307

DR   CLDB; cl3366

DR   CLDB; cl3367

DR   CLDB; cl3368

DR   CLDB; cl3369

DR   CLDB; cl3370

DR   CLDB; cl3371

DR   CLDB; cl3372

DR   CLDB; cl3373

DR   CLDB; cl3375

DR   ATCC; CRL-12584

DR   ATCC; HTB-22

DR   BCRC; 60436

DR   BCRJ; 0162

DR   BioSample; SAMN01821575

DR   BioSample; SAMN01821646

DR   BioSample; SAMN01821698

DR   BioSample; SAMN03473276

DR   CCLE; MCF7_BREAST

DR   CCRID; 3111C0001CCC000013

DR   CCRID; 3111C0001CCC000328

DR   CCRID; 3131C0001000700074

DR   CCRID; 3142C0001000000054

DR   ChEMBL-Cells; CHEMBL3307491

DR   ChEMBL-Cells; CHEMBL3308403

DR   ChEMBL-Targets; CHEMBL387

DR   ChEMBL-Targets; CHEMBL614345

DR   CLS; 300273/p2720_MCF-7

DR   Cosmic; 687490

DR   Cosmic; 755293

DR   Cosmic; 809239

DR   Cosmic; 871143

DR   Cosmic; 875876

DR   Cosmic; 877449

DR   Cosmic; 894096

DR   Cosmic; 897419

DR   Cosmic; 904373

DR   Cosmic; 905946

DR   Cosmic; 912001

DR   Cosmic; 921976

DR   Cosmic; 923059

DR   Cosmic; 934534

DR   Cosmic; 944293

DR   Cosmic; 947352

DR   Cosmic; 949189

DR   Cosmic; 970089

DR   Cosmic; 979723

DR   Cosmic; 991328

DR   Cosmic; 997916

DR   Cosmic; 1000123

DR   Cosmic; 1010932

DR   Cosmic; 1017161

DR   Cosmic; 1018463

DR   Cosmic; 1019310

DR   Cosmic; 1046936

DR   Cosmic; 1047712

DR   Cosmic; 1066224

DR   Cosmic; 1071901

DR   Cosmic; 1092612

DR   Cosmic; 1102382

DR   Cosmic; 1136341

DR   Cosmic; 1152527

DR   Cosmic; 1175832

DR   Cosmic; 1176603

DR   Cosmic; 1176648

DR   Cosmic; 1183770

DR   Cosmic; 1287893

DR   Cosmic; 1289391

DR   Cosmic; 1305382

DR   Cosmic; 1308991

DR   Cosmic; 1312369

DR   Cosmic; 1326278

DR   Cosmic; 1434950

DR   Cosmic; 1436031

DR   Cosmic; 1477426

DR   Cosmic; 1481420

DR   Cosmic; 1523770

DR   Cosmic; 1524349

DR   Cosmic; 1571788

DR   Cosmic; 1603215

DR   Cosmic; 1609459

DR   Cosmic; 1945860

DR   Cosmic; 1995500

DR   Cosmic; 1998454

DR   Cosmic; 2162161

DR   Cosmic; 2165024

DR   Cosmic; 2301233

DR   Cosmic; 2301526

DR   Cosmic; 2307194

DR   Cosmic; 2318370

DR   Cosmic; 2361358

DR   Cosmic; 2525755

DR   Cosmic; 2553502

DR   Cosmic-CLP; 905946

DR   DSMZ; ACC-115

DR   ECACC; 86012803

DR   ENCODE; ENCBS000AAA

DR   ENCODE; ENCBS001AAA

DR   ENCODE; ENCBS017ENC

DR   ENCODE; ENCBS034XKZ

DR   ENCODE; ENCBS036ENC

DR   ENCODE; ENCBS037ENC

DR   ENCODE; ENCBS050QMU

DR   ENCODE; ENCBS053YJT

DR   ENCODE; ENCBS056AAA

DR   ENCODE; ENCBS094ENC

DR   ENCODE; ENCBS095ENC

DR   ENCODE; ENCBS096ENC

DR   ENCODE; ENCBS097ENC

DR   ENCODE; ENCBS098ENC

DR   ENCODE; ENCBS102ENC

DR   ENCODE; ENCBS103ENC

DR   ENCODE; ENCBS104ENC

DR   ENCODE; ENCBS105ENC

DR   ENCODE; ENCBS108ENC

DR   ENCODE; ENCBS123ZGI

DR   ENCODE; ENCBS134PJO

DR   ENCODE; ENCBS135SOE

DR   ENCODE; ENCBS143XXF

DR   ENCODE; ENCBS155VQC

DR   ENCODE; ENCBS158RRU

DR   ENCODE; ENCBS168ISE

DR   ENCODE; ENCBS174OTK

DR   ENCODE; ENCBS200IWR

DR   ENCODE; ENCBS216AOQ

DR   ENCODE; ENCBS236AAA

DR   ENCODE; ENCBS237AAA

DR   ENCODE; ENCBS240AAA

DR   ENCODE; ENCBS241AAA

DR   ENCODE; ENCBS242AAA

DR   ENCODE; ENCBS243AAA

DR   ENCODE; ENCBS244AAA

DR   ENCODE; ENCBS245AAA

DR   ENCODE; ENCBS246AAA

DR   ENCODE; ENCBS247AAA

DR   ENCODE; ENCBS248AAA

DR   ENCODE; ENCBS249AAA

DR   ENCODE; ENCBS250AAA

DR   ENCODE; ENCBS251AAA

DR   ENCODE; ENCBS252AAA

DR   ENCODE; ENCBS254AYH

DR   ENCODE; ENCBS267CRP

DR   ENCODE; ENCBS308QKF

DR   ENCODE; ENCBS325VCY

DR   ENCODE; ENCBS328UKJ

DR   ENCODE; ENCBS331EJR

DR   ENCODE; ENCBS488MMM

DR   ENCODE; ENCBS496HCC

DR   ENCODE; ENCBS530DHL

DR   ENCODE; ENCBS536NWC

DR   ENCODE; ENCBS546VBU

DR   ENCODE; ENCBS547AXB

DR   ENCODE; ENCBS564FRY

DR   ENCODE; ENCBS567IJO

DR   ENCODE; ENCBS581MUA

DR   ENCODE; ENCBS584TFV

DR   ENCODE; ENCBS609QTY

DR   ENCODE; ENCBS614ENC

DR   ENCODE; ENCBS615ENC

DR   ENCODE; ENCBS616ENC

DR   ENCODE; ENCBS616MBU

DR   ENCODE; ENCBS661RDG

DR   ENCODE; ENCBS670IYV

DR   ENCODE; ENCBS705BBA

DR   ENCODE; ENCBS747ZRJ

DR   ENCODE; ENCBS748WRO

DR   ENCODE; ENCBS789UPK

DR   ENCODE; ENCBS866ZXX

DR   ENCODE; ENCBS867ORK

DR   ENCODE; ENCBS873NNF

DR   ENCODE; ENCBS912WOF

DR   ENCODE; ENCBS957OEW

DR   ENCODE; ENCBS959SHH

DR   ENCODE; ENCBS967MVZ

DR   ENCODE; ENCBS974BZV

DR   GDSC; 905946

DR   GEO; GSM1723

DR   GEO; GSM50183

DR   GEO; GSM50247

DR   GEO; GSM69199

DR   GEO; GSM73693

DR   GEO; GSM115111

DR   GEO; GSM155207

DR   GEO; GSM156025

DR   GEO; GSM185091

DR   GEO; GSM185092

DR   GEO; GSM211175

DR   GEO; GSM276773

DR   GEO; GSM276774

DR   GEO; GSM276775

DR   GEO; GSM276776

DR   GEO; GSM276777

DR   GEO; GSM276778

DR   GEO; GSM276779

DR   GEO; GSM320172

DR   GEO; GSM344347

DR   GEO; GSM344397

DR   GEO; GSM350552

DR   GEO; GSM378140

DR   GEO; GSM388212

DR   GEO; GSM459726

DR   GEO; GSM472936

DR   GEO; GSM481303

DR   GEO; GSM510510

DR   GEO; GSM533396

DR   GEO; GSM533413

DR   GEO; GSM590108

DR   GEO; GSM679692

DR   GEO; GSM679693

DR   GEO; GSM679694

DR   GEO; GSM739996

DR   GEO; GSM739997

DR   GEO; GSM739998

DR   GEO; GSM750771

DR   GEO; GSM750777

DR   GEO; GSM750778

DR   GEO; GSM750801

DR   GEO; GSM783949

DR   GEO; GSM799320

DR   GEO; GSM799383

DR   GEO; GSM816627

DR   GEO; GSM816670

DR   GEO; GSM827593

DR   GEO; GSM847394

DR   GEO; GSM847490

DR   GEO; GSM844586

DR   GEO; GSM844587

DR   GEO; GSM887291

DR   GEO; GSM888366

DR   GEO; GSM945269

DR   GEO; GSM945274

DR   GEO; GSM967819

DR   GEO; GSM967823

DR   GEO; GSM1008565

DR   GEO; GSM1008581

DR   GEO; GSM1008603

DR   GEO; GSM1008904

DR   GEO; GSM1029440

DR   GEO; GSM1029441

DR   GEO; GSM1029442

DR   GEO; GSM1029443

DR   GEO; GSM1029444

DR   GEO; GSM1029445

DR   GEO; GSM1029446

DR   GEO; GSM1029447

DR   GEO; GSM1029448

DR   GEO; GSM1029449

DR   GEO; GSM1040306

DR   GEO; GSM1040376

DR   GEO; GSM1068138

DR   GEO; GSM1068139

DR   GEO; GSM1153389

DR   GEO; GSM1181258

DR   GEO; GSM1181263

DR   GEO; GSM1214589

DR   GEO; GSM1374643

DR   GEO; GSM1374644

DR   GEO; GSM1374645

DR   GEO; GSM1401653

DR   GEO; GSM1670076

DR   GEO; GSM1833626

DR   GEO; GSM2046560

DR   GEO; GSM2046561

DR   GEO; GSM2046562

DR   GEO; GSM2046563

DR   GEO; GSM2046564

DR   GEO; GSM2046565

DR   GEO; GSM2046566

DR   GEO; GSM2046567

DR   GEO; GSM2046568

DR   GEO; GSM2046569

DR   GEO; GSM2046570

DR   GEO; GSM2046571

DR   GEO; GSM2046572

DR   GEO; GSM2046573

DR   GEO; GSM2046574

DR   GEO; GSM2046575

DR   GEO; GSM2046576

DR   GEO; GSM2046577

DR   GEO; GSM2046578

DR   GEO; GSM2046579

DR   GEO; GSM2046580

DR   GEO; GSM2046581

DR   GEO; GSM2046582

DR   GEO; GSM2046583

DR   GEO; GSM2046584

DR   GEO; GSM2046585

DR   GEO; GSM2046586

DR   GEO; GSM2046587

DR   GEO; GSM2046588

DR   GEO; GSM2046589

DR   GEO; GSM2046590

DR   GEO; GSM2046591

DR   GEO; GSM2046592

DR   GEO; GSM2046593

DR   GEO; GSM2046594

DR   GEO; GSM2046595

DR   GEO; GSM2046596

DR   GEO; GSM2046597

DR   GEO; GSM2046598

DR   GEO; GSM2046599

DR   GEO; GSM2046600

DR   GEO; GSM2046601

DR   GEO; GSM2046602

DR   GEO; GSM2046603

DR   GEO; GSM2046604

DR   GEO; GSM2046605

DR   GEO; GSM2046606

DR   GEO; GSM2046607

DR   GEO; GSM2136630

DR   GEO; GSM2136631

DR   GEO; GSM2136632

DR   GEO; GSM2136633

DR   GEO; GSM2136634

DR   GEO; GSM2136635

DR   GEO; GSM2176269

DR   GEO; GSM2176270

DR   ICLC; HTL95021

DR   IGRhCellID; MCF7

DR   IZSLER; BS TCL 38

DR   JCRB; JCRB0134

DR   JCRB; NIHS0200

DR   KCB; KCB 200831YJ

DR   KCLB; 30022

DR   LINCS; 50029

DR   Lonza; 113

DR   MeSH; D061986

DR   NCBI_Iran; C135

DR   PRIDE; PXD000275

DR   PRIDE; PXD000281

DR   PRIDE; PXD000309

DR   PRIDE; PXD000623

DR   PRIDE; PXD000691

DR   PRIDE; PXD001274

DR   PRIDE; PXD001352

DR   PRIDE; PXD001812

DR   PRIDE; PXD002104

DR   PRIDE; PXD002192

DR   PRIDE; PXD002395

DR   PRIDE; PXD002421

DR   PRIDE; PXD002998

DR   PRIDE; PXD004051

DR   PRIDE; PXD004085

DR   PRIDE; PXD004357

DR   PRIDE; PXD005032

DR   RCB; RCB1904

DR   SKY/M-FISH/CGH; 2814

DR   TKG; TKG 0479

DR   TOKU-E; 2383

DR   TOKU-E; 3748

DR   Wikidata; Q1881253

RX   CelloPub=CLPUB00336;

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=1000504;

RX   PubMed=1000505;

RX   PubMed=1000506;

RX   PubMed=1911442;

RX   PubMed=2041050;

RX   PubMed=3702420;

RX   PubMed=4357757;

RX   PubMed=6582512;

RX   PubMed=6935474;

RX   PubMed=7498097;

RX   PubMed=8626706;

RX   PubMed=8824553;

RX   PubMed=9242427;

RX   PubMed=9671407;

RX   PubMed=10862037;

RX   PubMed=11044355;

RX   PubMed=11078910;

RX   PubMed=12353263;

RX   PubMed=12661003;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=15767549;

RX   PubMed=17088437;

RX   PubMed=17157791;

RX   PubMed=17254797;

RX   PubMed=19372543;

RX   PubMed=19582160;

RX   PubMed=19727395;

RX   PubMed=20070913;

RX   PubMed=21247443;

RX   PubMed=21378333;

RX   PubMed=22278370;

RX   PubMed=22336246;

RX   PubMed=22414580;

RX   PubMed=22460905;

RX   PubMed=23325432;

RX   PubMed=23601657;

RX   PubMed=23671654;

RX   PubMed=23770244;

RX   PubMed=23856246;

RX   PubMed=23868472;

RX   PubMed=23933261;

RX   PubMed=24162158;

RX   PubMed=24618588;

RX   PubMed=25321415;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26055192;

RX   PubMed=26330541;

RX   PubMed=27362937;

RX   PubMed=27397505;

RX   PubMed=27456714;

RX   PubMed=27761513;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://en.wikipedia.org/wiki/MCF-7

WW   http://mcf7.com/

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MCF-7

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=1

WW   http://www.proteinatlas.org/learn/cellines

WW   http://141.61.102.20/mxdb/project/show/9191407937500

WW   http://www.genboree.org/java-bin/MCF7/index.jsp?isPublic=Yes

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/mcf7.htm

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MCF7

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/MCF-7_Crawford_protocol.pdf

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://www.addexbio.com/productdetail?pid=402

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-36.html

WW   http://archive.bcaction.org/index.php?page=newsletter-66i

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 2.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377).

CC   Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 25.4 hours (DTP); ~50 hours, with a range of 30-72 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using proteomics.

CC   Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established.

CC   Anecdotal: Frances Mallon, the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan.

CC   Misspelling: 'MFC-7'in ChEMBL CHEMBL614345 and CHEMBL3307491.

CC   Discontinued: ATCC; CRL-12584; probable.

CC   Discontinued: JCRB; NIHS0200; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25321415; PubMed=25877200; PubMed=27456714; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 14

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 21,23

ST   D3S1358: 16

ST   D5S818: 11,12 (ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25321415; PubMed=25877200; PubMed=27456714; RCB; TKG)

ST   D5S818: 12 (CLS)

ST   D7S820: 8,9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 7,12

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 14,15

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_N481 ! Hs 631.T

SX   Female

CA   Cancer cell line

//

ID   MCF-7 clone 33

AC   CVCL_4Y65

RX   PubMed=2055945;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-CEBPG

AC   CVCL_HA11

DR   ENCODE; ENCBS467NVT

DR   ENCODE; ENCBS787WNX

DR   ENCODE; ENCBS948XBF

CC   Transfected with: HGNC; 1837; CEBPG.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-E2F4

AC   CVCL_HA12

DR   ENCODE; ENCBS452IKC

DR   ENCODE; ENCBS660MSK

DR   ENCODE; ENCBS742UIG

CC   Transfected with: HGNC; 3118; E2F4.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-ELF1

AC   CVCL_HA13

DR   ENCODE; ENCBS370XRA

DR   ENCODE; ENCBS377JBD

DR   ENCODE; ENCBS580NZH

CC   Transfected with: HGNC; 3316; ELF1.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-GABPA

AC   CVCL_HA14

DR   ENCODE; ENCBS274OZJ

DR   ENCODE; ENCBS368ZAX

DR   ENCODE; ENCBS980KNO

CC   Transfected with: HGNC; 4071; GABPA.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-GTF2E2

AC   CVCL_HA15

DR   ENCODE; ENCBS071FIF

DR   ENCODE; ENCBS829WBT

DR   ENCODE; ENCBS948MKG

CC   Transfected with: HGNC; 4651; GTF2E2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-HBP1

AC   CVCL_HA16

DR   ENCODE; ENCBS812LYE

CC   Transfected with: HGNC; 23200; HBP1.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-KLF4

AC   CVCL_HA17

DR   ENCODE; ENCBS033ECJ

DR   ENCODE; ENCBS949BEW

DR   ENCODE; ENCBS984RGW

CC   Transfected with: HGNC; 6348; KLF4.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-KLF9

AC   CVCL_HA18

DR   ENCODE; ENCBS180ROE

DR   ENCODE; ENCBS183KOB

DR   ENCODE; ENCBS418UGY

CC   Transfected with: HGNC; 1123; KLF9.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 eGFP-ZNF148

AC   CVCL_HA19

DR   ENCODE; ENCBS004ION

CC   Transfected with: HGNC; 12933; ZNF148.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 RR1

AC   CVCL_IU96

SY   MCF-7_RR1

DR   Cosmic; 2553503

RX   PubMed=27279227;

CC   Characteristics: Has a MTOR p.Ala2034Val mutation.

CC   Selected for resistance to: ChEBI; CHEBI:9168; Sirolimus (Rapamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 RR2

AC   CVCL_IU97

SY   MCF-7_RR2

DR   Cosmic; 2553505

RX   PubMed=27279227;

CC   Characteristics: Has a MTOR p.Phe2108Leu mutation.

CC   Selected for resistance to: ChEBI; CHEBI:9168; Sirolimus (Rapamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 SimpleCell O-GalNAc

AC   CVCL_S030

SY   MCF-7 SimpleCell; MCF-7 SC

RX   PubMed=23584533;

CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.

CC   Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7 TKi-R

AC   CVCL_IU98

SY   MCF-7_TKi-R

DR   Cosmic; 2553506

RX   PubMed=27279227;

CC   Characteristics: Has a MTOR p.Met2327Ile mutation.

CC   Selected for resistance to: ChEBI; CHEBI:91329; AZD8055.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-2a

AC   CVCL_4Y54

SY   MCF-7/2a; MCF7-2A; MCF7-2a; MCF-7.2A

DR   ChEMBL-Cells; CHEMBL3307366

DR   ChEMBL-Targets; CHEMBL614323

RX   PubMed=8138561;

RX   PubMed=8903422;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Caution: There is confusion in the literature between estrogen-independent MCF-7:2A (CVCL_4Y53), L-mimosine-resistant MCF-7/2a (CVCL_0412) and EREwtcluc transfected MCF-7-2a (CVCL_4Y54).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7.5C

AC   CVCL_DC70

SY   MCF-7 clone 5C; 5C

RX   PubMed=9242427;

RX   PubMed=1301400;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-BAG

AC   CVCL_R954

SY   MCF-7 BAG

RX   PubMed=1384607;

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-EpiR

AC   CVCL_4V96

RX   PubMed=23514751;

CC   Selected for resistance to: ChEBI; CHEBI:47898; 4'-epidoxorubicin (Epirubicin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-FLV1000

AC   CVCL_5I64

SY   MCF-7 FLV1000; MCF-7/Flv1000; MCF7-FLV1000; MCF-7FL-1000; MCF-7-FL1000; MCF-7 FL1000; MCF7FL1000

RX   PubMed=11205902;

CC   Selected for resistance to: ChEBI; CHEBI:47344; Alvocidib (Flavopiridol; HMR-1275).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-Luc

AC   CVCL_J259

DR   JCRB; JCRB1372

DR   JCRB; NIHS0638

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0638; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 14,15

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-luc-F5

AC   CVCL_5J35

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: PerkinElmer; Catalog number 119262.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-Red-Fluc

AC   CVCL_5J04

SY   MCF7-Red-Fluc; MCF7 Red-Fluc

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW119262

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7-TaxR

AC   CVCL_4V97

RX   PubMed=23514751;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/164R-1

AC   CVCL_1D48

SY   MCF7/164R-1; 164R-1

DR   Ximbio; 152091

RX   PubMed=7759159;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/164R-4

AC   CVCL_1D49

SY   MCF7/164R-4; 164R-4

DR   Ximbio; 152101

RX   PubMed=7759159;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/164R-5

AC   CVCL_1D38

SY   MCF7/164R-5; MCF-7/164(R)-5; 164R-5

DR   Ximbio; 152102

RX   PubMed=7759159;

RX   PubMed=16172194;

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/164R-7

AC   CVCL_1D39

SY   MCF7/164R-7; 164R-7

DR   Ximbio; 152103

RX   PubMed=7759159;

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/182R-1

AC   CVCL_1D40

SY   MCF7/182R-1; 182R-1

DR   Ximbio; 152104

RX   PubMed=7759159;

RX   PubMed=16172194;

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/182R-6

AC   CVCL_W536

SY   MCF-7/182(R)-6; MCF7/182R-6; 182R-6

DR   ECACC; 16022506

DR   Ximbio; 152105

RX   PubMed=7759159;

RX   PubMed=10027303;

RX   PubMed=16172194;

RX   PubMed=25362855;

CC   Doubling time: 24 hours, in estradiol-deprived medium (PubMed=10027303).

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/182R-7

AC   CVCL_1D41

SY   MCF7/182R-7; 182R-7

DR   Ximbio; 152106

RX   PubMed=7759159;

RX   PubMed=16172194;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/2a

AC   CVCL_0412

SY   MCF-7/2A; MCF7/2a; MCF-7 clone 2A

DR   BTO; BTO:0002270

DR   MCCL; MCC:0000308

RX   PubMed=10766749;

RX   PubMed=15531579;

CC   Selected for resistance to: ChEBI; CHEBI:29063; L-mimosine.

CC   Caution: There is confusion in the literature between estrogen-independent MCF-7:2A (CVCL_4Y53), L-mimosine-resistant MCF-7/2a (CVCL_0412) and EREwtcluc transfected MCF-7-2a (CVCL_4Y54).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/4-HC

AC   CVCL_4V53

SY   MCF-7/4-hc; MCF7/4HC; MCF-7/OAP

RX   PubMed=3180059;

RX   PubMed=8328987;

CC   Selected for resistance to: ChEBI; CHEBI:196991; 4-hydroperoxycyclophosphamide.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/5-23

AC   CVCL_4V44

SY   MCF 7/5-23; MCF 5-23; 5-23

RX   PubMed=8244585;

RX   PubMed=10070856;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/6

AC   CVCL_W972

SY   MCF-7-6

DR   Cosmic; 2036670

RX   PubMed=1648947;

RX   PubMed=8528519;

RX   PubMed=22161839;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/AdrVp

AC   CVCL_4Y46

SY   MCF7/AdrVp; MCF-7-ADRVP

RX   PubMed=1972154;

RX   PubMed=9865745;

RX   PubMed=14576842;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Selected for resistance to: ChEBI; CHEBI:9948; Verapamil (VPL).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/AnaR-1

AC   CVCL_5A09

SY   MCF7/AnaR-1; AnaR-1

DR   Ximbio; 152551

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:2704; Anastrozole.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/AnaR-2

AC   CVCL_5A10

SY   MCF7/AnaR-2; AnaR-2

DR   Ximbio; 152552

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:2704; Anastrozole.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/AnaR-3

AC   CVCL_5A11

SY   MCF7/AnaR-3; AnaR-3

DR   Ximbio; 152553

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:2704; Anastrozole.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/AnaR-4

AC   CVCL_5A12

SY   MCF7/AnaR-4; AnaR-4

DR   ECACC; 16022519

DR   Ximbio; 152554

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:2704; Anastrozole.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 7,12

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 14,15

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/AZ

AC   CVCL_W971

SY   MCF-7AZ

DR   Cosmic; 2036668

RX   PubMed=1648947;

RX   PubMed=8528519;

RX   PubMed=22161839;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/C4-12

AC   CVCL_GX99

SY   MCF-7 C4-12; MCF7 C4-12; MCF-7:C4-12; MCF-7C4-12; C4-12

DR   TOKU-E; 4086

RX   PubMed=11479214;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/CG-4

AC   CVCL_4D03

SY   CG-4

RX   PubMed=6575841;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/CG-5

AC   CVCL_4D04

SY   CG-5; CG5

DR   CLO; CLO_0002398

RX   PubMed=6575841;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/E2F1

AC   CVCL_HA20

DR   ENCODE; ENCBS106ENC

DR   ENCODE; ENCBS107ENC

CC   Characteristics: Transfected with E2F1 fused at the N-terminus to an HA tag and the estrogen receptor ligand binding domain.

CC   Transfected with: HGNC; 3113; E2F1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/E6

AC   CVCL_M439

SY   MCF7-E6; MCF 7 E6

RX   PubMed=7712469;

CC   Transfected with: UniProtKB; P03126; HPV16 E6.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/ExeR-1

AC   CVCL_5A13

SY   MCF7/ExeR-1; MCF-7/S0.5/ExeR-1; ExeR-1

DR   Ximbio; 152555

RX   PubMed=25625755;

RX   PubMed=25667100;

CC   Selected for resistance to: ChEBI; CHEBI:4953; Exemestane.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/ExeR-2

AC   CVCL_5A14

SY   MCF7/ExeR-2; ExeR-2

DR   Ximbio; 152556

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:4953; Exemestane.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/ExeR-3

AC   CVCL_5A15

SY   MCF7/ExeR-3; MCF-7/S0.5/ExeR-3; ExeR-3

DR   Ximbio; 152557

RX   PubMed=25625755;

RX   PubMed=25667100;

CC   Selected for resistance to: ChEBI; CHEBI:4953; Exemestane.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/ExeR-4

AC   CVCL_5A16

SY   MCF7/ExeR-4; ExeR-4

DR   ECACC; 16022523

DR   Ximbio; 152558

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:4953; Exemestane.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 7,12

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 14,15

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/GFP

AC   CVCL_5J37

WW   http://www.cellbiolabs.com/mcf-7-reporter-cells

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/HER2-18

AC   CVCL_0U80

SY   MCF-7 HER2-18; MCF-7/Her2-18; MCF7/HER2-clone 18; MCF7/HER2-18; MCF/HER2-18

DR   BioSample; SAMN03471643

RX   PubMed=8095168;

CC   Transfected with: HGNC; 3430; ERBB2.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 7,12

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 14,15

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/LetR-1

AC   CVCL_5A17

SY   MCF7/LetR-1; MCF-7/S0.5/LetR-1; LetR-1

DR   ECACC; 16022524

DR   Ximbio; 152547

RX   PubMed=25625755;

RX   PubMed=25667100;

CC   Selected for resistance to: ChEBI; CHEBI:6413; Letrozole.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 7,12

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 14,15

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/LetR-2

AC   CVCL_5A18

SY   MCF7/LetR-2; LetR-2

DR   Ximbio; 152548

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:6413; Letrozole.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/LetR-3

AC   CVCL_5A19

SY   MCF7/LetR-3; MCF-7/S0.5/LetR-3; LetR-3

DR   Ximbio; 152549

RX   PubMed=25625755;

RX   PubMed=25667100;

CC   Selected for resistance to: ChEBI; CHEBI:6413; Letrozole.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/LetR-4

AC   CVCL_5A20

SY   MCF7/LetR-4; LetR-4

DR   Ximbio; 152550

RX   PubMed=25625755;

CC   Selected for resistance to: ChEBI; CHEBI:6413; Letrozole.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/Luc

AC   CVCL_5J36

WW   http://www.cellbiolabs.com/mcf-7-reporter-cells

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/LY2

AC   CVCL_9579

SY   LY2; LY-2

DR   EFO; EFO_0001199

DR   Cosmic; 1136350

DR   LINCS; 51095

DR   Lonza; 982

RX   PubMed=4029083;

RX   PubMed=17157791;

CC   Selected for resistance to: ChEBI; CHEBI:90187; Lilly 117018 (LY 117018).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/MDD2

AC   CVCL_Z704

SY   MDD2

RX   PubMed=8700512;

RX   PubMed=11802204;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/MN1

AC   CVCL_Z705

SY   MN1; MN-1

RX   PubMed=8700512;

RX   PubMed=11802204;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/RTx6

AC   CVCL_4V43

SY   MCF-7 Rtx6; RTx6; RTX6; RTx-6; Rtx-6

RX   PubMed=6574477;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/RU58R-1

AC   CVCL_K235

SY   MCF-7/RU58(R)-1; RU58(R)-1; RU58R-1

RX   PubMed=15868441;

RX   PubMed=16172194;

CC   Selected for resistance to: ChEBI; CHEBI:90223; RU 58668.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/S0.5

AC   CVCL_1D47

SY   MCF7/S0.5; MCF7 S0.5

DR   ECACC; 16022501

DR   Millipore; SCC100

DR   Ximbio; 152090

RX   PubMed=6362856;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 7,12

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 14,15

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/S9

AC   CVCL_AS09

SY   MCF7/S9

DR   Ximbio; 152602

RX   PubMed=3513694;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TAMR-1

AC   CVCL_M436

SY   MCF7/TAMR-1; MCF7 TAMR-1; MCF-7/TAM(R)-1; TAMR-1; TamR-1; TamR1; AL-1

DR   Millipore; SCC101

DR   Ximbio; 152089

RX   PubMed=1622627;

RX   PubMed=7664983;

RX   PubMed=16172194;

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TAMR-4

AC   CVCL_1D42

SY   MCF7/TAMR-4; TAMR-4; TamR-4; TamR4

DR   Ximbio; 152088

RX   PubMed=16172194;

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TAMR-7

AC   CVCL_1D43

SY   MCF7/TAMR-7; TAMR-7; TamR7

DR   ECACC; 16022509

DR   Ximbio; 152087

RX   PubMed=16172194;

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TAMR-8

AC   CVCL_1D44

SY   MCF7/TAMR-8; TAMR-8; TamR8

DR   Ximbio; 152086

RX   PubMed=16172194;

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D47 ! MCF-7/S0.5

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TAX

AC   CVCL_IJ26

RX   PubMed=24289639;

CC   Doubling time: 44.60 +- 1 hours (PubMed=24289639).

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/Taxol

AC   CVCL_M355

RX   PubMed=20926015;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TMX2

AC   CVCL_4Y63

SY   TMX2

RX   PubMed=12943988;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4Y65 ! MCF-7 clone 33

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TMX2-11

AC   CVCL_4Y64

SY   TMX2-11

RX   PubMed=12943988;

RX   PubMed=24225485;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4Y63 ! MCF-7/TMX2

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TMX2-28

AC   CVCL_6957

SY   TMX2-28

RX   PubMed=12943988;

RX   PubMed=17189381;

RX   PubMed=24225485;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4Y63 ! MCF-7/TMX2

SX   Female

CA   Cancer cell line

//

ID   MCF-7/TPT300

AC   CVCL_4V42

SY   MCF7/TPT300

RX   PubMed=10930538;

CC   Selected for resistance to: ChEBI; CHEBI:63632; Topotecan.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/Twist

AC   CVCL_DR99

RX   PubMed=16322226;

RX   PubMed=20019840;

CC   Transfected with: HGNC; 12428; TWIST1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/VD(R)

AC   CVCL_2Z97

RX   PubMed=11500919;

CC   Selected for resistance to: ChEBI; CHEBI:27300; Vitamin D.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7/VP

AC   CVCL_5I65

SY   MCF7-VP; MCF7/VP; MCF-7/VP16; MCF7-VP16

DR   ChEMBL-Cells; CHEMBL3307299

DR   ChEMBL-Cells; CHEMBL3307368

DR   ChEMBL-Targets; CHEMBL614128

DR   ChEMBL-Targets; CHEMBL614329

RX   PubMed=7903202;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7:2A

AC   CVCL_4Y53

RX   PubMed=7780972;

CC   Caution: There is confusion in the literature between estrogen-independent MCF-7:2A (CVCL_4Y53), L-mimosine-resistant MCF-7/2a (CVCL_0412) and EREwtcluc transfected MCF-7-2a (CVCL_4Y54).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7aro

AC   CVCL_9580

SY   MCF-7-Aro; MCF7aro

DR   EFO; EFO_0002072

RX   PubMed=2208160;

RX   PubMed=9449203;

CC   Transfected with: HGNC; 2594; CYP19A1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7aro Let-R

AC   CVCL_W348

SY   MCF-7aro/LetR; MCF-7-AroR-Let-R; MCF7aroLetR; Let-R

DR   Ximbio; 151781

RX   DOI=10.1186/1753-6561-6-S4-P3;

WW   http://www.rcsismj.com/wp-content/uploads/RCSIsmj-Vol5-Aromatase-Inhibitor-Resistant-Breast-Ca.pdf

CC   Selected for resistance to: ChEBI; CHEBI:6413; Letrozole.

CC   Transfected with: HGNC; 2594; CYP19A1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9580 ! MCF-7aro

SX   Female

CA   Cancer cell line

//

ID   MCF-7aro/ERE

AC   CVCL_9581

RX   PubMed=18550029;

CC   Transfected with: HGNC; 2594; CYP19A1.

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9580 ! MCF-7aro

SX   Female

CA   Cancer cell line

//

ID   MCF-7B

AC   CVCL_6860

SY   MCF 7B

DR   CCRID; 3111C0001CCC000041

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7D3Res

AC   CVCL_2Z98

RX   PubMed=8593782;

CC   Selected for resistance to: ChEBI; CHEBI:27300; Vitamin D.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7L

AC   CVCL_0088

SY   MCF-7 L

RX   PubMed=10811993;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7M

AC   CVCL_6672

SY   MCF-7 M

RX   PubMed=9671407;

RX   PubMed=10811993;

CC   Doubling time: 1.4 days (PubMed=9671407).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7N

AC   CVCL_6673

SY   MCF-7 N; MCF-7n

RX   PubMed=10811993;

RX   PubMed=15138590;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7R

AC   CVCL_Y493

SY   MCF7R

DR   ChEMBL-Cells; CHEMBL3307593

DR   ChEMBL-Targets; CHEMBL614327

RX   PubMed=17671737;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF-7TN-R

AC   CVCL_6674

RX   PubMed=15138590;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6673 ! MCF-7N

SX   Female

CA   Cancer cell line

//

ID   MCF-hGH

AC   CVCL_9V74

SY   MCF-HGH

DR   NCBI_Iran; C628

RX   PubMed=10388519;

CC   Transfected with: HGNC; 4261; GH1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF/MX

AC   CVCL_4Y47

SY   MCF-7/MX; MCF-7/mtxR

RX   PubMed=1358431;

RX   PubMed=9865745;

CC   Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF10A-Er-Src

AC   CVCL_N805

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/MCF-10A_Struhl_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF10A-Myc

AC   CVCL_0411

SY   MCF10AMyc

DR   MCCL; MCC:0000306

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0598 ! MCF-10A

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MCF10CA1a

AC   CVCL_6675

DR   GEO; GSM498025

DR   GEO; GSM498029

DR   IGRhCellID; MCF10CA1a

RX   PubMed=11261825;

RX   PubMed=15375546;

RX   PubMed=20169162;

RX   PubMed=24262153;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Omics: CNV analysis.

CC   Omics: Glycoproteome analysis by proteomics.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5554 ! MCF-10A-neoT

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1a.cl1

AC   CVCL_6676

RX   PubMed=11261825;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6675 ! MCF10CA1a

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1b

AC   CVCL_6677

RX   PubMed=11261825;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5554 ! MCF-10A-neoT

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1c

AC   CVCL_6678

RX   PubMed=11261825;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5554 ! MCF-10A-neoT

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1d

AC   CVCL_6679

RX   PubMed=11261825;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5554 ! MCF-10A-neoT

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1d.cl1

AC   CVCL_6680

RX   PubMed=11261825;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6679 ! MCF10CA1d

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1d.cl2

AC   CVCL_6681

RX   PubMed=11261825;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6679 ! MCF10CA1d

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1d.cl3

AC   CVCL_6682

RX   PubMed=11261825;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6679 ! MCF10CA1d

SX   Female

CA   Transformed cell line

//

ID   MCF10CA1h

AC   CVCL_6683

DR   GEO; GSM271344

DR   GEO; GSM498024

DR   GEO; GSM498028

DR   IGRhCellID; MCF10CA1h

RX   PubMed=11261825;

RX   PubMed=20169162;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Omics: CNV analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5554 ! MCF-10A-neoT

SX   Female

CA   Transformed cell line

//

ID   MCF10DCIS.com

AC   CVCL_5552

SY   MCF10DCIS.COM; MCF10ADCIS.com; MCF10DCIS; MCFDCIS; DCIS.COM

DR   EFO; EFO_0006643

DR   Cosmic; 1219447

DR   GEO; GSM271345

DR   GEO; GSM271398

RX   PubMed=10904098;

RX   PubMed=18455123;

RX   PubMed=25485619;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5555 ! MCF-10AT

SX   Female

CA   Transformed cell line

//

ID   MCF3B

AC   CVCL_M373

RX   PubMed=11079502;

CC   Transfected with: RGD; 69267; Slc5a5.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7 NucLight Green

AC   CVCL_DF45

WW   http://www.essenbioscience.com/essen-products/reagents-and-consumables/mcf7-nuclight-green-cells/

CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7 NucLight Red

AC   CVCL_DF46

WW   http://www.essenbioscience.com/essen-products/reagents-and-consumables/mcf7-nuclight-red-cells/

CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.

CC   Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7 Tet-Off

AC   CVCL_V357

SY   MCF-7 Tet-Off

DR   PRIDE; PXD001202

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7 Tet-On

AC   CVCL_V332

SY   MCF-7 Tet-On

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_Cell_Lines

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7 tTS

AC   CVCL_V358

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-tTS_Cell_Lines

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-382

AC   CVCL_3397

DR   CLO; CLO_0007607

DR   CLDB; cl3376

DR   CLDB; cl3377

DR   ICLC; HTL95018

CC   Characteristics: Control line for MCF7-422 (CVCL_3398) and MCF7-432 (CVCL_3399); transfected with emtpy vector pBact.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-422

AC   CVCL_3398

DR   CLO; CLO_0007608

DR   CLDB; cl3378

DR   CLDB; cl3379

DR   ICLC; HTL95017

CC   Transfected with: HGNC; 3467; ESR1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-432

AC   CVCL_3399

DR   CLO; CLO_0007609

DR   CLDB; cl3380

DR   CLDB; cl3381

DR   ICLC; HTL95019

CC   Transfected with: HGNC; 3467; ESR1 (exon 4 defective).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-488X1

AC   CVCL_3400

DR   CLO; CLO_0007610

DR   CLDB; cl3382

DR   CLDB; cl3383

DR   ICLC; HTL96004

CC   Transfected with: HGNC; 3467; ESR1 (exon 5 defective).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-490X1

AC   CVCL_3401

DR   CLO; CLO_0007611

DR   CLDB; cl3384

DR   CLDB; cl3385

DR   ICLC; HTL96002

CC   Transfected with: HGNC; 3467; ESR1 (exon 4 defective).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-492X1

AC   CVCL_3402

DR   CLO; CLO_0007612

DR   CLDB; cl3386

DR   ICLC; HTL96028

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-AFA[r]

AC   CVCL_4V66

WW   http://www.chemoscreen.com/product/mcf7-afar-dna

CC   Selected for resistance to: ChEBI; CHEBI:61390; Afatinib (BIBW-2992).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7-TamR

AC   CVCL_EG55

DR   PRIDE; PXD001812

RX   PubMed=26330541;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Omics: Deep phosphoproteome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7/BUS

AC   CVCL_0413

SY   MCF-7/BUS; MCF-7 BUS; MCF7 BUS

DR   MCCL; MCC:0000309

RX   PubMed=7498097;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7/c

AC   CVCL_EQ28

DR   GEO; GSM212605

DR   GEO; GSM212606

DR   GEO; GSM212607

RX   PubMed=17660348;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7/D40

AC   CVCL_M437

SY   MCF-7/D40

RX   PubMed=1676902;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7/LCC1

AC   CVCL_DP50

SY   MCF-7/LCC-1; MCF-7/LCC1; LCC1

RX   PubMed=8324732;

RX   PubMed=8380254;

RX   PubMed=8380760;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DP49 ! MCF7/MIII

SX   Female

CA   Cancer cell line

//

ID   MCF7/LCC2

AC   CVCL_DP51

SY   MCF-7/LCC-2; MCF-7/LCC2; MCF-7-LCC2; LCC2

DR   PRIDE; PXD000281

RX   PubMed=8324732;

RX   PubMed=11078910;

RX   PubMed=23868472;

CC   Selected for resistance to: ChEBI; CHEBI:44616; Afimoxifene (4-hydroxytamoxifen; 4-OH TAM).

CC   Omics: Proteome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DP50 ! MCF7/LCC1

SX   Female

CA   Cancer cell line

//

ID   MCF7/LCC9

AC   CVCL_DP52

SY   MCF-7/LCC9; LCC9

DR   BTO; BTO:0005970

RX   PubMed=9270017;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DP50 ! MCF7/LCC1

SX   Female

CA   Cancer cell line

//

ID   MCF7/MIII

AC   CVCL_DP49

SY   MCF-7/MIII; MIII

RX   PubMed=8380254;

RX   PubMed=8380760;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7/Mitox

AC   CVCL_M438

SY   MCF-7/Mitox; MCF-7/MITOX

RX   PubMed=1676902;

CC   Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7/XBP1

AC   CVCL_EQ29

DR   GEO; GSM212608

DR   GEO; GSM212609

DR   GEO; GSM212610

RX   PubMed=17660348;

CC   Transfected with: HGNC; 12801; XBP1.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCF7mp53

AC   CVCL_0415

SY   MCF7 mp53; MCF-7-mp53; MCF-7mp53

DR   MCCL; MCC:0000311

RX   PubMed=11278253;

CC   Transfected with: HGNC; 11998; TP53.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCH-MN-1

AC   CVCL_C855

DR   Cosmic; 1181080

RX   PubMed=11441343;

DI   NCIt; C6569; Congenital mesoblastic nephroma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCH015

AC   CVCL_0D90

SY   MCH15

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   MCH024

AC   CVCL_0F57

SY   MCH24; MCH 24

RX   PubMed=3478720;

RX   PubMed=7909321;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   MCH029

AC   CVCL_0D91

SY   MCH29

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   MCH039

AC   CVCL_0D92

SY   MCH 39; MCH39

RX   PubMed=1437403;

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH045

AC   CVCL_U483

SY   MCH45

RX   PubMed=3478720;

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH046

AC   CVCL_0D93

SY   MCH 46; MCH46

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   MCH047

AC   CVCL_U484

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH055

AC   CVCL_U485

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH058

AC   CVCL_U486

SY   MCH58

RX   PubMed=3478720;

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH059

AC   CVCL_U487

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MCH060

AC   CVCL_U488

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MCH064

AC   CVCL_U489

SY   MCH 064; MCH 64; M64

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH065

AC   CVCL_U490

SY   MCH 065; M65

RX   PubMed=20876107;

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MCH068

AC   CVCL_U491

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH069

AC   CVCL_U492

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MCH070

AC   CVCL_U493

SY   MCH 70

RX   PubMed=1437403;

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH071

AC   CVCL_U494

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH072

AC   CVCL_U495

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MCH073

AC   CVCL_U496

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MCH074

AC   CVCL_U497

SY   MCH 74

WW   http://www.cellbank.mcgill.ca/cgi-bin/cellbank/allnormals.cgi

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MCH262A1.D6

AC   CVCL_6C50

SY   MCH-262A1D6; MCH262-A1D6

RX   PubMed=1559705;

RX   PubMed=2300817;

RX   PubMed=8302587;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3984 ! A-9

CA   Hybrid cell line

//

ID   MCHR2-SHG-44

AC   CVCL_L602

RX   DOI=10.3724/SP.J.1008.2008.00896;

CC   Transfected with: HGNC; 20867; MCHR2.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6728 ! SHG-44

CA   Cancer cell line

//

ID   MCJB2

AC   CVCL_AV59

RX   DOI=10.1158/1538-7445.AM2014-LB-95;

WW   http://technologies.ventures.mayoclinic.org/technologies/2010-305_new-cell-lines

DI   NCIt; C71732; Triple-negative breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MCL-5

AC   CVCL_5332

DR   CLO; CLO_0007616

DR   ATCC; CRL-10575

RX   PubMed=1793807;

CC   Discontinued: ATCC; CRL-10575; probable.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,13

ST   D16S539: 10

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3640 ! AHH-1

SX   Male

CA   Transformed cell line

//

ID   MCM-B2

AC   CVCL_L365

RX   PubMed=7659855;

CC   Breed/subspecies: Pointer.

DI   NCIt; C124249; Canine mammary carcinoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   MCM1

AC   CVCL_DH35

DR   GEO; GSM878881

RX   PubMed=22570180;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MCM1G

AC   CVCL_DH36

RX   PubMed=22570180;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH35 ! MCM1

SX   Male

CA   Cancer cell line

//

ID   MCO-Y4

AC   CVCL_L366

RX   PubMed=17085882;

CC   Breed/subspecies: Mixed breed.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   MCP-5

AC   CVCL_R863

SY   MCP5

RX   PubMed=7683224;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MCP21

AC   CVCL_L538

DR   ECACC; 96030418

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MCP6

AC   CVCL_1Q51

SY   MCP-6; GM09191

DR   CLO; CLO_0010632

DR   Coriell; GM09191

RX   PubMed=6641706;

RX   PubMed=6686281;

RX   PubMed=6951167;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_1Q46 ! G3.32.2

HI   CVCL_1Q47 ! PCC4AO

CA   Hybrid cell line

//

ID   MCPV-8

AC   CVCL_D803

RX   PubMed=9745959;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=10047; ! Meriones unguiculatus

SX   Male

CA   Transformed cell line

//

ID   MCS-2

AC   CVCL_R955

DR   BTO; BTO:0002271

RX   PubMed=14623544;

CC   Transfected with: HGNC; 11425; STS.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   MCT

AC   CVCL_0416

SY   Mouse Cortical Tubule cells

DR   MCCL; MCC:0000312

RX   PubMed=3170633;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: SJL.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mCT1

AC   CVCL_IN71

RX   PubMed=11121394;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   mCT1-CF

AC   CVCL_IN72

RX   PubMed=11121394;

CC   Characteristics: Homozygous for the Cftr p.Ser489Ter mutation.

CC   Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MCW12

AC   CVCL_Z799

DR   DGRC; 160

RX   PubMed=16537908;

WW   http://flybase.org/reports/FBrf0205933.html

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MCW23

AC   CVCL_Z800

DR   DGRC; 161

WW   http://flybase.org/reports/FBrf0205933.html

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MD

AC   CVCL_6420

DR   CLO; CLO_0007622

DR   ATCC; CRL-9850

DR   BioSample; SAMN03471074

RX   Patent=US5447861;

ST   Source(s): ATCC; PubMed=11416159

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11,15

ST   D18S51: 14

ST   D21S11: 27,30

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 23,24

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MD 144

AC   CVCL_J841

DR   ATCC; HB-8409

RX   Patent=US4666845;

CC   Discontinued: ATCC; HB-8409; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MD-IGF-I

AC   CVCL_HG41

RX   Patent=US5455164;

RX   PubMed=1480169;

CC   Transfected with: UniProtKB; P10763; Sheep IGF1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_U226 ! MAC-T

SX   Female

CA   Transformed cell line

//

ID   MD0003

AC   CVCL_8Y18

DR   ECACC; 00102801

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex ambiguous

CA   Transformed cell line

//

ID   MD2

AC   CVCL_9220

DR   CLO; CLO_0007623

DR   ATCC; HB-229

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MD901

AC   CVCL_D709

SY   MD-901

DR   Cosmic; 2297016

DR   GEO; GSM119487

RX   PubMed=8274736;

RX   PubMed=16960149;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MD903

AC   CVCL_D710

SY   MD-903

DR   Cosmic; 1670151

DR   Cosmic; 2297017

DR   GEO; GSM119488

RX   PubMed=16960149;

RX   PubMed=23699601;

CC   Omics: Genome sequenced.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA 435TR

AC   CVCL_J435

SY   MDA 435(TR)

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA-1186

AC   CVCL_6977

SY   MDA 1186; MDA1186

DR   BTO; BTO:0002716

DR   Cosmic; 2513917

RX   PubMed=11389082;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9,10

ST   D16S539: 12,13

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 17,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-1386

AC   CVCL_6979

SY   MDA 1386; MDA1386

RX   PubMed=11389082;

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-1386Ln

AC   CVCL_H541

SY   MDA-1386LN; MDA1386LN; MDA1386Ln; 1386LN; 1386Ln

DR   Cosmic; 2131849

DR   Cosmic; 2439757

RX   PubMed=14724901;

RX   PubMed=15641986;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,13

ST   D5S818: 12

ST   D7S820: 8,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 20

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6979 ! MDA-1386

SX   Male

CA   Cancer cell line

//

ID   MDA-1386tu

AC   CVCL_H542

SY   MDA1386TU; MDA1386Tu; 1386TU; 1386Tu

DR   Cosmic; 2131850

RX   PubMed=14724901;

RX   PubMed=15641986;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,13

ST   D5S818: 12

ST   D7S820: 8,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 20

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6979 ! MDA-1386

SX   Male

CA   Cancer cell line

//

ID   MDA-1483

AC   CVCL_6980

SY   MDA 1483; MDA1483; Line 1483; 1483; SCC 1483

DR   BTO; BTO:0003304

DR   Cosmic; 948038

DR   Cosmic; 2131841

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2452013;

RX   PubMed=11389082;

RX   PubMed=21868764;

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,12

ST   D16S539: 9,11

ST   D5S818: 13

ST   D7S820: 7,10

ST   TH01: 9,9.3

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-1586

AC   CVCL_6981

SY   MDA 1586; MDA1586

DR   Cosmic; 2043892

DR   Cosmic; 2550365

RX   PubMed=11389082;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 8,9

ST   D13S317: 12

ST   D16S539: 10

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 7,9

ST   TPOX: 10,11

ST   vWA: 16,17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-1686

AC   CVCL_AT79

SY   MDA 1686; MDA1686

DR   Cosmic; 2131851

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 12,13

ST   D5S818: 13

ST   D7S820: 8,11

ST   TH01: 7,10

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-183

AC   CVCL_6978

SY   MDA 183; MDA183; Line 183; 183; 183A

DR   Cosmic; 948036

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2452013;

RX   PubMed=21868764;

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 13

ST   D5S818: 10,13

ST   D7S820: 9

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-1986

AC   CVCL_6982

SY   MDA 1986; MDA1986

DR   Cosmic; 1530749

RX   PubMed=11389082;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AT80 ! MDA-1986LN

CA   Cancer cell line

//

ID   MDA-1986LN

AC   CVCL_AT80

SY   MDA 1986LN; MDA1986LN

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 13

ST   D16S539: 9,12

ST   D5S818: 9,11

ST   D7S820: 8,9

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17,19,20

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6982 ! MDA-1986

CA   Cancer cell line

//

ID   MDA-584

AC   CVCL_V278

SY   584A2; 584-A2; 584

DR   Cosmic; 2043889

RX   PubMed=3148118;

RX   PubMed=11389082;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 6,12

ST   D16S539: 11,13

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-686

AC   CVCL_6983

SY   MDA 686; MDA686

RX   PubMed=11389082;

DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-686Ln

AC   CVCL_6984

SY   MDA 686Ln; MDA686Ln; MDA686LN; MDA 686LN; MDA 686-LN; MDA 686 Ln; 686LN; 686Ln

DR   BTO; BTO:0003052

RX   PubMed=14724901;

RX   PubMed=15641986;

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 8,9

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 7,8

ST   TPOX: 10,11

ST   vWA: 15,16

DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6983 ! MDA-686

SX   Male

CA   Cancer cell line

//

ID   MDA-686Tu

AC   CVCL_6985

SY   MDA 686Tu; MDA686Tu; MDA686TU; 686TU; 686Tu

RX   PubMed=14724901;

RX   PubMed=15641986;

RX   PubMed=21868764;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 8,9

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 7,8

ST   TPOX: 10,11

ST   vWA: 15,16

DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6983 ! MDA-686

SX   Male

CA   Cancer cell line

//

ID   MDA-8788-6

AC   CVCL_H539

SY   MDA8788-6

RX   PubMed=23032744;

ST   Source(s): PubMed=23032744;

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 9,11

ST   D16S539: 12,13

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C54294; Sinonasal undifferentiated carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_H540 ! MDA-8788-7

SX   Female

CA   Cancer cell line

//

ID   MDA-8788-7

AC   CVCL_H540

SY   MDA8788-7

RX   PubMed=23032744;

ST   Source(s): PubMed=23032744;

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 9,11

ST   D16S539: 12,13

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C54294; Sinonasal undifferentiated carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_H539 ! MDA-8788-6

SX   Female

CA   Cancer cell line

//

ID   MDA-886

AC   CVCL_6986

SY   MDA 886; MDA886; HN 886

DR   BTO; BTO:0002717

RX   PubMed=11389082;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-886Ln

AC   CVCL_6987

SY   MDA 886Ln; MDA-886LN; MDA 886-Ln; MDA886Ln; MDA886LN

DR   Cosmic; 948037

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17,19

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6986 ! MDA-886

SX   Male

CA   Cancer cell line

//

ID   MDA-ACC-01(hTERT)

AC   CVCL_GZ62

RX   PubMed=25086988;

CC   Transfected with: HGNC; 11730; TERT.

DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Telomerase immortalized cell line

//

ID   MDA-AMP7

AC   CVCL_EI94

SY   MDAAmp-7

DR   PRIDE; PXD002657

RX   PubMed=1582987;

RX   PubMed=26951071;

CC   Omics: Deep proteome analysis.

CC   Derived from metastatic site: Peritoneum.

DI   NCIt; C6650; Ampulla of Vater adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-BoM-1833

AC   CVCL_DP48

SY   BoM-1833; 1833 BoM; MDA-MB-231 1833 BoM; MDA-MB-231-1833; MDA-MB-231 subline 1833; MDA-MB-231 Bone Tropic 1833 subclone; 1833

DR   PRIDE; PXD000397

RX   PubMed=12842083;

RX   PubMed=18425382;

RX   PubMed=26649326;

CC   Omics: Proteome analysis by 2D-DE.

CC   Omics: Secretome proteome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-IBC-3

AC   CVCL_HC47

SY   MDA-IBC3; MDAIBC3

DR   GEO; GSM1008922

DR   GEO; GSM1215265

RX   PubMed=20808935;

RX   PubMed=24162158;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=20808935

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   TH01: 8

ST   TPOX: 10,11

ST   vWA: 18,19

DI   NCIt; C4001; Inflammatory breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-kb2

AC   CVCL_6421

SY   MDA-Kb2

DR   CLO; CLO_0007630

DR   ATCC; CRL-2713

RX   PubMed=11861974;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Pericardial effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 6

ST   TPOX: 10

ST   vWA: 17,18

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0418 ! MDA-MB-453

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-134-VI

AC   CVCL_0617

SY   MDA-MB-134 VI; MDA MB 134VI; MDA-MB-134VI; MDAMB134VI; MDA-MB-134; MDAMB134; MDA-134; MDA134; MM134

DR   CLO; CLO_0007631

DR   EFO; EFO_0001205

DR   CLDB; cl3398

DR   ATCC; HTB-23

DR   BioSample; SAMN03471473

DR   CCLE; MDAMB134VI_BREAST

DR   CCRID; 3111C0001CCC000380

DR   ChEMBL-Cells; CHEMBL3308340

DR   ChEMBL-Targets; CHEMBL2366242

DR   Cosmic; 687491

DR   Cosmic; 735125

DR   Cosmic; 809233

DR   Cosmic; 904374

DR   Cosmic; 908119

DR   Cosmic; 934525

DR   Cosmic; 997933

DR   Cosmic; 1000129

DR   Cosmic; 1046947

DR   Cosmic; 1047696

DR   Cosmic; 1090333

DR   Cosmic; 1136347

DR   Cosmic; 1152519

DR   Cosmic; 1287908

DR   Cosmic; 1289392

DR   Cosmic; 1603216

DR   GDSC; 908119

DR   GEO; GSM115107

DR   GEO; GSM186432

DR   GEO; GSM186433

DR   GEO; GSM186434

DR   GEO; GSM217584

DR   GEO; GSM320180

DR   GEO; GSM350523

DR   GEO; GSM783960

DR   GEO; GSM847398

DR   GEO; GSM847491

DR   GEO; GSM887292

DR   GEO; GSM888367

DR   GEO; GSM1215268

DR   GEO; GSM1226522

DR   GEO; GSM1226523

DR   GEO; GSM1226524

DR   GEO; GSM1226525

DR   GEO; GSM1226526

DR   GEO; GSM1226527

DR   GEO; GSM1226528

DR   GEO; GSM1226529

DR   GEO; GSM1226530

DR   GEO; GSM1226531

DR   GEO; GSM1226532

DR   GEO; GSM1226533

DR   GEO; GSM1226534

DR   GEO; GSM1226535

DR   GEO; GSM1226536

DR   GEO; GSM1226537

DR   GEO; GSM1226538

DR   GEO; GSM1226539

DR   GEO; GSM1226540

DR   GEO; GSM1226541

DR   GEO; GSM1374647

DR   GEO; GSM1401662

DR   GEO; GSM1661981

DR   GEO; GSM1670078

DR   IZSLER; BS TCL 236

DR   LINCS; 50327

RX   PubMed=730202;

RX   PubMed=833871;

RX   PubMed=4412247;

RX   PubMed=9671407;

RX   PubMed=10862037;

RX   PubMed=11044355;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=24425047;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/mda-mb-134.htm

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 6.4 days (PubMed=9671407).

CC   Omics: CNV analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MDA-MB-134IV' in Cosmic 1000129.

CC   Misspelling: 'MDA-MB-134-IV' in Cosmic 1090333.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 13

ST   D18S51: 10,16

ST   D21S11: 26,28

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   D8S1179: 14

ST   FGA: 21,22

ST   Penta D: 12,13

ST   Penta E: 7,9

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C7950; Invasive lobular breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-157

AC   CVCL_0618

AS   CVCL_3740

SY   MDA-MB157; MDAMB157; MDA-157; MDA157; MB 157; MB157

DR   CLO; CLO_0007544

DR   CLO; CLO_0007632

DR   EFO; EFO_0001206

DR   CLDB; cl3400

DR   CLDB; cl3401

DR   ATCC; HTB-24

DR   ATCC; CRL-7721

DR   BCRJ; 0319

DR   BioSample; SAMN03472739

DR   BioSample; SAMN03473083

DR   CCLE; MDAMB157_BREAST

DR   CCLE; MB157_BREAST

DR   CCRID; 3111C0001CCC000077

DR   ChEMBL-Cells; CHEMBL3308759

DR   ChEMBL-Targets; CHEMBL1075496

DR   Cosmic; 687492

DR   Cosmic; 809234

DR   Cosmic; 871144

DR   Cosmic; 897421

DR   Cosmic; 904375

DR   Cosmic; 925338

DR   Cosmic; 934535

DR   Cosmic; 979714

DR   Cosmic; 1010921

DR   Cosmic; 1017166

DR   Cosmic; 1018462

DR   Cosmic; 1027052

DR   Cosmic; 1044207

DR   Cosmic; 1044228

DR   Cosmic; 1046954

DR   Cosmic; 1047692

DR   Cosmic; 1136372

DR   Cosmic; 1176640

DR   Cosmic; 1287919

DR   Cosmic; 1289393

DR   Cosmic; 1477429

DR   Cosmic; 1523776

DR   Cosmic; 1603217

DR   Cosmic; 1609468

DR   Cosmic; 1995501

DR   Cosmic; 2009506

DR   Cosmic; 2301527

DR   Cosmic-CLP; 925338

DR   ECACC; 92020422

DR   GDSC; 925338

DR   GDSC; 1298233

DR   GEO; GSM73731

DR   GEO; GSM115112

DR   GEO; GSM186435

DR   GEO; GSM186436

DR   GEO; GSM217585

DR   GEO; GSM350548

DR   GEO; GSM783948

DR   GEO; GSM783970

DR   GEO; GSM827192

DR   GEO; GSM847399

DR   GEO; GSM847492

DR   GEO; GSM844591

DR   GEO; GSM887293

DR   GEO; GSM888368

DR   GEO; GSM1374648

DR   GEO; GSM1374649

DR   GEO; GSM1401671

DR   GEO; GSM1670079

DR   LINCS; 50324

DR   LINCS; 50328

RX   PubMed=730202;

RX   PubMed=833871;

RX   PubMed=4412247;

RX   PubMed=4471183;

RX   PubMed=9671407;

RX   PubMed=10862037;

RX   PubMed=11044355;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/mda-mb-157.htm

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MDA-MB-157

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Doubling time: 2.8 days (PubMed=9671407).

CC   Microsatellite instability: Stable (MSS) (PubMed=15677628; Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MDA-MB-15' in Cosmic 897421.

CC   Discontinued: BCRJ; 0319; probable.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12 (ATCC)

ST   D13S317: 11 (Cosmic-CLP; ECACC; PubMed=20679594; PubMed=25877200)

ST   D16S539: 11

ST   D18S51: 16

ST   D21S11: 31,31.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 12,14

ST   FGA: 23

ST   Penta D: 3.2,9

ST   Penta E: 11

ST   TH01: 7,8

ST   TPOX: 9,11 (ATCC; ECACC; PubMed=20679594; PubMed=25877200)

ST   TPOX: 11 (Cosmic-CLP)

ST   vWA: 15

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-175-VII

AC   CVCL_1400

SY   MDA MB 175 VII; MDA-MB-175VII; MDAMB175VII; MDA-MB-175; MDAMB175; MDA-175; MDA175

DR   BTO; BTO:0003471

DR   CLO; CLO_0007633

DR   EFO; EFO_0001208

DR   ATCC; HTB-25

DR   BioSample; SAMN03472690

DR   CCLE; MDAMB175VII_BREAST

DR   CCRID; 3111C0001CCC000349

DR   ChEMBL-Cells; CHEMBL3308404

DR   ChEMBL-Targets; CHEMBL1075497

DR   Cosmic; 687493

DR   Cosmic; 809236

DR   Cosmic; 871145

DR   Cosmic; 894086

DR   Cosmic; 897422

DR   Cosmic; 904376

DR   Cosmic; 908120

DR   Cosmic; 934526

DR   Cosmic; 997917

DR   Cosmic; 1010931

DR   Cosmic; 1044227

DR   Cosmic; 1046955

DR   Cosmic; 1047690

DR   Cosmic; 1176646

DR   Cosmic; 1287894

DR   Cosmic; 1289394

DR   Cosmic; 1309001

DR   Cosmic; 1434951

DR   Cosmic; 1603218

DR   Cosmic; 1609470

DR   Cosmic; 2165025

DR   Cosmic-CLP; 908120

DR   GDSC; 908120

DR   GEO; GSM115106

DR   GEO; GSM217586

DR   GEO; GSM320175

DR   GEO; GSM344348

DR   GEO; GSM344398

DR   GEO; GSM350511

DR   GEO; GSM466359

DR   GEO; GSM783950

DR   GEO; GSM847400

DR   GEO; GSM847493

DR   GEO; GSM844592

DR   GEO; GSM844593

DR   GEO; GSM887294

DR   GEO; GSM888369

DR   GEO; GSM1374650

DR   IGRhCellID; MDAMB175VII

DR   LINCS; 50329

DR   NCBI_Iran; C432

RX   PubMed=730202;

RX   PubMed=4412247;

RX   PubMed=11044355;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/MDA-MB-175.html

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://www.addexbio.com/productdetail?pid=4885

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 7,8

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D18S51: 15

ST   D21S11: 29,30

ST   D3S1358: 16,18

ST   D5S818: 11

ST   D7S820: 11,12

ST   D8S1179: 14,17

ST   FGA: 23,26

ST   Penta D: 3.2

ST   Penta E: 8,15

ST   TH01: 7

ST   TPOX: 6,8

ST   vWA: 15,16

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231

AC   CVCL_0062

SY   MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB231; MDA-231; MDA231; MB231

DR   BTO; BTO:0000815

DR   CLO; CLO_0007634

DR   EFO; EFO_0001209

DR   MCCL; MCC:0000313

DR   CLDB; cl3402

DR   CLDB; cl3404

DR   CLDB; cl3405

DR   CLDB; cl4945

DR   ATCC; CRL-12532

DR   ATCC; HTB-26

DR   ATCC; CRM-HTB-26

DR   BCRC; 60425

DR   BCRJ; 0164

DR   BioSample; SAMN03472205

DR   CCLE; MDAMB231_BREAST

DR   CCRID; 3111C0001CCC000014

DR   CCRID; 3131C0001000700104

DR   ChEMBL-Cells; CHEMBL3307960

DR   ChEMBL-Targets; CHEMBL400

DR   CLS; 300275/p536_MDA-MB-231

DR   Cosmic; 687494

DR   Cosmic; 871146

DR   Cosmic; 875878

DR   Cosmic; 877450

DR   Cosmic; 894087

DR   Cosmic; 897423

DR   Cosmic; 904377

DR   Cosmic; 905960

DR   Cosmic; 934536

DR   Cosmic; 944294

DR   Cosmic; 974235

DR   Cosmic; 991324

DR   Cosmic; 997929

DR   Cosmic; 1010924

DR   Cosmic; 1018477

DR   Cosmic; 1027053

DR   Cosmic; 1044226

DR   Cosmic; 1046950

DR   Cosmic; 1047693

DR   Cosmic; 1071900

DR   Cosmic; 1092613

DR   Cosmic; 1136369

DR   Cosmic; 1152528

DR   Cosmic; 1175833

DR   Cosmic; 1176602

DR   Cosmic; 1176636

DR   Cosmic; 1183773

DR   Cosmic; 1219444

DR   Cosmic; 1287926

DR   Cosmic; 1289395

DR   Cosmic; 1305383

DR   Cosmic; 1309003

DR   Cosmic; 1312370

DR   Cosmic; 1434952

DR   Cosmic; 1436032

DR   Cosmic; 1466805

DR   Cosmic; 1477428

DR   Cosmic; 1481426

DR   Cosmic; 1524347

DR   Cosmic; 1571793

DR   Cosmic; 1609458

DR   Cosmic; 1927242

DR   Cosmic; 1945862

DR   Cosmic; 1998455

DR   Cosmic; 2009512

DR   Cosmic; 2036667

DR   Cosmic; 2164997

DR   Cosmic; 2301528

DR   Cosmic; 2318377

DR   Cosmic; 2361355

DR   Cosmic-CLP; 905960

DR   DSMZ; ACC-732

DR   ECACC; 92020424

DR   GDSC; 905960

DR   GEO; GSM812

DR   GEO; GSM50184

DR   GEO; GSM50248

DR   GEO; GSM69194

DR   GEO; GSM155213

DR   GEO; GSM185093

DR   GEO; GSM185094

DR   GEO; GSM344349

DR   GEO; GSM344399

DR   GEO; GSM350547

DR   GEO; GSM378148

DR   GEO; GSM388213

DR   GEO; GSM459713

DR   GEO; GSM481304

DR   GEO; GSM587393

DR   GEO; GSM587394

DR   GEO; GSM750781

DR   GEO; GSM799321

DR   GEO; GSM799384

DR   GEO; GSM847036

DR   GEO; GSM847401

DR   GEO; GSM844594

DR   GEO; GSM844595

DR   GEO; GSM887295

DR   GEO; GSM888370

DR   GEO; GSM967818

DR   GEO; GSM1008905

DR   GEO; GSM1153390

DR   GEO; GSM1181242

DR   GEO; GSM1181365

DR   GEO; GSM1214569

DR   GEO; GSM1374651

DR   GEO; GSM1374652

DR   GEO; GSM1401658

DR   GEO; GSM1613823

DR   GEO; GSM1670080

DR   GEO; GSM1833624

DR   ICLC; HTL99004

DR   IZSLER; BS TCL 223

DR   KCB; KCB 200776YJ

DR   KCLB; 30026

DR   LINCS; 50058

DR   Lonza; 815

DR   NCBI_Iran; C578

DR   PRIDE; PXD000239

DR   PRIDE; PXD000397

DR   PRIDE; PXD000691

DR   PRIDE; PXD000914

DR   PRIDE; PXD001553

DR   PRIDE; PXD002192

DR   PRIDE; PXD002649

DR   SKY/M-FISH/CGH; 2815

DR   TOKU-E; 2394

DR   Wikidata; Q17577870

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=730202;

RX   PubMed=833871;

RX   PubMed=1000504;

RX   PubMed=1000505;

RX   PubMed=1000506;

RX   PubMed=2041050;

RX   PubMed=4412247;

RX   PubMed=6582512;

RX   PubMed=6935474;

RX   PubMed=7000337;

RX   PubMed=7272986;

RX   PubMed=7459858;

RX   PubMed=8824553;

RX   PubMed=9671407;

RX   PubMed=11697798;

RX   PubMed=12353263;

RX   PubMed=12661003;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=15767549;

RX   PubMed=17088437;

RX   PubMed=17157791;

RX   PubMed=18714363;

RX   PubMed=19372543;

RX   PubMed=19582160;

RX   PubMed=20070913;

RX   PubMed=21378333;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=26055192;

RX   PubMed=26218769;

RX   PubMed=26649326;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://de.wikipedia.org/wiki/MDA-MB-231_(Zelllinie)

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=2

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MDA-MB-231

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/MDA-MB-231_Struhl_protocol.pdf

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://www.addexbio.com/productdetail?pid=58

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-394.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Registration: Chiron Master Culture Collection; CMCC 10583 (CMCC #10583).

CC   Doubling time: 1.3 days (PubMed=9671407); 41.9 hours (DTP); 38 hours (ATCC); ~25-30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Cell surface proteome.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Metabolome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Secretome proteome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MDA-MD-231' in Cosmic 1071900 and Cosmic 1176602.

CC   Misspelling: 'MDA-321' in GEO GSM459713.

CC   Misspelling: 'MDA-MG-231' in PubMed=6582512.

CC   Discontinued: ATCC; CRL-12532; probable.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 13

ST   D16S539: 12

ST   D18S51: 11,16

ST   D19S433: 11,14

ST   D21S11: 30,33.2 (CLS)

ST   D21S11: 33.2 (DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)

ST   D2S1338: 20,21

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 13

ST   FGA: 22,23

ST   Penta D: 11,14

ST   Penta E: 11

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 15,18 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)

ST   vWA: 15,19 (CLS)

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 25PACR

AC   CVCL_4Y38

RX   PubMed=25312014;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 50PACR

AC   CVCL_4Y39

RX   PubMed=25312014;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 CMV

AC   CVCL_IN16

SY   MDA Mb231 (CMV)

DR   GEO; GSM246285

DR   GEO; GSM246286

DR   GEO; GSM246287

DR   GEO; GSM246288

DR   GEO; GSM246289

DR   GEO; GSM246290

DR   GEO; GSM246267

DR   GEO; GSM246268

DR   GEO; GSM246269

DR   GEO; GSM246270

DR   GEO; GSM246271

DR   GEO; GSM246272

RX   PubMed=19321454;

CC   Characteristics: Control cell line for the MDA-MB-231 ERalpha (CVCL_IN17), MDA-MB-231 ERalpha203/4/11 (CVCL_IN15), MDA-MB-231 ERbeta (CVCL_IN18) and MDA-MB-231 ERbetaDBD (CVCL_IN19) cell lines.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 ERalpha

AC   CVCL_IN17

SY   MDA Mb231 (ERa)

DR   GEO; GSM246273

DR   GEO; GSM246274

DR   GEO; GSM246275

DR   GEO; GSM246276

DR   GEO; GSM246277

DR   GEO; GSM246278

RX   PubMed=19321454;

CC   Transfected with: HGNC; 3467; ESR1.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 ERalpha203/4/11

AC   CVCL_IN15

SY   MDA Mb231 (ERa3411)

DR   GEO; GSM246279

DR   GEO; GSM246280

DR   GEO; GSM246281

DR   GEO; GSM246282

DR   GEO; GSM246283

DR   GEO; GSM246284

RX   PubMed=19321454;

CC   Transfected with: HGNC; 3467; ESR1 (with A-203; A-204 and E-211).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 ERbeta

AC   CVCL_IN18

SY   MDA Mb231 (ERb)

DR   GEO; GSM246297

DR   GEO; GSM246298

DR   GEO; GSM246299

DR   GEO; GSM246300

DR   GEO; GSM246301

DR   GEO; GSM246302

RX   PubMed=19321454;

CC   Transfected with: HGNC; 3468; ESR2.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 ERbetaDBD

AC   CVCL_IN19

SY   MDA Mb231 (ERbDBD)

DR   GEO; GSM246303

DR   GEO; GSM246304

DR   GEO; GSM246305

DR   GEO; GSM246306

DR   GEO; GSM246307

DR   GEO; GSM246308

RX   PubMed=19321454;

CC   Transfected with: HGNC; 3468; ESR2 (ERE-binding defective).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 NucLight Green

AC   CVCL_DF47

CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 NucLight Red

AC   CVCL_DF48

CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.

CC   Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 SimpleCell O-GalNAc

AC   CVCL_S031

SY   MDA-MB-231 SimpleCell; MDA-MB-231 SC

RX   PubMed=23584533;

CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.

CC   Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231 SimpleCell O-GalNAC/O-Man

AC   CVCL_S032

RX   PubMed=24101494;

CC   Characteristics: Cell engineered to produce only truncated GalNAc, NeuAc-alpha-2-6-GalNAc and Man O-glycans.

CC   Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.

CC   Knockout cell: Method=ZFN; HGNC; 19139; POMGNT1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S031 ! MDA-MB-231 SimpleCell O-GalNAc

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-5a

AC   CVCL_9U30

SY   MDA-5a

RX   PubMed=16309168;

RX   PubMed=17129361;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-5a-D

AC   CVCL_9U31

SY   MDA-231-D

RX   PubMed=17129361;

RX   PubMed=18663362;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9U30 ! MDA-MB-231-5a

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-5a-D-TbetaFluc/Rluc

AC   CVCL_9U32

SY   MDA-231-D-TbetaFluc/Rluc; MDA-D-TbetaFluc/Rluc; 5a-D-Luc

RX   PubMed=17129361;

RX   PubMed=18663362;

RX   PubMed=26691676;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Transfected with: UniProtKB; P27652; Renilla-type luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9U31 ! MDA-MB-231-5a-D

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-5a-D-TbetaFluc/Rluc-ZsGreen

AC   CVCL_9U33

SY   5a-D-Luc-ZsGreen

RX   PubMed=26691676;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Transfected with: UniProtKB; P27652; Renilla-type luciferase.

CC   Transfected with: UniProtKB; Q9U6Y4; Zoanthus sp. chromoprotein FP538 (modified and distributed as ZsGreen1).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9U32 ! MDA-MB-231-5a-D-TbetaFluc/Rluc

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-BAG

AC   CVCL_R956

SY   MDA-MB-231 BAG

DR   BTO; BTO:0004474

RX   PubMed=1384607;

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-luc-D3H1

AC   CVCL_1D88

SY   D3H1

RX   PubMed=15987449;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: PerkinElmer; Catalog number 119261.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-luc-D3H2LN

AC   CVCL_D257

SY   D3H2LN

RX   PubMed=15987449;

WW   http://web.archive.org/web/20150202002416/http://www.perkinelmer.com/catalog/product/id/119369

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: PerkinElmer; Catalog number 119369.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D88 ! MDA-MB-231-luc-D3H1

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-luc2

AC   CVCL_D582

SY   MDA-MB-231-Luc2

DR   BTO; BTO:0005172

RX   DOI=10.1158/1538-7445.AM2013-3908;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Discontinued: PerkinElmer; Catalog number 124319.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-luc2-GFP

AC   CVCL_1D89

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Discontinued: PerkinElmer; Catalog number 128442.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D582 ! MDA-MB-231-luc2

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-luc2-LN

AC   CVCL_1D92

RX   DOI=10.1158/1538-7445.AM2013-3908;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D582 ! MDA-MB-231-luc2

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-luc2-tdTomato

AC   CVCL_1D90

SY   MDA-MB231-luc2-tdTomato

RX   DOI=10.1158/1538-7445.AM2013-3908;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: tdTomato; a bright red fluorescent protein derived from drFP583 (DsRed).

CC   Discontinued: PerkinElmer; Catalog number 125738.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D582 ! MDA-MB-231-luc2

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-luc2-tdTomato-LN

AC   CVCL_1E88

RX   DOI=10.1158/1538-7445.AM2013-3908;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: tdTomato; a bright red fluorescent protein derived from drFP583 (DsRed).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D90 ! MDA-MB-231-luc2-tdTomato

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-MEK-R

AC   CVCL_V403

DR   Cosmic; 1927243

RX   PubMed=22402123;

CC   Selected for resistance to: ChEBI; CHEBI:88249; 391210-10-9 (PD0325901).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-Red-FLuc

AC   CVCL_5J05

SY   MDA-MB231-Red-FLuc

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW124319

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-Red-FLuc-GFP

AC   CVCL_5J06

SY   MDA-MB231-Red-FLuc-GFP

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW128442

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231-tdTomato

AC   CVCL_1D91

CC   Transfected with: tdTomato; a bright red fluorescent protein derived from drFP583 (DsRed).

CC   Discontinued: PerkinElmer; Catalog number 125737.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231/B02

AC   CVCL_5T76

SY   MDA-MB-231-B02; MDA-B02; B02

DR   BTO; BTO:0004955

RX   PubMed=11697798;

RX   PubMed=18714363;

CC   Omics: Cell surface proteome.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231/PacR

AC   CVCL_4Z64

RX   CelloPub=CLPUB00286;

RX   PubMed=25275030;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231DR

AC   CVCL_4Z65

RX   PubMed=16928833;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231LLM

AC   CVCL_M354

RX   PubMed=22977471;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-231/5-FU

AC   CVCL_S511

RX   PubMed=24126575;

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-253

AC   CVCL_M384

RX   PubMed=730202;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-309

AC   CVCL_M385

RX   PubMed=730202;

RX   PubMed=833871;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-330

AC   CVCL_0619

SY   MDAMB330; MDA-330; MDA330

DR   CLO; CLO_0007635

DR   EFO; EFO_0006454

DR   ATCC; HTB-127

DR   BioSample; SAMN03473067

DR   Cosmic; 871154

DR   Cosmic; 904378

DR   Cosmic; 934537

DR   Cosmic; 979725

DR   Cosmic; 997918

DR   Cosmic; 1046956

DR   Cosmic; 1152521

DR   Cosmic; 1287917

DR   Cosmic; 1289396

DR   Cosmic; 1603219

DR   Cosmic-CLP; 1330941

DR   GDSC; 1330941

DR   GEO; GSM783951

DR   GEO; GSM1661982

DR   GEO; GSM1670081

RX   PubMed=327080;

RX   PubMed=730202;

RX   PubMed=833871;

RX   PubMed=9671407;

RX   PubMed=23601657;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Doubling time: 1.7 days (PubMed=9671407).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 9,12

ST   D18S51: 21

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 13

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 21,22

ST   Penta D: 9,14

ST   Penta E: 12,13,17

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-331

AC   CVCL_M386

RX   PubMed=730202;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-361

AC   CVCL_0620

SY   MDA-MB 361; MDA MB 361; MDA-MB361; MDAMB361; MDA-361; MDA361

DR   BTO; BTO:0001569

DR   CLO; CLO_0007636

DR   EFO; EFO_0001211

DR   CLDB; cl3406

DR   ATCC; HTB-27

DR   BCRC; 60549

DR   BioSample; SAMN03472909

DR   CCLE; MDAMB361_BREAST

DR   CCRID; 3111C0001CCC000381

DR   ChEMBL-Cells; CHEMBL3308405

DR   ChEMBL-Targets; CHEMBL614129

DR   Cosmic; 687495

DR   Cosmic; 809235

DR   Cosmic; 871147

DR   Cosmic; 904379

DR   Cosmic; 908121

DR   Cosmic; 934527

DR   Cosmic; 979709

DR   Cosmic; 997919

DR   Cosmic; 1000124

DR   Cosmic; 1010928

DR   Cosmic; 1017160

DR   Cosmic; 1018464

DR   Cosmic; 1046933

DR   Cosmic; 1047695

DR   Cosmic; 1136355

DR   Cosmic; 1176627

DR   Cosmic; 1287895

DR   Cosmic; 1289397

DR   Cosmic; 1308994

DR   Cosmic; 1348961

DR   Cosmic; 1434953

DR   Cosmic; 1523777

DR   Cosmic; 1603220

DR   Cosmic; 1609461

DR   Cosmic; 2165011

DR   Cosmic; 2301529

DR   Cosmic-CLP; 908121

DR   ECACC; 92020423

DR   GDSC; 908121

DR   GEO; GSM73751

DR   GEO; GSM115119

DR   GEO; GSM155208

DR   GEO; GSM186437

DR   GEO; GSM186438

DR   GEO; GSM186439

DR   GEO; GSM217587

DR   GEO; GSM344350

DR   GEO; GSM344400

DR   GEO; GSM350546

DR   GEO; GSM481306

DR   GEO; GSM783952

DR   GEO; GSM827280

DR   GEO; GSM847402

DR   GEO; GSM847494

DR   GEO; GSM887296

DR   GEO; GSM888371

DR   GEO; GSM1008906

DR   GEO; GSM1264070

DR   GEO; GSM1264072

DR   GEO; GSM1264112

DR   GEO; GSM1264114

DR   GEO; GSM1374653

DR   GEO; GSM1374654

DR   GEO; GSM1374655

DR   GEO; GSM1401664

DR   GEO; GSM1670082

DR   LINCS; 50331

DR   Lonza; 143

DR   NCBI_Iran; C433

RX   PubMed=730202;

RX   PubMed=833871;

RX   PubMed=6935474;

RX   PubMed=7272986;

RX   PubMed=9671407;

RX   PubMed=10862037;

RX   PubMed=11044355;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/mda-mb-361.html

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MDA-MB-361

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).

CC   Doubling time: 4.3 days (PubMed=9671407).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Brain.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 12,15

ST   D21S11: 30,32.2

ST   D3S1358: 16

ST   D5S818: 10,11

ST   D7S820: 9,12

ST   D8S1179: 15

ST   FGA: 20,24

ST   Penta D: 12,13

ST   Penta E: 8,14

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-361-Luc#1

AC   CVCL_4Y09

DR   JCRB; NIHS0718

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Brain.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0620 ! MDA-MB-361

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-390

AC   CVCL_M387

RX   PubMed=730202;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-411

AC   CVCL_M388

RX   PubMed=730202;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-415

AC   CVCL_0621

SY   MDA-MB415; MDAMB415; MDA-415; MDA415

DR   CLO; CLO_0007637

DR   EFO; EFO_0001212

DR   CLDB; cl3407

DR   CLDB; cl7127

DR   ATCC; HTB-128

DR   BioSample; SAMN03471279

DR   CCLE; MDAMB415_BREAST

DR   CCRID; 3111C0001CCC000350

DR   ChEMBL-Cells; CHEMBL3308760

DR   ChEMBL-Targets; CHEMBL1075498

DR   Cosmic; 871148

DR   Cosmic; 894088

DR   Cosmic; 897424

DR   Cosmic; 904380

DR   Cosmic; 924240

DR   Cosmic; 949190

DR   Cosmic; 1010917

DR   Cosmic; 1027054

DR   Cosmic; 1044225

DR   Cosmic; 1046928

DR   Cosmic; 1047697

DR   Cosmic; 1090334

DR   Cosmic; 1136348

DR   Cosmic; 1176650

DR   Cosmic; 1287896

DR   Cosmic; 1289398

DR   Cosmic; 1434954

DR   Cosmic; 1502207

DR   Cosmic; 1603221

DR   Cosmic; 1609460

DR   Cosmic; 2165026

DR   Cosmic; 2301530

DR   Cosmic-CLP; 924240

DR   GDSC; 924240

DR   GEO; GSM115101

DR   GEO; GSM149982

DR   GEO; GSM149990

DR   GEO; GSM149998

DR   GEO; GSM186440

DR   GEO; GSM186441

DR   GEO; GSM217588

DR   GEO; GSM344351

DR   GEO; GSM344401

DR   GEO; GSM783953

DR   GEO; GSM847415

DR   GEO; GSM847495

DR   GEO; GSM844596

DR   GEO; GSM844597

DR   GEO; GSM844598

DR   GEO; GSM844599

DR   GEO; GSM887297

DR   GEO; GSM888372

DR   GEO; GSM1008907

DR   GEO; GSM1215266

DR   GEO; GSM1374656

DR   GEO; GSM1670083

DR   ICLC; HTL02005

DR   LINCS; 50332

DR   Lonza; 1252

DR   PRIDE; PXD002486

RX   PubMed=730202;

RX   PubMed=6935474;

RX   PubMed=7272986;

RX   PubMed=12800145;

RX   PubMed=17157791;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/MDA-MB-415.html

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 13

ST   D18S51: 13

ST   D21S11: 27,28

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   D8S1179: 8,12

ST   FGA: 22

ST   Penta D: 9,10

ST   Penta E: 7,16

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-416

AC   CVCL_M389

RX   PubMed=730202;

RX   PubMed=7272986;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-431

AC   CVCL_M390

RX   PubMed=730202;

RX   PubMed=7272986;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-435

AC   CVCL_0417

SY   MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435

DR   BTO; BTO:0001567

DR   EFO; EFO_0001213

DR   MCCL; MCC:0000314

DR   ATCC; CRL-12583

DR   BioSample; SAMN03151832

DR   BioSample; SAMN03470861

DR   CCRID; 3111C0001CCC000351

DR   ChEMBL-Cells; CHEMBL3307686

DR   ChEMBL-Cells; CHEMBL3308414

DR   ChEMBL-Targets; CHEMBL614333

DR   ChEMBL-Targets; CHEMBL614697

DR   Cosmic; 687496

DR   Cosmic; 875879

DR   Cosmic; 905988

DR   Cosmic; 974069

DR   Cosmic; 974236

DR   Cosmic; 991325

DR   Cosmic; 1000131

DR   Cosmic; 1010930

DR   Cosmic; 1044219

DR   Cosmic; 1092614

DR   Cosmic; 1175834

DR   Cosmic; 1176643

DR   Cosmic; 1219445

DR   Cosmic; 1305366

DR   Cosmic; 1312349

DR   Cosmic; 1477425

DR   Cosmic; 1524346

DR   Cosmic; 1571794

DR   Cosmic; 1945861

DR   Cosmic; 1998456

DR   GEO; GSM50203

DR   GEO; GSM50265

DR   GEO; GSM206523

DR   GEO; GSM344352

DR   GEO; GSM344402

DR   GEO; GSM750814

DR   GEO; GSM783965

DR   GEO; GSM799354

DR   GEO; GSM799417

DR   GEO; GSM844589

DR   GEO; GSM844590

DR   GEO; GSM847037

DR   GEO; GSM1008908

DR   GEO; GSM1153424

DR   GEO; GSM1181294

DR   GEO; GSM1181337

DR   GEO; GSM1215267

DR   GEO; GSM1670084

DR   SKY/M-FISH/CGH; 2816

DR   TOKU-E; 3544

RX   DOI=10.1038/npjbcancer.2015.2;

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=730202;

RX   PubMed=2041050;

RX   PubMed=7272986;

RX   PubMed=11044355;

RX   PubMed=17004106;

RX   PubMed=17088437;

RX   PubMed=17157791;

RX   PubMed=19372543;

RX   PubMed=19549886;

RX   PubMed=20143388;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://dtp.cancer.gov/discovery_development/nci-60/mda-mb-435.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=51

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/mda-mb-435.htm

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

WW   https://www.ncbi.nlm.nih.gov/pubmed/25902968#cm25902968_13561

CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=17004106, PubMed=20143388). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting view that states that M14 is a breast cancer cell line.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 25.8 hours (DTP).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MDA-MB-43' in ChEMBL CHEMBL614333 and CHEMBL3308414.

CC   Discontinued: ATCC; CRL-12583; probable.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 13,17 (DOI=10.4172/2157-7145.S2-005; PubMed=19372543)

ST   D18S51: 13 (PubMed=25877200)

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 19,24

ST   D3S1358: 14

ST   D5S818: 11,12 (DOI=10.4172/2157-7145.S2-005; PubMed=19372543)

ST   D5S818: 12 (PubMed=25877200)

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 21

ST   Penta D: 9,11

ST   Penta E: 10,12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1395 ! M14

SX   Male

CA   Cancer cell line

//

ID   MDA-MB-435-BAG

AC   CVCL_R957

SY   MDA-MB-435 BAG

RX   PubMed=1384607;

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA-MB-435-LCC15

AC   CVCL_1U14

SY   LCC15-MB

RX   PubMed=9637769;

RX   PubMed=10432004;

RX   PubMed=15679051;

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative. Was first thought to originate from the femoral metastasis of a breast carcinoma but was later shown to be contaminated by MDA-MB-435 (PubMed=15679051).

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA-MB-435-Luc#1

AC   CVCL_4Y10

DR   JCRB; NIHS0719

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA-MB-435HGF

AC   CVCL_6684

SY   MDA-MB-435 HGF; MDA-MB-HGF

DR   BTO; BTO:0004164

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA-MB-435S

AC   CVCL_0622

SY   MDA-MB-435s; MDA-MB-435 S; MDA-MB-435-S; MDAMB435S

DR   BTO; BTO:0003941

DR   CLO; CLO_0007638

DR   CLDB; cl7142

DR   ATCC; HTB-129

DR   BCRJ; 0165

DR   CCLE; MDAMB435S_SKIN

DR   CCRID; 3111C0001CCC000015

DR   CCRID; 3131C0001000700036

DR   CCRID; 3142C0001000000052

DR   CLS; 300277/p513_MDA-MB-435S

DR   Cosmic; 809237

DR   Cosmic; 871155

DR   Cosmic; 894089

DR   Cosmic; 904381

DR   Cosmic; 1044202

DR   Cosmic; 1046951

DR   Cosmic; 1287922

DR   Cosmic; 1289399

DR   Cosmic; 1523969

DR   Cosmic; 1609477

DR   Cosmic; 2301531

DR   GEO; GSM149983

DR   GEO; GSM149991

DR   GEO; GSM149999

DR   GEO; GSM887298

DR   GEO; GSM888373

DR   GEO; GSM1374657

DR   ICLC; HTL03006

DR   LINCS; 50030

RX   PubMed=12661003;

RX   PubMed=15677628;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

WW   http://www.atcc.org/support/faqs/91699/ATCC%20HTB-129%20Derivative-1051.aspx

WW   http://www.atcc.org/support/faqs/79d25/Morphology%20of%20ATCC%20HTB-129-495.aspx

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).

CC   Omics: Array-based CGH.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): ATCC; CLS

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 13,17

ST   D21S11: 30

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 21

ST   Penta D: 9,11

ST   Penta E: 10,12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA-MB-435s-mKate2

AC   CVCL_5T70

RX   PubMed=25902968;

CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0622 ! MDA-MB-435S

SX   Male

CA   Cancer cell line

//

ID   MDA-MB-436

AC   CVCL_0623

SY   MDA MB 436; MDA-Mb-436; MDA-MB436; MDAMB436; MDA-436; MDA436

DR   BTO; BTO:0001568

DR   CLO; CLO_0007639

DR   EFO; EFO_0001214

DR   CLDB; cl7218

DR   ATCC; HTB-130

DR   BioSample; SAMN03471588

DR   BioSample; SAMN03472712

DR   CCLE; MDAMB436_BREAST

DR   CCRID; 3111C0001CCC000352

DR   CLS; 300278/p514_MDA-MB-436

DR   Cosmic; 809240

DR   Cosmic; 871156

DR   Cosmic; 897425

DR   Cosmic; 904382

DR   Cosmic; 934528

DR   Cosmic; 949191

DR   Cosmic; 979718

DR   Cosmic; 1010926

DR   Cosmic; 1017165

DR   Cosmic; 1027055

DR   Cosmic; 1044206

DR   Cosmic; 1044222

DR   Cosmic; 1046957

DR   Cosmic; 1071902

DR   Cosmic; 1176604

DR   Cosmic; 1287923

DR   Cosmic; 1289400

DR   Cosmic; 1309008

DR   Cosmic; 1434955

DR   Cosmic; 1609474

DR   Cosmic; 2009513

DR   Cosmic; 2164998

DR   Cosmic; 2361353

DR   Cosmic-CLP; 1240172

DR   GDSC; 1240172

DR   GEO; GSM115100

DR   GEO; GSM149985

DR   GEO; GSM149993

DR   GEO; GSM150001

DR   GEO; GSM217589

DR   GEO; GSM344354

DR   GEO; GSM344404

DR   GEO; GSM350541

DR   GEO; GSM783954

DR   GEO; GSM845397

DR   GEO; GSM847416

DR   GEO; GSM847496

DR   GEO; GSM844600

DR   GEO; GSM844601

DR   GEO; GSM887299

DR   GEO; GSM888374

DR   GEO; GSM1008909

DR   GEO; GSM1214583

DR   GEO; GSM1374658

DR   GEO; GSM1374659

DR   GEO; GSM1401656

DR   GEO; GSM1670085

DR   ICLC; HTL11005

DR   IZSLER; BS TCL 246

DR   LINCS; 50333

DR   TOKU-E; 2399

RX   PubMed=730202;

RX   PubMed=7272986;

RX   PubMed=10862037;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 9,11 (ATCC)

ST   D16S539: 9 (CLS; Cosmic-CLP; PubMed=25877200)

ST   D18S51: 12

ST   D21S11: 30,31.2

ST   D3S1358: 18

ST   D5S818: 13

ST   D7S820: 10

ST   D8S1179: 10,14

ST   FGA: 24

ST   Penta D: 9

ST   Penta E: 10,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14,20

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-453

AC   CVCL_0418

SY   MDA-MB 453; MDA MB 453; MDA-MB453; MDAMB453; MDA-453; MDA453

DR   BTO; BTO:0001908

DR   CLO; CLO_0007640

DR   CLO; CLO_0050867

DR   EFO; EFO_0001215

DR   MCCL; MCC:0000315

DR   CLDB; cl3411

DR   CLDB; cl7187

DR   ATCC; HTB-131

DR   BCRC; 60429

DR   BioSample; SAMN01821576

DR   BioSample; SAMN01821647

DR   BioSample; SAMN03472899

DR   CCLE; MDAMB453_BREAST

DR   CCRID; 3111C0001CCC000016

DR   CCRID; 3131C0001000700035

DR   ChEMBL-Cells; CHEMBL3307596

DR   ChEMBL-Targets; CHEMBL614334

DR   Cosmic; 687497

DR   Cosmic; 871157

DR   Cosmic; 897426

DR   Cosmic; 904383

DR   Cosmic; 908122

DR   Cosmic; 923060

DR   Cosmic; 934529

DR   Cosmic; 979712

DR   Cosmic; 991326

DR   Cosmic; 997920

DR   Cosmic; 1010927

DR   Cosmic; 1018468

DR   Cosmic; 1027056

DR   Cosmic; 1044223

DR   Cosmic; 1046931

DR   Cosmic; 1047694

DR   Cosmic; 1129656

DR   Cosmic; 1136356

DR   Cosmic; 1152522

DR   Cosmic; 1176651

DR   Cosmic; 1287911

DR   Cosmic; 1289401

DR   Cosmic; 1308995

DR   Cosmic; 1434956

DR   Cosmic; 1524345

DR   Cosmic; 1601924

DR   Cosmic; 1603222

DR   Cosmic; 1609457

DR   Cosmic; 2165012

DR   Cosmic; 2301532

DR   Cosmic; 2318375

DR   Cosmic; 2564832

DR   Cosmic-CLP; 908122

DR   DSMZ; ACC-65

DR   GDSC; 908122

DR   GEO; GSM813

DR   GEO; GSM115117

DR   GEO; GSM217590

DR   GEO; GSM344355

DR   GEO; GSM344405

DR   GEO; GSM350530

DR   GEO; GSM481307

DR   GEO; GSM783928

DR   GEO; GSM847417

DR   GEO; GSM844602

DR   GEO; GSM887300

DR   GEO; GSM888375

DR   GEO; GSM1008910

DR   GEO; GSM1264071

DR   GEO; GSM1264075

DR   GEO; GSM1264113

DR   GEO; GSM1264117

DR   GEO; GSM1374660

DR   GEO; GSM1374661

DR   GEO; GSM1374662

DR   GEO; GSM1401667

DR   GEO; GSM1421431

DR   GEO; GSM1664568

DR   GEO; GSM1661983

DR   GEO; GSM1670086

DR   ICLC; HTL01013

DR   IGRhCellID; MDAMB453

DR   IZSLER; BS TCL 247

DR   KCLB; 30131

DR   LINCS; 50334

DR   Lonza; 837

DR   NCBI_Iran; C214

DR   PRIDE; PXD000309

DR   RCB; RCB1192

RX   PubMed=730202;

RX   PubMed=9671407;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=21378333;

RX   PubMed=22414580;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26218769;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/MDA-MB-453.html

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MDA-MB-453

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-56.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).

CC   Doubling time: 38 hours (PubMed=25984343); ~50-60 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Metabolome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MDA-MB-345' in Cosmic 1129656.

CC   Discontinued: IZSLER; BS TCL 247; probable.

CC   Derived from metastatic site: Pericardial effusion.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 9

ST   D18S51: 15,20

ST   D21S11: 29,31

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 10,12

ST   FGA: 18,23

ST   Penta D: 9,10

ST   Penta E: 11

ST   TH01: 6

ST   TPOX: 10

ST   vWA: 17,18

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-461

AC   CVCL_M391

DR   Cosmic; 1129657

RX   PubMed=730202;

CC   Derived from metastatic site: Brain.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-468

AC   CVCL_0419

SY   MDA-MB 468; MDA-MB468; MDAMB468; MDA-468; MDA468; MB468

DR   BTO; BTO:0001570

DR   CLO; CLO_0007641

DR   EFO; EFO_0001216

DR   MCCL; MCC:0000316

DR   CLDB; cl4973

DR   ATCC; HTB-132

DR   BCRJ; 0166

DR   BioSample; SAMN03473056

DR   CCLE; MDAMB468_BREAST

DR   CCRID; 3111C0001CCC000249

DR   CCRID; 3131C0001000700120

DR   ChEMBL-Cells; CHEMBL3308424

DR   ChEMBL-Targets; CHEMBL614335

DR   CLS; 300279/NA

DR   Cosmic; 809241

DR   Cosmic; 850823

DR   Cosmic; 871149

DR   Cosmic; 877448

DR   Cosmic; 897427

DR   Cosmic; 904384

DR   Cosmic; 908123

DR   Cosmic; 923061

DR   Cosmic; 934530

DR   Cosmic; 949192

DR   Cosmic; 991327

DR   Cosmic; 997921

DR   Cosmic; 1000125

DR   Cosmic; 1010920

DR   Cosmic; 1017167

DR   Cosmic; 1018467

DR   Cosmic; 1046929

DR   Cosmic; 1044224

DR   Cosmic; 1047691

DR   Cosmic; 1136363

DR   Cosmic; 1152526

DR   Cosmic; 1176635

DR   Cosmic; 1287918

DR   Cosmic; 1289402

DR   Cosmic; 1305384

DR   Cosmic; 1309004

DR   Cosmic; 1477427

DR   Cosmic; 1523775

DR   Cosmic; 1524344

DR   Cosmic; 1571795

DR   Cosmic; 1603223

DR   Cosmic; 1609465

DR   Cosmic; 1998490

DR   Cosmic; 2009514

DR   Cosmic; 2036673

DR   Cosmic; 2164999

DR   Cosmic; 2301533

DR   Cosmic; 2318380

DR   Cosmic; 2361357

DR   Cosmic-CLP; 908123

DR   DSMZ; ACC-738

DR   GDSC; 908123

DR   GEO; GSM75169

DR   GEO; GSM185095

DR   GEO; GSM185096

DR   GEO; GSM217591

DR   GEO; GSM344356

DR   GEO; GSM344406

DR   GEO; GSM350502

DR   GEO; GSM388214

DR   GEO; GSM459714

DR   GEO; GSM459722

DR   GEO; GSM466357

DR   GEO; GSM783955

DR   GEO; GSM847418

DR   GEO; GSM847497

DR   GEO; GSM887301

DR   GEO; GSM888376

DR   GEO; GSM1008911

DR   GEO; GSM1214565

DR   GEO; GSM1374663

DR   GEO; GSM1374664

DR   GEO; GSM1374665

DR   GEO; GSM1401650

DR   GEO; GSM1556177

DR   GEO; GSM1556178

DR   GEO; GSM1556179

DR   GEO; GSM1556180

DR   GEO; GSM1556181

DR   GEO; GSM1661984

DR   GEO; GSM1670087

DR   GEO; GSM1833629

DR   ICLC; HTL99024

DR   KCB; KCB 2011114YJ

DR   LINCS; 50335

DR   Lonza; 809

DR   NCBI_Iran; C208

DR   PRIDE; PXD001680

DR   TOKU-E; 2401

DR   TOKU-E; 3604

DR   Wikidata; Q16880225

RX   PubMed=730202;

RX   PubMed=2041050;

RX   PubMed=9671407;

RX   PubMed=11414198;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=18262045;

RX   PubMed=19582160;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://en.wikipedia.org/wiki/MDA-MB-468

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/mda-mb-468.html

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MDA-MB-468

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://www.addexbio.com/productdetail?pid=4673

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-53.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 62 hours (DTP); ~30-40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=15677628; Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: CLS; 300279; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D18S51: 17

ST   D21S11: 27,28

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8

ST   D8S1179: 13

ST   FGA: 23

ST   Penta D: 8,10

ST   Penta E: 5

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-468GFP

AC   CVCL_DH83

SY   468GFP

DR   GEO; GSM390975

DR   GEO; GSM390978

RX   PubMed=16170671;

RX   PubMed=20084286;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Omics: CNV analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0419 ! MDA-MB-468

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-468LN

AC   CVCL_M372

SY   MDA-MB-468GFP-LN; 468GFP-LN; 468LN

DR   GEO; GSM390976

DR   GEO; GSM390977

RX   PubMed=16170671;

RX   PubMed=18262045;

RX   PubMed=20084286;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Omics: CNV analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH83 ! MDA-MB-468GFP

SX   Female

CA   Cancer cell line

//

ID   MDA-MB-469

AC   CVCL_M392

RX   PubMed=730202;

RX   PubMed=7272986;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-N

AC   CVCL_1910

SY   MDAN

DR   BioSample; SAMN03151833

DR   ChEMBL-Cells; CHEMBL3307532

DR   ChEMBL-Targets; CHEMBL614078

DR   Cosmic; 875880

DR   Cosmic; 1998491

DR   GEO; GSM750823

DR   GEO; GSM799355

DR   GEO; GSM799418

DR   GEO; GSM1153425

DR   GEO; GSM1181357

DR   GEO; GSM1181358

RX   PubMed=2041050;

RX   PubMed=12661003;

RX   PubMed=19372543;

RX   PubMed=20143388;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://dtp.cancer.gov/discovery_development/nci-60/mda-mb-435.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=52

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388).

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 22.5 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): PubMed=19372543

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 13,17

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 19,24

ST   D3S1358: 14

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 21

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA-Panc-28

AC   CVCL_3917

SY   MDA Panc-28; MDAPanc-28; MDAPanc28

DR   BTO; BTO:0003303

RX   PubMed=8656025;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDA-Panc-3

AC   CVCL_3918

SY   MDA Panc-3; MDAPanc-3; MDAPanc3

DR   BTO; BTO:0003302

DR   Cosmic; 710860

RX   PubMed=1688394;

RX   PubMed=11169959;

RX   PubMed=11787853;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/MDA%20Panc-3.html

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDA-PCa-2a

AC   CVCL_4747

SY   MDA PCa 2a; MDAPC2A; MDA2A

DR   ATCC; CRL-2421

DR   BioSample; SAMN03471839

DR   GEO; GSM91925

RX   PubMed=9815652;

RX   PubMed=12725112;

RX   PubMed=14518029;

RX   PubMed=15486987;

WW   http://capcelllines.ca/details.asp?id=158

CC   Omics: Array-based CGH.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2421; true.

CC   Derived from metastatic site: Bone.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4748 ! MDA-PCa-2b

SX   Male

CA   Cancer cell line

//

ID   MDA-PCa-2b

AC   CVCL_4748

SY   MDA PCa 2b; MDAPCa-2b; MDAPC2B; MDA2B

DR   BTO; BTO:0005050

DR   CLO; CLO_0007629

DR   ATCC; CRL-2422

DR   BioSample; SAMN03471841

DR   CCLE; MDAPCA2B_PROSTATE

DR   Cosmic; 1689712

DR   GEO; GSM91928

DR   GEO; GSM648821

DR   GEO; GSM887302

DR   GEO; GSM888377

RX   PubMed=9815652;

RX   PubMed=12725112;

RX   PubMed=14518029;

RX   PubMed=15486987;

RX   PubMed=22460905;

RX   PubMed=23671654;

WW   http://capcelllines.ca/details.asp?id=160

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Instable (MSI) (PubMed=23671654).

CC   Omics: Array-based CGH.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4747 ! MDA-PCa-2a

SX   Male

CA   Cancer cell line

//

ID   MDA-PCa-2b-hr

AC   CVCL_4867

SY   MDA PCa 2b-hr

RX   PubMed=14500404;

WW   http://capcelllines.ca/details.asp?id=162

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4748 ! MDA-PCa-2b

SX   Male

CA   Cancer cell line

//

ID   MDA-T32

AC   CVCL_W913

DR   Cosmic; 2054087

RX   PubMed=23833040;

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MDA-T41

AC   CVCL_W914

DR   Cosmic; 2054114

RX   PubMed=23833040;

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MDA231-DOX[r]

AC   CVCL_4V67

WW   http://www.chemoscreen.com/product/mda231-doxr-cells

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA231-LM2-4142

AC   CVCL_DG21

SY   LM2-4142

DR   GEO; GSM587389

RX   PubMed=16049480;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA231-LM2-4175

AC   CVCL_5998

SY   MDA231-LM2; LM2-4175; 4175

DR   GEO; GSM587391

RX   PubMed=16049480;

RX   PubMed=18425382;

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0062 ! MDA-MB-231

SX   Female

CA   Cancer cell line

//

ID   MDA435/LCC6

AC   CVCL_IN99

DR   BTO; BTO:0005866

RX   PubMed=8546900;

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   MDA435/LCC6MDR1

AC   CVCL_IP00

SY   MDA435/LCC6MDR

DR   BTO; BTO:0005867

RX   PubMed=8546900;

CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: HGNC; 40; ABCB1.

CC   Derived from metastatic site: Subcutaneous; right buttock.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_IN99 ! MDA435/LCC6

SX   Male

CA   Cancer cell line

//


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 52-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。